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SUMMARY
Aromatic compounds are made via the shikimate pathway. 
The N.crassa pentafunctional arom enzyme has five shikimate 
pathway activities on one polypeptide whereas in E.coli 
all seven activities are separate enzymes. It has been 
hypothesised that arom arose by the fusion of genes for 
monofunctional enzymes. To test this proposal requires 
comparison of the sequences of arom and its monofunctional 
counterparts. Towards this future goal the author set 
out to sequence the E.coli aroE gene encoding shikimate 
dehydrogenas e ("E3”)•
AroE was cloned from the previously isolated transducing 
phage \ spcl by selection in an aroE” auxotroph. The E3 
overexpressed by strains carrying these clones is identical 
to wild-type E3 by native and SDS PAGE. A protocol was 
developed which permits the renaturation of E3 after 
SDS PAGE.
A 1.82 kbp region of DNA containing aroE was sequenced 
on both strands by the M13/dideoxy method. The open 
reading frame (ORF) corresponding to aroE was initially 
identified by size and by further subcloning.
A high level of E3 overproduction was obtained by 
placing the aroE gene in an expression vector. This gave 
E3 specific activities more than 3 00 times higher than in 
wild-type cells.
Overproduced E3 was purified to homogeneity using a 
previously developed method. 20g (wet weight) of cells 
yielded 10 mg of E3«
The E3 amino acid sequence deduced from the DNA 
sequence was confirmed by N-terminal amino acid sequencing 
and amino acid analysis of the overproduced E3*
Vithin the 1.82 kbp of DNA sequenced on both strands, 
together with the adjacent 0.6 kbp sequenced on only one 
strand, two large 0RFfs were found in addition to aroE 
("UPSORF 1M and "UPSORF 2”). Biased codon utilisation 
and Fickett analysis hinted that UPSORF*s 1 and 2 might 
be genes, as might be a truncated ORF ("UPSORF 3?”) at 
the end of the single strand sequence. It remains to be 
seen if these UPSORF*s encode proteins.
Strong indirect evidence that UPSORF 2 encodes a 
protein comes from its predicted amino acid sequence 
(180 a.a.*s) which contains four internal homologous 
sub-regions, suggesting internal gene duplication. In 
particular, each sub-region has two pairs of cysteine 
residues. Preliminary sequence comparisons indicate the 
possibility of very weak homologies between UPSORF 2 and 
some iron-sulphur proteins.
Truncation of sequences kbp and ^0.8 kbp
upstream from the 3* end of aroE may be the cause of the 
observed 4-3 fold and 20-23 fold reductions (respectively) 
in E3 specific activity with some of the smaller aroE 
subclones (relative to the larger subclones). This may be 
indirect evidence that aroE is part of a "mixed" operon, 
with UPSORF’s 1, 2, and 3, analogous to that found for aro_A.
CHAPTER 1 INTRODUCTION
PART A - GENERAL INTRODUCTION
1.0 The problem
The reader, like the author and all other animals, 
cannot make aromatic compounds de novo. The work described 
in this thesis was not provoked by envy of plants, bacteria, 
and other microorganisms - all of which are equipped for the 
biosynthesis of aromatics - but rather by the striking 
differences between these organisms in the exercise of their 
synthetic abilities.
All aromatic compounds are made from the common precursor 
chorismate (reviewed by Haslam, 1974; Weiss and Edwards, 1980; 
Herrmann, 1 9 8 3). The route to chorismate, which is known as 
the shikimate pathway or common (aromatic) pathway, is the 
same in all species so far studied and is shown in Figure 1.1. 
It is in the organisation of the enzyme activities which 
catalyse the seven universal reactions of the pathway that 
one sees great differences between species.
In the bacterium Escherichia coli (E.coli) all seven 
common pathway activities are separate enzymes (Berlyn and 
Giles, 1 9 6 9) encoded by widely scattered genes (Pittard and 
Wallace, 1 9 6 6 ). In contrast, in the fungus Neurospora crassa 
(N.crassa) five of the seven common pathway activities occur 
as a multifunctional protein - the arom multifunctional 
enzyme - consisting of two identical pentafunctional poly-
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Figure 1.1 The shikimate pathway 
Abbreviations used:
EO DAHP synthase EC 4.1.2.15
El DHQ synthase EC 4.6.1.3
E2 dehydroquinase EC 4.2.1.10
E3 shikimate dehydrogenase EC 1.1.1.25
E4 shikimate kinase EC 2*7»1»71
E5 EPSP synthase EC 2.5-1*19






Dpeptide subunits encoded by a single gene (Lumsden and 
Coggins, 1977, 1978; Gaertner and Cole, 1977; Giles e_t al. . 
1 9 6 7a). This system thus provides a stark example of* a 
phenomenon which is not well understood. For instance, why 
should a particular pathway involve multifunctional proteins 
in some species but not in others? Within one species, why 
are some functions handled by multifunctional proteins and 
not others? Such questions, and ramifications thereof, 
provided the main stimulus to the work described here. The 
shikimate pathway is also interesting in itself both for 
pure and applied reasons.
1.1 Format of the introduction
There follows a brief survey of various facets of the 
shikimate pathway. Attention is given to the organisation 
of the pathway in different species. The known properties of 
individual enzymes are summarised and progress made in their 
purification, and in cloning the corresponding genes, is 
described.
The latter part of the general introduction considers 
multifunctional proteins and the many questions they raise.
A more detailed description of the arom multifunctional 
enzyme will be given here.
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Figure 1«2 The utilisation of* chorismate
1. 2 Elucidation of the pathway
The deduction of the sequence of intermediates in the 
shikimate pathway was a long and intricate process in which 
key roles were played by the groups of B.D. Davis and D.B. 
Sprinson. Some of the decisive events are described below.
Davis (l95l), using the then newly invented technique 
of penicillin enrichment, was the first to isolate auxotrophic 
mutants of E.coli which required supplementation with more 
than one aromatic end-product for growth. He demonstrated 
the central role of shikimate in the pathway. In a similar 
"way, 3-dehydroquinate (DHQ) and 3-dehydroshikimate (DHS) 
were shown to be earlier precursors of shikimate (Davis and 
Weiss, 1953)*
The enzymatic formation of 5-enolpyruvylshikimate-3- 
phosphate (EPSP) from shikimate-3-phosphate was demonstrated 
by Levin and Sprinson (1 9 6 4) who also showed that there was 
a common pathway intermediate after EPSP and guessed correctly 
that it was chorismate (Levin and Sprinson, 1964; and 
references therein)•
ill Utilisation of chorismate
Many pathways diverge from chorismate to give the end- 
products of aromatic biosynthesis and these are shown in 
Figure 1.2. There may be some minor end-products which are 
as yet undiscovered. The major end-products are the three 
aromatic amino acids phenylalanine, tyrosine, and tryptophan 
and the pathways to these are shown in Figure 1.3 (Umbarger, 
1978). Phenylalanine is the precursor of lignins which are
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some of the major structural polymers of wood tissue - one 
of the more abundant materials in the biosphere.
1.4 Organisation of the shikimate pathway in fungi
1.4.1 The arom multifunctional enzyme of N.crassa
1.4.1A Early genetic studies in N.crassa
Mutants of N.crassa which require all three aromatic 
amino acids as growth factors are known as arom mutants.
They are defective in one or more enzyme activities of the 
common pathway and can be grouped into different classes by, 
for example, enzyme assays or by genetic complementation 
tests in heterokaryons.
Gross and Fein (i9 6 0 ) reported that arom mutations in 
at least three distinct complementation groups all mapped 
in a cluster on linkage group II of N. crassa. This work was 
extended by Giles et al. (1 9 6 7a). Five distinct complementation 
groups of arom mutations all mapped in a very tight cluster 
at the "arom region”. Each of these complementation groups 
is associated with the loss of one of the activities for 
steps 2 through 6 of the shikimate pathway (activities El, E2, 
E3, E4 and E5; see Figure l.l). Fine structure genetic mapping 
revealed that the five classes of simple mutations map in 
five discrete non-overlapping subregions of the arom cluster.
As well as mutations associated with the loss of only one
activity other mutations were found causing the loss of 
two or more activities. These pleiotropic mutations map 
within the arom region and their complementation map shows 
a clear polarity (hence, "polarity mutants") implying that 
the arom cluster is transcribed as a single unit.
It was also discovered that the five activities which 
mapped to the arom locus all cosedimented rapidly during 
sucrose density gradient centrifugation, suggesting that the 
five activities were associated in a multienzyme complex 
(Giles ejb al. , 1 9 6 7a).
1.4.133 Purification of the N.crassa arom complex to homogeneity 
Early attempts at purification did not immediately 
conflict with the idea of a multienzyme complex but gave 
confusing results (Burgoyne e_t al•, 1 9 6 9)* Only with the 
advent of a new purification procedure, which took full 
precautions against endogenous proteases, did it become clear 
that the arom complex consisted of two identical 165 kDa 
pent afunctional subunits and was thus a multifunctional enzyme 
(Lumsden and Coggins, 1977? 1978; Gaertner and Cole, 1977)* 
Although the genetic data of Giles e_t al. (1 9 6 7a) were 
originally interpreted in terms of separate genes these 
results are very useful when reinterpreted in terms of a 
multifunctional polypeptide. These data will be considered 
again in the section on arom structure.
1.4.2 Separability of the shikimate pathway enzymes In other
fungi
Ahmed and Giles (1 9 6 9) investigated the separability of 





(Ascomycetes, like N.crassa) Aspergillus nidulans (A.nidulans) 
(Basidiomycetes) Coprinus lagopus
Ustilago maydis
The activities which cosediment in extracts of N.crassa - El, 
E2, E3, E4, and E5 - also sediment together on sucrose density 
gradients in extracts of all these six species of fungi.
The sedimentation coefficients are all similar and comparable 
with that observed in the case of N.crassa.
At least three of the same five "arom" activities (El, E2, 
and E3) in the budding yeast Saccharomyces cerevisiae 
(S.cerevisiae) also cosediment in sucrose gradients, with a 
sedimentation coefficient like that of the N.crassa arom 
complex (De Leeuw, 1 9 6 7)*
None of the above "aggregates" have been purified to 
homogeneity so it is not known whether they constitute penta- 
functional enzymes, as in N.crassa. or multienzyme complexes. 
However, other evidence (discussed below) suggests that at 
least in budding yeast the complex is a multifunctional 
protein.
1.4.3 Genetic organisation of the shikimate pathway in other
fungi and cloning of arom loci
1.4.3A A.nidulans
t
The molecular cloning of a subset of the A.nidulans arom 
locus (which is very similar, if not identical, to that in 
N.crassa) has been reported (Kinghorn and Hawkins, 1 9 8 2 ).
Their recombinant plasmid was isolated by selecting for relief 
of auxotrophy in an aroD" E.coli strain defective for dehydro- 
quinase (E2) activity, an approach which has been successful 
for a number of lower eukaryotic genes. The interpretation 
of this work is complicated by the existence in N. crassa and
A.nidulans of a second, inducible, catabolic dehydroquinase 
activity (see Section 1.8.4B) which is heat-stable unlike the 
constitutive arom dehydroquinase activity. The gene for the 
N.crassa catabolic dehydroquinase (qa-2) was originally cloned 
by relief of auxotrophy in an aroD~ E. coli mutant (Vapnek ejb al. .
1977) so that the selection procedure used by Kinghorn and 
Hawkins (1 9 8 2) could lead to the isolation not only of an arom 
clone but also a catabolic E2 clone. Unfortunately the criteria 
used to identify the particular A.nidulans recombinant obtained 
were both negative' - the E2 activity produced was not heat- 
stable and did not react with antibodies which recognise
A.nidulans catabolic dehydroquinase. Since the location of 
the cloned gene relative to the insert is unknown, and since 
slight truncation of a catabolic E2 gene could lead to loss 
of heat stability and loss of the relevant epitopes, there is
II
slight doubt whether part of the A.nidulans arom locus has 
actually been cloned. However, from the restriction map 
their clone definitely does not contain the E.coli aroD+ gene 
(Kinghorn e_t al. , 1981).
1.4.3B N.crassa
A preliminary report has been published of the cloning of 
that portion of the N.crassa arom gene which specifies the 
biosynthetic dehydroquinase activity (Catcheside and Storer,
1984).
1.4.3C S.cerevisiae
In the budding yeast S.cerevisiae a complex locus 
specifying shikimate pathway activities was identified by De 
Leeuw (1 9 6 7)* He found four complementation groups in a 
preliminary study, each corresponding to a deficiency in one 
of the common pathway activities El, E3, E4, and E5» Mutations 
in all four complementation groups are closely linked in a 
cluster, the "arom-l locus”, as in N.crassa. The finding of 
various classes of polarity mutant which affect two, three, 
or four activities, and which can be arranged in a unique 
linear order, is also very reminiscent of the situation in 
N.crassa. Furthermore, completely noncomplementing mutants 
were isolated and found to lack E2 activity in addition to 
the other four activities.
From the above evidence and the cosedimentation data it 
appears likely that S.cerevisiae might possess a pentafunctional
Y \ .  '■
arom polypeptide. Further support for this idea comes from 
the cloning of the S.cerevisiae arom-1 locus, also called 
the "AR01 cluster gene" (Larimer et al., 1 9 8 3)* The AR01 
clone was isolated selectively by its ability to complement 
an appropriate yeast mutant. The insert fragment from the 
original recombinant plasmid was subcloned to yield a 6.2 kbp 
fragment which still retained full complementation activity.
Since the N.crassa arom polypeptide contains about 1500 amino 
acid residues (Lumsden and Coggins, 1978) it is rather unlikely 
that the 6.2 kbp fragment contains five separate genes.
Moreover, when present as an episome in yeast cells the cloned 
locus results not only in the overexpression of all five 
activities but also of an unidentified polypeptide identical 
in size (by SDS PAGE) to N.crassa arom.
The 6.2 kbp fragment carrying AR01 is present being 
sequenced in this laboratory (K. Duncan, unpublished work) 
and the results are eagerly awaited.
1. 4.3D Schizosaccharomryces pombe
In the fission yeast Schizosaccharomyces pombe (S.pombe). 
which is only distantly related to the budding yeast S.cerevisiae, 
there is a complex locus aro3 containing five genetically 
defined subregions A-E, in that linear order (Strauss, 1979)*
These subregions all apparently affect shikimate pathway 
enzymes, from the growth factor requirements of aro3 alleles, 
but a specific biochemical defect has only been assigned to 
mutations in three of them - A: El , C: E4 , E: E3 • From
the polarity of the complementation patterns characterising 
the nonsense aro3 alleles it was inferred that the direction 
of transcription of the aro3 locus, whether it encoded a 
multifunctional protein or a polycistronic mRNA for several 
proteins, is from subregion A to E. This implies that the 
order and spacing of the three assigned activities within the 
aro3 locus is the same as that in the N.crassa arom locus 
(3*-El, E5, E4, E2, E3-31; see Section 1.10) but this does 
not provide evidence that aro3 encodes a multifunctional 
polypeptide. However, the aro3 locus clearly resembles the 
N.crassa arom locus very closely at the genetic level.
Most, if not all, of the aro3 locus of S.pombe has been 
isolated as a set of overlapping cloned DNA fragments by 
Nakanishi and Yamamoto (1984). They also demonstrated that 
E2 is encoded by aro3 and probably by subregion D, thus 
extending the analogy with N.crassa arom. They discovered that 
the whole locus is represented by a single 4.5 kb mRNA 
transcript. Although it seems likely that aro3 encodes a 
pentafunctional polypeptide the aggregation state of the 
shikimate pathway enzymes has never been scrutinised in this 
species. Also, it has yet to be established that E5 is 
encoded by aro3«
iii Organisation of the shikimate pathway in bacteria
1.5* 1 Separability of the shikimate pathway enzymes in bacteria
The five common pathway activities E1-E5 sediment 
independently during sucrose density gradient centrifugation
of* extracts from the following six species of bacteria:
E.coli. Salmonella typhimurium (S.typhimurium). Aerobacter 
aerogenes, Bacillus subtilis (B.subtilis). Pseudomonas 
aeruginosa, and Streptomyces coelicolor (Berlyn and Giles, 
1 9 6 9)* Two peaks of shikimate kinase activity were identified 
in E.coli and S.typhimurium.
Although it is clear that these bacteria do not contain 
multifunctional arom enzymes (or subsets thereof) or stable 
multienzyme complexes it would perhaps be premature to discard 
the possibility that some of them might contain weakly bound 
multienzyme complexes that do not survive normal extraction 
procedures (Fulton, 1 9 8 2).
1.5« 2 Genetic organisation of the shikimate pathway in E.coli
The common pathway enzymes in E.coli are encoded by 
widely scattered genes (Pittard and Wallace, 1966 ; Bachmann, 
1 9 8 3 ). The distribution of the genes is shown in Figure 1.4 
and a very similar distribution is seen in S.typhimurium 
(Gollub ei; al., 1 9 6 7 )* There are no operons which contain 
more than one shikimate pathway gene.
The failure to isolate multiple aromatic auxotrophs of 
E. coli defective for shikimate kinase, together with the 
finding of two distinct shikimate kinase activities in E.coli 
(Berlyn and Giles, 1 9 6 9), suggested that there are (at least) 
two E4 genes in this species. This appears to be the case 







Gene Map position (min) Enzyme encoded
aroF 56 EO(Tyr) DAHP synthase (Tyr
sensitive)
aroG 17 EO(Phe) DAHP synthase (Phe
sensitive)
aroH 37 EO(Trp) DAHP synthase (Trp
sensitive)
aroB 74 El DHQ synthase
aroD 37 E2 dehydroquinase
aroE 72 E3 shikimate dehydrogenase
aroA 20 E 5 EPSP synthase
aroC 30 e 6 chorismate synthase
Figure 1.4 Positions of genes for shikimate pathway enzymes 
on the E.coli chromosome
strains with mutations defining aroL, the structural gene 
for the isozyme E4ll. The aroL gene maps at about 9 minutes 
on the E.coli chromosome (Ely and Pittard, 1979)* The 
location of the gene for the E4l isozyme is a mystery.
Although at least one gene is known for every shikimate 
pathway enzyme in E.coli there is another gene, arol. defined 
by a temperature-sensitive mutant which requires phenylalanine, 
tyrosine, and tryptophan for growth at 42°C (Gibson and Pittard, 
1 9 6 8). The arol gene maps at 84 minutes on the E.coli chromosome 
and its function is unknown. M. Boocock has suggested (personal 
communication) that it might encode a diaphorase subunit for 
the chorismate synthase activity (see Section 1.8.8).
The purification and properties of individual E.coli 
shikimate pathway enzymes and the cloning of their genes will 
be considered in Section 1.8.
1.6 Organisation of the shikimate pathway in photosynthetic 
organisms
1.6.1 Separability of the shikimate pathway enzymes in 
photosynthetic organisms 
Berlyn ej; al. (1970) studied whether the enzyme activities 
E1-E5, from the photosynthetic organisms listed below, could 
be separated on sucrose density gradients:
Anabaena variabilis (prokaryotic blue-green algae) 
Chlamydomonas reinhardi (unicellular green flagellate)
Buglena gracilis (unicellular green flagellate)
Physcomitrella patens (P.patens; moss - a lower plant) 
Nicotiana tabacum (higher plant)
In Anabaena all five activities were separable, as in other 
prokaryotes. In Euglena all five activities cosediment as a 
large aggregate. In the other three species E2 and E3 co­
sediment but El, E4, and E5 are quite separate.
The complex of the five activities in Euglena was 
subsequently purified 2000-fold (Patel and Giles, 1979)•
Its native m.w. appears to be slightly less than that of 
N.crassa arom and it is still not known whether this is a 
multifunctional enzyme or a multi-enzyme complex or a 
combination of both.
Boudet and Lecussan (197^0 examined the separability of 
E2 and E3 (they did not look at other activities) in a variety 
of higher plants including Zea mays. Pisum sativum, Phaseolus 
vulgaris, and Triticum sativum. They used a range of enzyme 
purification techniques and in all cases E2 and E3 copurified.
Koshiba (1979) showed that in Phaseolus mungo (mung beans) 
El, E4, and E5 are all separable by ion-exchange chromatography 
and gel filtration but E2 and E3 are not.
1.6.2 Purification of multifunctional shikimate pathway 
enzymes from plants 
It appears that in many plants E2 and E3 are associated 
in some way. The manner of this association was first 
established in the moss P.patens. From this lower plant 
Polley (1978) purified to homogeneity a monomeric bifunctional 
polypeptide having both E2 and E3 activities which copurified 
in constant ratio. The molecular weight of this bifunctional
protein is 48 kDa as estimated by SDS PAGE.
In the higher plant P.sativum (peas) the E2, E3 complex 
has been purified to homogeneity and is a monomeric bifunctional 
enzyme of m.w. 60 kDa (M.S. Campbell, unpublished work).
The purification and properties of various monofunctional 
plant enzymes from the shikimate pathway will be described 
in Section 1.8.
1.6.3 Genetic organisation of the shikimate pathway in plants 
Almost nothing is known about this aspect. In the 
Triticinae the structural genes for the two isozymic forms 
of E3 activity are located on the nuclear chromosomes (Koebner 
and Shepherd, 1 9 8 2) thus dashing hopes that they might have 
been conveniently "packaged” in the chloroplast genome to the 
advantage of gene cloners.
1.7 Organisation of the five "arom” activities in fungi, 
bacteria, and photosynthetic organisms - a summary 
Only a small sample of species from the three groups - 
fungi, bacteria, and photosynthetic organisms - has been 
looked at, and only in a few cases has there been detailed 
characterisation of some of the shikimate pathway enzymes. 
However, bearing these points in mind, there is a clear trend 
in the results. The five activities found in the N.crassa 
arom enzyme are also associated in other fungi and at least 
in S.cerevisiae there is strong circumstantial evidence for 
an arom-like enzyme. In bacteria and blue-green algae the
same five activities are all separate enzymes, whereas in 
plants and Chiamydomonas reinhardi - but not in Englena which 
in this resembles the fungi more closely - only E2 and E3 
are associated, probably as a bifunctional enzyme as has been 
demonstrated in two cases.
1.8 A survey of the seven shikimate pathway catalytic 
activities
1.8.1 Preliminary remarks
This section considers the individual reactions of the 
shikimate pathway. Work on the purification of monofunctional 
shikimate pathway enzymes and the cloning of their genes will 
also be described here. Attention will be drawn to the general’ 
similarities between particular activities whether they occur 
in mono- or multifunctional enzymes, a feature of relevance 
to later discussion, and the practical importance of studies 
on the pathway will become apparent.
1.8.2 DAHP synthase (EO) and the regulation of the common 
pathway
This area has been well reviewed by Herrmann (1983)* In 
E. coli carbon flow through the common pathway is regulated at 
the first step but chorismate, the immediate end-product, is 
not a feedback inhibitor in this species. E.coli possesses 
three DAHP synthase (EO) isozymes each sensitive to feedback 
inhibition (and repression) by one of the end-products of the
major terminal pathways - phenylalanine, tyrosine and 
tryptophan (Doy and Brown, 1 9 6 5 )* These isozymes are 
designated EO(Phe), EO(Tyr), and EO(Trp) and have all been 
purified to homogeneity (Herrmann, 1 9 8 3)* El, E2, E3, E4l,
E5, and E6 are all constitutively expressed and they are
not regulated at the protein level by any of the three aromatic
amino acids, nor by chorismate or DAHP (Tribe al., 1976).
The aroL gene, encoding the second shikimate kinase isozyme 
E4ll, possibly represents a second point of control since its 
expression is affected by the tyrR locus (Ely and Pittard,
1979).
The aroF gene for EO(Tyr) has been cloned (Zurawski ejfc al.
1978) and sequenced (Shultz jet al. , 1984). Davies and Davidson 
(1 9 8 2) cloned and sequenced the aroG gene for EO(Phe).
Similarly, the EO(Trp) gene, aroH, has been cloned and 
sequenced (Zurawski ejfc al., 1981).
In addition to being regulated by feedback inhibition 
at the enzyme level the DAHP synthase activities in E.coli 
are also regulated at the transcriptional level by feedback 
repression (Umbarger, 1978; Herrmann, 1 9 8 3)* The expression 
of aroG is controlled by the levels of phenylalanine and 
tryptophan which act via the tyrR gene product. The expression 
of the "tyr” operon, which includes aroF, is regulated by the 
levels of tyrosine (and possibly of phenylalanine), also via 
the tyrR protein. The level of tryptophan controls the 
transcription of aroH via the trp repressor. Attenuation
has been ruled out as an additional form of control for
aroG and aroH but not completely for aroF.
13From C nuclear magnetic resonance studies on whole 
E. coli cells it appears that feedback inhibition is quantitatively 
the major regulatory mechanism for the shikimate pathway 
(Ogino al. , 1 9 8 2).
N.crassa. like E.coli has three DAHP synthase isozymes 
that are each inhibited by one of the three aromatic amino 
acids. The N.crassa tryptophan-sensitive EO has been purified 
to homogeneity (Nimmo and Coggins, 1981).
B.subtilis has only a single DAHP synthase. It has been 
purified to homogeneity from strain 168 in which EO and 
chorismate mutase form a bifunctional enzyme which in turn 
is part of a complex that includes noncovalently bound shikimate 
kinase (Herrmann, 1 9 8 3)* Tbe EO is insensitive to inhibition 
by aromatic amino acids but is inhibited by chorismate and 
prephenate. There is evidence that the bifunctional E0- 
chorismate mutase arose from a monofunctional EO during 
mutagenesis of the wild-type Marburg strain of B.subtilis 
(Llewellyn e^t al. , 1 9 8 0). It appears that in strain 168 the 
wild-type gene for chorismate mutase has been lost and its 
function replaced inefficiently by a mutated prephenate 
aliosteric binding site of the original EO.
1.8.3 DHQ synthase (El)
The E.coli aroB gene, which encodes DHQ synthase, has 
been cloned (Duncan and Coggins, 1 9 8 3 )* Subsequently, other 
workers placed aroB in the expression vector pKK2 2 3 -3 (see 
Section 4.2.2) giving a strain which overproduces DHQ synthase 
1000-fold, thus facilitating the purification of this enzyme 
to homogeneity (Frost et al•, 1984). 50$ pure El was also
obtained from wild-type E.coli and the major band on SDS PAGE 
of this material corresponded exactly to the pure over­
expressed El (Frost et al., 1984). The specific activity of 
the overproduced El is twelve times greater than that observed 
previously for "pure” E.coli El by Maitra and Sprinson (1978). 
Frost at al. (1984) found El to be a monomer of 40 kDa whereas 
Maitra and Sprinson (1978) estimated the subunit m.w. to be 
57 kDa. These serious discrepancies must cast considerable 
doubt on the earlier work of Maitra and Sprinson. However,
the observations (Maitra and Sprinson, 1978) that E.coli El
2+ + requires Co and catalytic NAD for full activity are not
in dispute.
The aroB gene has been sequenced in this laboratory and 
confirmation obtained by N-terminal amino acid sequencing 
and determination of the amino acid composition of the over­
produced polypeptide (G. Millar, unpublished results). The 
sequence predicts a m.w. of 39 kDa for the El protein.
DHQ synthase has been purified to homogeneity from
B.subtilis where it is part of a multienzyme complex with
chorismate synthase and the associated flavin reductase
(Hasan and Nester, 1978b; see Section 1.8.8). The m.w.
of the El subunit is 17 kDa and, like the E.coli enzyme, it
/ 2+ 2+\requires a divalent transition metal cation (Co or Mn ) 
and catalytic quantities of NAD .
Yamamoto (1 9 8 0) purified the El from mung beans to
•f*
homogeneity. It too requires NAD and a divalent transition 
metal cation.
The DHQ synthase activity of the N.crassa arom multi-
+ 2+functional enzyme requires catalytic NAD and Zn for 
activity thus resembling the monofunctional El1s described 
above (Lambert jet al •, 1 9 8 5)*
1.8.4 Dehydroquinase (E2)
1.8.4 A Biosynthetic dehydroquinases
The monofunctional E.coli dehydroquinase has been 
purified to homogeneity from wild-type K12 cells (S. Chaudhuri 
and J.R. Coggins, submitted to Biochem. J.). It is a dimer 
and the subunit m.w. deduced from the DNA sequence (see below) 
is 28 kDa. The enzyme can be inhibited by treatment with 
borohydride in the presence of substrate which strongly suggest 
that a Schiff*s base intermediate is formed between an active 
site lysine residue and the carbonyl group of the substrate. 
This is known to be a feature of two other dehydroquinases 
described below.
The E. coli aroD gene which encodes E2 was originally 
cloned by Kinghorn <et al. (1 9 8 1). It was later subcloned 
and sequenced by Duncan (1 9 8 5)* The sequence has been 
confirmed by purification of the overproduced polypeptide 
(S. Chaudhuri, unpublished work) and determination of the 
amino acid composition and the N-terminal amino acid sequence 
(M.S. Campbell, unpublished results).
Little is known about the E2 activities of the purified 
bifunctional plant E2, E3 enzymes.
Like the E.coli E2, the dehydroquinase activity of 
N.crassa arom can be specifically inhibited by treatment with 
sodium borohydride in the presence of substrate, again implying 
a Schiff's base intermediate (Smith and Coggins, 1 9 8 3 )* This 
"substrate trapping” has been exploited to radiolabel (using 
tritiated borohydride), isolate, and sequence an active site 
peptide which contains the essential lysine residue of arom 
E2 (S. Chaudhuri and J.R. Coggins, submitted to Biochem. J.).
1.8.4B Catabolic dehydroquinases
The arom E2 is not the only dehydroquinase activity in 
N.crassa. There is also an inducible, catabolic dehydroquinase 
- the qa-2 gene product - which forms part of a degradative 
pathway for the utilisation of quinate (Giles ejfc al.. 1 9 6 7b; 
Chaleff, 1974). N.crassa can grow on the plant product quinate 
as sole carbon source and shikimate can be used similarly.
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of the pathway are all separate monofunctional activities. 
However, the separate genes all lie together in the ”qa 
cluster” and they are coordinately expressed as monocistronic 
transcripts. Induction by substrates is mediated by the qa-1 
gene products. The whole cja cluster has been cloned (Schweizer 
et al., 198l) and this system is now an important model for 
transcriptional regulation in eukaryotes (e.g. Huiet, 1984).
The catabolic dehydroquinase has been purified to 
homogeneity (S. Chaudhuri and J.R. Coggins, submitted to 
Biochem. J; Chaudhuri and Coggins, 198l). Early attempts at 
purification yielded material which was proteolytically 
degraded (Hautala et al*, 1975)* The enzyme appears to be 
a dodecamer of 20 kDa subunits and, like other E2*s, is 
inhibited by borohydride in the presence of substrate 
(Chaudhuri and Coggins, 198l). The amino acid sequence has 
been revealed by the sequence of the qa-2 gene (Alton ejfc al., 
1982; M.E. Case, personal communication) and there is no 
readily detectable homology at the protein level between the 
E. coli aroD sequence and the N .crassa qa-2 sequence (Duncan,
1985).
In corn seedlings there are two E2 activities, one 
associated with a shikimate dehydrogenase and the other with 
a quinate dehydrogenase (Graziana at al*=, 1980). It is 
possible that these are both bifunctional enzymes and that 
the second E2 plays a catabolic roie.
1» 8.5 Shikimate dehydrogenase (B3)
1 * 8.5A E.coli shikimate dehydrogenase
Shikimate dehydrogenase (dehydroshikimate reductase; 
shikimate:NADP+ oxidoreductase; E3) catalyses the NADPH-1inked 
reduction of 3-dehydroshikimate. This reaction was first 
detected in partially purified extracts of E.coli (Yaniv and 
Gilvarg, 1935)* The K !eq in the direction of shikimate is 
about 28 at pH 7*0» Quinate is not a significant substrate 
for E.coli E3 nor can NAD+ be substituted as cofactor. E.coli 
E3 transfers the hydrogen atom from the A side of the reduced
nicotinamide ring (Dansette and Azerad, 197^ -) •
The only monofunctional biosynthetic shikimate dehydrogenase 
which has been purified to homogeneity is that from E.coli 
(Chaudhuri and Coggins, 1 9 8 5)* The purification factor 
required was 20,000 fold. It is a monomer of m.w. 29 kDa.
There are very few examples known of monomeric NAD(P) +-linked 
dehydrogenases. NADP+-linked dihydrofolate reductase from 
a variety of species is monomeric (Volz erfc al., 1 9 8 2 ) as is 
the catabolic NAD+-lihked quinate/shikimate dehydrogenase of 
N.crassa (Barea and Giles, 1978; see below).
The E.coli aroE gene, which encodes E3, has been cloned
and sequenced (Anton and Coggins, 1 9 8 3 ; this study) and the 
DNA sequence has been confirmed by analysis of the overproduced 
polypeptide (this study).
1.8.5B The catabolic quinate/shikimate dehydrogenase of N.crassa
The inducible, catabolic quinate/shikimate dehydrogenase
of N.crassa has been purified to homogeneity (Barea and Giles,
1978; see Figure 1.5)• It is the product of the qa-3
gene (Chaleff, 197^) and is a monomer. Its activities as a
shikimate dehydrogenas’e and as a quinate dehydrogenase are of
+ +similar magnitude, and it has a preference for NAD over NADP 
as cofactor, unlike all known biosynthetic E3's. There is 
almost certainly only a single active site from inhibition 
studies (Barea and Giles, 1978) and from genetic evidence 
(Chaleff, 1974). The qa-3 gene has been sequenced and predicts 
a m.w. of 33 kDa for the gene product (Alton et al., 1982;
M.E. Case, personal communication). The question of possible 
homologies between qa-3 and aroE will be discussed in Chapter 
Five.
1.8.5C Plant shikimate dehydrogenases
The association between E2 and E3 in higher plants has 
been described in Section 1.6.1 and the purification to 
homogeneity of two bifunctional plant E2, E3 enzymes was 
outlined in Section 1.6.2.
Balinsky ejt al. (l97l) and Dowsett et al. (l97l) carried 
out detailed kinetic studies on the partially purified E3 
from peas. It appears to have an ordered sequential mechanism 
in which NADP+ or NADPH binds first to the enzyme. The enzyme 
from peas, like that from E.coli. shows A-stereospecificity
for hydrogen transfer (Davies £t al•, 1972). There have 
been unsuccessful attempts to use analogues of dehydroshikimat 
as herbicides (Baillie _et al., 1972).
1.8.6 Shikimate kinase (e 4)
The existence of at least two isozymes of E.coli E4 was 
discussed in Section 1.3*2. Both forms appear to have native 
molecular weights of about 20 kDa (Ely and Pittard, 1979)*
The aroL gene encoding E4II has recently been cloned and 
sequenced. The overexpressed polypeptide has been purified 
to homogeneity and the sequence confirmed by determination of 
the amino acid composition and the N—terminal amino acid 
sequence (G. Millar, A. Lewendon, M. Hunter, and J.R. Coggins, 
submitted to Biochem. J.). The sequence of E4II contains 
the faint homologies found between other ATP utilising enzymes 
by Walker jet al. (1 9 8 2).
1.8.7 EPSP synthase (E5)
E.coli E5 was the first monofunctional EPSP synthase to
be purified to homogeneity (Lewendon and Coggins, 1 9 8 3 )* It
is a monomeric enzyme and the m.w. deduced from the sequence
(see below) is 46 kDa. The monofunctional E5 from pea
seedlings has also been purified to homogeneity and it too 
is a monomer with an estimated m.w. of 50 kDa (Mousdale and 
Coggins, 1984).
The E.coli aroA gene encoding E5 has been cloned and 
homogeneous enzyme can now be obtained easily in milligram 
quantities (Duncan and Coggins, 1983; Duncan _et al. , 1984a). 
The aroA gene has been sequenced and the sequence confirmed 
by analysis of the overproduced polypeptide (Duncan ejfc al., 
1984b). The aroA gene is part of an operon which also includes 
the gene, serC, for phosphoserine aminotransferase. This is 
the first mixed operon discovered in E.coli (Duncan, 1985; 
see Section 5*8 for further discussion of this topic).
In plants, E5 is the target of the enormously successful 
and relatively benign herbicide glyphosate (N-phosphonomethyl- 
glycine) which is a competitive inhibitor with respect to 
phosphoenolpyruvate. The first indications that E5 might be 
the site of action of this compound came from the finding 
that the EPSP synthases of Aerobacter aerogenes (Amrhein ejfc al.
1980) and of N.crassa (Boocock and Coggins, 1 9 8 3) were highly 
sensitive to inhibition by glyphosate. That this was actually 
the site of action in vivo was confirmed, at least in bacteria, 
by the finding that either a mutated aroA gene (Comai e_t al., 
1 9 8 3) or overproduction of E5 (Duncan et; al., 1984a) could 
make bacteria much less sensitive to glyphosate. The E5 
from pea seedlings is an order of magnitude more sensitive 
to glyphosate than the E5 from E.coli or from N.crassa (Duncan 
et al., 1984a)•
1.8.8 Chorismate synthase (E6)
Chorismate synthase catalyses what is probably the 
least understood step of the shikimate pathway. In particular, 
the requirement for reduced flavin nucleotides is mysterious.
E.coli E6 has been partially purified and some of its 
requirements for activity have been studied (Morell et al., 
1 9 6 7)* It was found to be very sensitive to 0^ and was most 
readily assayed under an or atmosphere in the presence 
of a reduced flavin adenine dinucleotide regenerating system.
The gene aroC encodes at least the catalytic subunit of 
E.coli chorismate synthase and is situated at about 50 minutes 
on the genetic map. Recombinant plasmids have been identified, 
from the Clarke and Carbon (1979) E.coli genomic library 
(see Part B of the introduction), which can complement E.coli 
aroC” mutants. This has been done both by direct selection 
from the entire library (Hagervall and Bjork, 1984), and by 
testing of a recombinant plasmid, pLC33-l> known to carry 
the fabB gene, a flanking marker of aroC (i. Anton, unpublished 
work). More definitive identification of the complementing 
gene has come from the subcloning of complementing fragments 
of pLC 33-1 into the high copy number plasmid vector pAT153 
and the demonstration that E.coli strains carrying these 
subclones overexpress E6 20-40 fold (Millar at al., 1 9 8 5 )* 
Clearly much work remains to be done on the E.coli chorismate 
synthase.
E6 from B.subtilis has been purified to homogeneity
(Hasan and Nester, 1978b). It is part of a complex which
includes El (see Section 1.8*3) and a flavin reductase
("diaphorase") subunit required for E6 activity. The subunit
m.w.!s of the three components of the complex are 13 kDa
(flavin reductase), 2 k kDa (E6), and 17 kDa (El). The flavin
reductase has also been purified to homogeneity in a
dissociated form (Hasan and Nester, 1978a). The flavin
24-reductase is specific for NADPH and requires M and either 
FMN or FAD for maximal rates of NADPH oxidation.
Preliminary work suggests that the N.crassa chorismate 
synthase can now be purified to homogeneity (M. Boocock and 
P.J. "White, unpublished results).
1.9 Multifunctional proteins 
1.9»1 Definition and distribution
Kirschner and Bisswanger (1976) defined multifunctional 
proteins as those proteins in which more than one distinct 
biochemical function is located on a single polypeptide 
chain. The field has been reviewed (Kirschner and Bisswanger, 
1976$ Bisswanger and Schmincke-Ott, 1 9 8 0 ). Enzymes with 
broad substrate specificity are excluded from the definition. 
Multifunctional enzymes must clearly be distinguished from 
multienzyme complexes, like pyruvate dehydrogenase, which 
contain several kinds of subunit each carrying out different 
functions. Fatty acid synthase in fungi is both a multi­
functional protein and a multienzyme complex since it comprises
two different kinds of multifunctional subunits (McCarthy 
and Hardie, 1984). Non-catalytic functions such as binding 
functions (but not conventional allosteric effector binding) 
are usually considered acceptable as autonomous activities 
(Schmincke-Ott and Bisswanger, 1 9 8 0 ), however, these are 
really semantic problems which stem from the need to impose 
simplifying subdivisions on a continuous spectrum of structure 
and function.
Multifunctional proteins are found in all classes of 
organism and are involved in very diverse cellular processes.
In E.coli, DNA polymerase I and aspartokinase I-homoserine 
dehydrogenase I are two contrasting examples of multifunctional 
enzymes, and in mammalian cells fatty acid synthase and 
immunoglobulins are multifunctional (Schmincke-Ott and 
Bisswanger, 1 9 8 0). The simian virus 40 large tumour antigen 
is multifunctional (Rigby and Lane, 1 9 8 3). The N .crassa 
arom enzyme has already been described. Despite this 
considerable diversity it is clear that the known multifunctional 
enzymes are particularly common in the amino acid biosynthetic 
pathways of prokaryotes and fungi.
Various generalisations can be made about the reactions 
catalysed by multifunctional enzymes. All known naturally 
occurring multifunctional enzymes catalyse reactions which 
are functionally related. Many catalyse two or more 
consecutive steps in a biosynthetic pathway. However, there 
are some multifunctional enzymes which catalyse nonconsecutive 
steps from the same pathway, for example, the HIS4 gene
product of S.cerevisiae is a trifunctional enzyme which 
catalyses the second, third, and tenth steps in histidine 
biosynthesis (Donahue jet al. , 1 9 8 2 ). In E. coli the thrA 
gene encodes a bifunctional enzyme (aspartokinase I-homoserine 
dehydrogenase i) which catalyses the first and third steps 
in threonine biosynthesis (Katinka ejfc al•, 1 9 8 0).
Enzyme activities which are found in a multifunctional 
polypeptide in one species are often organised in a different 
way in unrelated species: the same activities may be carried
by independent polypeptides, or a number of distinct subunits 
may associate to form a multienzyme complex. However, 
related organisms usually have comparable types of organisation 
The structural organisation of the enzymes in the shikimate 
and tryptophan pathways of a range of organisms is shown in 
Figure 1.6. The evolution of multifunctional proteins will 
be considered in Section 1.11.
1.9*2 The structure of multifunctional proteins
1.9» 2A Structural domains within proteins
Structural "domains" within proteins were first recognised 
by crystallographers in immunoglobulin molecules and are a 
very common feature in enzymes and proteins. The term refers 
to a spatially separate, compact unit within a protein 
(Rossmann and Argos, 1981; Phillips etj aJL. , 1 9 8 3 ). The 
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Figure 1.6 Structural organisation of4 enzymes in the
shikimate pathways and tryptophan pathways of 
a range of organisms
The enzymes are numbered as in Figures 1.1 and 1»3« 
Rectangles represent multifunctional polypeptides while 
circles represent monofunctional polypeptides. Joined 
circles represent multienzyme complexes. After Boocock (1983)*
compact protein and is often described as being a tight 
"glob”• A few of the attributes commonly held by domains 
are listed below (Rossmann and Argos, 1 9 8 1):
1. Domains often have a specific function (for example, 
the nucleotide binding domain in dehydrogenases).
2. Active sites often lie between domains.
3« Domains are made up of one, or a very small number 
of, continuous stretches of a polypeptide chain.
4. Limited proteolysis will often separate the component 
domains of a protein.
There are several basic possibilities for the structure 
of multifunctional enzymes. Firstly, one could have an 
active site catalysing more than one reaction. In most 
cases this is very implausible from what is understood of 
enzyme function, and there is usually some evidence available 
which suggests that the active sites of a particular multi­
functional enzyme are separate (see below).
Secondly, one could hypothesise that one domain of a 
protein could carry two or more active sites, or at least 
contribute towards two or more active sites. This model 
implies that it would be almost impossible to isolate 
functional fragments by limited proteolysis (see below).
A further corollary is that it is very unlikely that - 
within one domain - those parts of the primary structure 
directly involved in a particular activity would come from 
just one, or a few, contiguous stretches of the sequence.
Thirdly, it has been proposed that each active site 
or binding site of a multifunctional protein is located 
within a discrete structural ’’domain” of the folded poly­
peptide, thus envisaging multifunctional proteins as mono­
functional proteins strung together (Kirschner and Bisswanger, 
1976). This hypothesis is often referred to as the "mosaic” 
model or the "beads on a string” model. Note that Kirschner 
and Bisswanger’s usage of the term "domain" is slightly 
different from that introduced above: allowance must be
made for one of their "domains" to include, if necessary, 
two adjacent interacting domains (as defined earlier) as 
in a dehydrogenase, for example. However, their basic 
proposal is clear. The mosaic model predicts that it may 
be feasible to separate the component activities as different 
fragments of the multifunctional protein. It also strongly 
suggests that the amino acid sequences directly responsible 
for a particular activity should be mainly contiguous, as 
has been observed in known domains.
The available evidence concerning the structure of 
multifunctional proteins is very far from being definitive 
and is considered in the next section. However, much of it 
favours the mosaic model.
1.9-2B Evidence for the mosaic model of multifunctional 
proteins
Some of the experimental approaches described here will
be illustrated for the N.crassa arom enzyme in Section 1.10.
The ideal technique for probing the structure of multi­
functional proteins, but one which requires a large investment 
in time and effort, is high resolution X-ray crystallography. 
Unfortunately very few relevant structures have yet been 
solved using this method. The only multifunctional protein 
whose whole structure is known at atomic resolution is a 
single type of immunoglobulin G molecule (Alberts e_t al., 
1 9 8 3)* As well as the function represented by the antigen 
binding sites there are also the functions associated with 
the Fc region of IgG. These include binding to specific 
receptors on placental and phagocytic cells as well as 
binding to and activating complement. The IgG molecule has 
a clear domain structure and, as predicted from internal 
amino acid sequence homologies, all the domains have very 
similar folding patterns. This is one of the most obvious 
examples of evolution by gene duplication. The different 
functions are associated with different domains.
The crystal structure of the Klenow fragment of E.coli 
DNA polymerase I has been determined very recently (Ollis 
et al., 1 9 8 5)• This proteolytic fragment has the DNA
polymerase and the 3 1-->5* exonuclease functions but not
the 5 f >3 1 exonuclease activity. Unfortunately the relation­
ships between structure and function here are not yet 
sufficiently understood for many conclusions to be drawn. 
However, there are two distinct domains the smaller of which 
binds dTMP and the larger of which has a very deep crevice
apparently well suited for binding B-DNA. Each domain is 
built from a contiguous stretch of amino acid sequence.
Hopefully the detailed structures of more multifunctional 
proteins will be determined soon. In the absence of X-ray 
crystallographic data various indirect approaches have been 
used to study the structure of multifunctional proteins.
Some of these are outlined below.
In a handful of cases (to be described in Section 1.11.2) 
sequence homologies have been demonstrated between a multi­
functional enzyme and the corresponding monofunctional 
enzymes from a different species. Since the monofunctional 
enzymes are independent folding units these homologies 
favour the idea of discrete functional domains within multi­
functional enzymes.
Chemical modification has been used to show that the 
different reactions of a multifunctional enzyme are catalysed 
at independent active sites. It is often possible to in­
activate specifically one function of a multifunctional enzyme 
without harming the other activities. This will be illustrated 
for arom in Section 1.10.2.
Genetic analysis is a powerful tool in the study of 
multifunctional enzymes from prokaryotes and lower eukaryotes. 
At a coarse level the isolation of mutants each deficient 
in only one activity of a multifunctional enzyme is evidence 
for the independence of the active, sites. Fine structure 
mapping of mutations in the genes for a variety of multi­
functional enzymes has been carried out, for example in the
td locus of N.crassa which encodes a bifunctional tryptophan 
synthase (Bonner at al. , 196 5) an(^  HIS4 gene of
S.cerevisiae which encodes a trifunctional enzyme involved 
in histidine biosynthesis (Donahue <et al., 1 9 8 2). In these 
cases, as for N.crassa arom (see Section 1.4.1A), mutations 
inactivating particular activities usually map in single, 
non-overlapping regions of the gene. This supports the 
mosaic model.
Limited proteolysis is one of the most useful techniques 
for demonstrating the existence of structural sub-regions 
corresponding to the component activities of a multifunctional 
enzyme. The linking regions between domains are known to 
be vulnerable to proteases and it is unlikely that internal 
fragments of a single domain would maintain a stable 
conformation. The Klenow fragment of E.coli DNA polymerase I 
is a classic example of the use of limited proteolysis to 
give functional subsets of multifunctional proteins. The 
application of this method to the N.crassa arom enzyme will 
be described in Section 1.10.3* Limited proteolysis has 
been used to study many multifunctional proteins including 
vertebrate fatty acid synthase (McCarthy and Hardie, 1984) 
and aspartokinase I-homoserine dehydrogenase I of E.coli 
(the bifunctional thrA gene product). In the latter case 
one can isolate a C-terminal fragment having only homoserine 
dehydrogenase activity (Katinka et al*, 1980).
Functional subsets of multifunctional proteins have 
also been isolated by exploiting chain termination (nonsense) 
mutants. A thrA nonsense mutant in E.coli. for instance, 
has permitted the isolation of an N-terminal fragment having 
only aspartokinase activity.
1.10 The arom multifunctional enzyme of N.crassa
1.10.1 Genetic studies
The results of the genetic analysis of the N.crassa arom 
locus have already been summarised (see Section 1.4.1A;
Giles ejb al., 1 9 6 7a; Rines ejb al • , 1 9 6 9)* When considered 
in terms of a single pentafunctional polypeptide these 
results support the hypothesis that each activity resides 
on an independent structural unit. The five classes of 
mutants in which only a single enzyme activity is lost are 
most simply interpreted as being due to missense mutations. 
They demonstrate that the active sites of arom are probably 
autonomous. The fine structure genetic map shows that 
mutations affecting individual activities map in unique 
non-overlapping regions which is the pattern the mosaic 
model predicts. The polarity mutants, at least some of which 
are suppressible by nonsense suppressors and are therefore 
probably chain termination mutants, also imply that there 
are discrete sub-regions within the polypeptide which are 
responsible for individual functions. Furthermore, the
polarity data suggest that the order of the activities 
along the polypeptide chain is (starting from the amino 
terminus): El, E3, E4, E2, E3 (see Figure 1.7)*
Giles ejfc al. (1 9 6 7a) observed interallelic complementation 
between mutants affecting E3 and also between mutants 
affecting El. Arom is a dimer of identical subunits (Lumsden 
and Coggins, 1977; 1978) and the interallelic complementation 
suggests that at least the El and E3 regions of each subunit 
interact with the homologous regions of the other subunit.
1.10.2 Chemical modification studies
In addition to the genetic data, there is substantial 
evidence from in vitro modification of the purified arom 
enzyme that all five active sites are spatially distinct.
The El activity can be specifically destroyed by removal 
of the essential Zn atom with chelating agents (Lambert ejfc al.. 
1 9 8 3)* The E2 activity alone can be inactivated by treatment 
with sodium borohydride in the presence of dehydroquinate 
(see Section 1.8.4A; Smith and Coggins, 1 9 8 3)* Treatment 
of arom with formaldehyde plus sodium borohydride inactivates 
both E2 and E3, however, only E3 is protected from inactivation 
by shikimate (j. Lumsden and J.R. Coggins, unpublished results). 
E5 can be uniquely inactivated in a variety of ways: by
oxidation, by the competitive inhibitor glyphosate, or by an 
endogenous N.crassa protease (Boocock, 1983; Boocock and 
Coggins, 1 9 8 3)* E4 can be almost uniquely destroyed by very 
mild treatment with trypsin or subtilisin (Smith and Coggins, 
1983; Boocock, 1983; see below).





Figure 1.7 The arom multifunctional enzyme of N.crassa
1»10. 3 Limited proteolysis studies
The susceptibility of the arom enzyme to cleavage by 
endogenous N.crassa proteases was one of the major problems 
in the purification of this protein. Such susceptibility 
is a general problem in the study of multifunctional proteins. 
However, the knowledge that the arom polypeptide could be 
cut in several places while still retaining all five activities 
encouraged deliberate attempts to fragment the intact protein 
into functional subsets.
The subunit m.w. of the arom enzyme is 165 kDa. Mild 
treatment of intact arom with trypsin or subtilisin gives a 
rapid initial cleavage resulting in two fragments of 110 kDa 
and 68 kDa on SDS PAGE (Smith and Coggins, 1 9 8 3)* EU activity 
is destroyed in parallel with the disappearance of the 165 kDa 
arom polypeptide but the other four activities are much more 
robust. Under native conditions the 110 and 68 kDa fragments 
remain noncovalently bound in a complex indistinguishable 
on native gels from intact arom enzyme. Smith and Coggins 
(1 9 8 3) showed that the 68 kDa fragment carries the active 
site lysine of E2 and can be renatured and stained for E3 
activity after treatment with 8M urea. It would appear that 
the 68 kDa fragment represents a bifunctional subset of the 
arom polypeptide. Prom the genetic data it is almost certainly 
a C-terminal fragment (see Figure 1.7)• It is interesting 
that at least the E3 activity can refold following denaturation 
in urea since this implies that no information other than 
that contained within the 68 kDa fragment is required for
this activity. Subsequent work, involving arom fragments 
generated by V8 protease and renaturation after SDS PAGE, 
has lowered the minimum size of polypeptide fragment required 
for recovery of E3 activity to k k kDa (M. Boocock, unpublished 
results). Further trimming may well be possible.
Smith and Coggins (1 9 8 3) suggested that the 110 kDa 
fragment (presumptively complementary to the 68 kDa fragment) 
carries El and E5 activities on the basis of the genetic data. 
It has now been shown that a 7^ - kDa fragment, derived from 
the 110 kDa fragment by prolonged treatment with trypsin and 
chymotrypsin, carries E5 activity (Boocock, 1 9 8 3 ? Coggins 
et al.. 1 9 8 3)* This fragment has been isolated preparatively. 
El activity is lost during the protreolysis procedure used 
here and the 68 kDa fragment is trimmed to 63 kDa.
Although much work remains to be done, the results 
already obtained from limited proteolysis of the arom enzyme 
support the mosaic model.
1.11 The evolution of multifunctional proteins
Questions about the evolution of multifunctional proteins 
can be divided into those concerned with "why?” they evolved 
and those directed at "how?" they evolved. As will shortly 
be described, the work for this thesis was mainly aimed at 
helping to answer a question of the second type.
1.11.1 Why have multifunctional proteins evolved?
The first possibility to consider is that there are 
selective advantages to be gained by having some functions 
organised in multifunctional proteins. Many hypothetical 
advantages have been put forward but none are yet generally 
accepted (Schmincke-Ott and Bisswanger, 1980). Some of 
these proposals are given below.
Multifunctional proteins may allow greater economy in 
the use of genetic information: one may obtain the expression
of n activities using only one promoter, terminator, and 
ribosome binding site.. However, this assumes that the kinetic 
properties of the different activities are sufficiently 
similar for the production of equimolar amounts of the 
different active sites to be appropriate.
The physical strength of a covalent connection between 
two functions may be useful in rare cases.
It has often been suggested that multifunctional enzymes 
might allow more efficient catalysis due to Mchannelling” of 
the product of one active site to the next active site. In 
a related argument Giles et al. (1 9 6 7a) suggested that the 
pentafunctional N.crassa arom enzyme might be necessary to 
segregate the shikimate pathway from the competing catabolic 
quinate pathway. However, this does not explain why E4 and 
E5 are included in arom. Also, S.cerevisiae apparently lacks 
any catabolic quinate pathway. In general, channelling 
cannot explain cases where a multifunctional enzyme catalyses 
non-sequential steps in a pathway unless there are other
subunits, in a multienzyme complex, which catalyse the 
intervening steps. No evidence for substrate channelling 
has yet been found with the N.crassa arom enzyme (G.A. Nimmo, 
J.M. Lambert, M.R. Boocock, J.R. Coggins, unpublished results) 
There is clearly a need for further work in this area. This 
will be facilitated by the cloning and overexpression of 
the genes for the relevant enzymes.
The above description of the possible merits of multi­
functional proteins, in comparison with monofunctional ones, 
has rather ignored a third "contestant” - the multienzyme 
complex. It is quite conceivable that a particular selective 
advantage could equally well be gained by two different routes 
It may be that in certain cases the covalent attachment of 
functions allows topologies which are not readily evolved 
as multienzyme complexes. Evolutionary processes are 
constrained by their functional environment (Gould, 1984).
For example, the symmetry relationships in two different 
homo-oligomers may put barriers in the way of the evolution 
from these subunits of a multienzyme complex with a particular 
arrangement of active sites.
A second major possibility is that some multifunctional 
proteins may confer no selective advantage and are found today 
only because their genes (after arising by chance) became 
fixed in the population and are difficult to eliminate. It 
is much easier for two genes to be fused (see below) by a 
deletion event than it is for the process to be reversed, 
whereupon all the control sequences which were lost during
the original deletion event must somehow be restored.
It has been argued (Schmincke-Ott and Bisswanger, 1980) 
that the relatedness of the functions in all known multi­
functional proteins rules out the possibility that multi­
functional proteins arose, say, by accidental gene fusions 
followed by neutral fixation. This argument is not impregnable 
It may be that accidental fusions between unrelated genes 
do occur but that these are more likely to be detrimental, 
for example, due to the disruption of regulatory processes. 
Furthermore, there may be some accidental fusions of unrelated 
genes that have simply not yet been detected. For instance, 
a bifunctional enzyme with two known activities could 
conceivably have an unknown, unrelated "Cinderella" activity 
which goes undetected because the appropriate assay is never 
performed.
1.11.2 How have multifunctional proteins evolved?
It is generally assumed that multifunctional proteins 
have evolved from monofunctional proteins. There are three 
plausible mechanisms for how this might occur:
1. There might be adaptation of an existing monofunctional 
enzyme to catalyse a second reaction (Llewellyn et: al. , 
1980).
2. There might be internal duplication within the gene for 
a monofunctional enzyme and subsequent adaptation of 
one active site for catalysis of a second reaction 
(Schmincke-Ott and Bisswanger, 1 9 8 0).
3» There might be fusion of the genes for two mono functional 
enzymes (Bonner et al • , 1 9 6 3)*
It has been proposed (see Section 1.8.2) that the bifunctional 
enzyme chorismate mutase/DAHP synthase of B.subtilis strain 
168 arose through adaptation of a regulatory prephenate binding 
site in an existing DAHP synthase (Llewellyn ejb al. , 1 9 8 0 ). 
However, this is an atypical case given the special nature of 
the chorismate mutase reaction. Also, the simple adaptation 
hypothesis is embarrassed by the fact that most multifunctional 
proteins tend to have "large" subunit molecular weights.
The evolution of immunoglobulins provides a clear example 
of gene duplication and adaptation (see Section 1*9*2B). It 
is not known how general this mechanism might be. Internal, 
repeating sequence homologies within a multifunctional protein 
would strongly imply a gene duplication mechanism for the 
evolution of that protein.
There is good evidence that several multifunctional 
enzymes evolved by a gene fusion mechanism. This evidence 
is based on the finding of sequence homologies between a 
multifunctional protein and its monofunctional counterparts 
from a different species (see Figure 1.8).
In E.coli the trpD gene is part of the trp operon and 
encodes a bifunctional enzyme having both the glutaminase 
(anthranilate synthase II; ASIl) and the anthranilate 
phosphoribosyl transferase (PRT) activities of the tryptophan 
pathway (Miozzari and Yanofsky, 1979; see Figure 1.3)*
Genetic analysis and limited proteolysis show that the two
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Figure 1.8 Evolution of multifunctional proteins by- 
gene fusion
activities are associated with different segments of the 
polypeptide chain, ASII being N-terminal. The E.coli trpD 
gene is often written trp(G)D. In contrast, in the related 
enteric bacterium Serratia marcescens (S.marcescens) the same 
two activities occur as separate proteins. In this species 
the trpD gene encodes only the PRT activity and the operon 
contains an extra gene, trjoG, which encodes ASII and lies 
immediately 5 1 of trpP, thus; ...-trpG-trpD-... Miozzari 
and Yanofsky (1979) compared the sequence of E.coli trpD 
with that of the S.marcescens trpG-trpP region. They found 
very extensive homology between the S>. marcescens trpG gene 
and the N-terminal part of E.coli trpD and between the
S.marcescens trpD gene and the C-terminal part of E.coli trpD. 
The intercistronic region in S.marcescens was only 16 nucleo­
tides long. It appears that there has been a gene fusion 
event in the E.coli operon, although one cannot entirely rule 
out the possibility of an ancestral fusion and subsequent 
separation in S.marcescens.
In the yeast S.cerevisiae the TRP5 gene encodes a 
bifunctional tryptophan synthase whereas in E.coli tryptophan 
synthase is a multienzyme complex consisting of two kinds of 
subunits encoded by the trpA and trpB genes. Sequence 
comparisons show clear homologies (at the protein level) 
between the N-terminal part of TRP5 and trpA and between
A1
the C-terminal part of TRP5 and trpB. thus implying that TRP5 
arose by fusion of two genes for monofunctional subunits 
(Zalkin and Yanofsky, 1 9 8 2). Similarly, there are homologies
between the bifunctional S.cerevisiae TRP3 gene product 
(ASIl/indole glycerol phosphate synthase) and the appropriate 
regions of the E.coli trpD and trpC (bifunctional; indole 
glycerol phosphate synthase/phosphoribosyl anthranilate 
isomerase) gene products, suggesting that TRP3 evolved by 
gene fusion (Zalkin jet al., 1984).
Fragmentary sequence homologies have been detected 
between the multifunctional mammalian fatty acid synthase 
and the corresponding monofunctional bacterial enzymes perhaps 
showing that the former arose by gene fusion (McCarthy and 
Hardie, 1984).
It is not known yet how general the gene fusion mechanism 
might be. Both gene duplication and gene fusion would predict 
the occurrence of independent functional domains encoded 
by contiguous genetic regions.
1.11.3 Gene fusion and the N.crassa arom multifunctional enzyme
It is not known how the N.crassa arom protein evolved. 
However, there are two very weak lines of evidence which point 
to gene fusion being the most plausible hypothesis. Firstly, 
there are the similarities between the various enzyme activities 
of arom and the corresponding monofunctional activities of 
E.coli. These were outlined in Section 1.8. Secondly, there 
is the arom subunit molecular weight which is very close to 
the sum of the corresponding E.coli subunit molecular weights. 
This is illustrated in Table 1.1. The bifunctional E2/E3
Table 1•1 Subunit molecular weights of the E.coli enzymes 
corresponding to the five arom activities
E.coli activity Subunit m.w.(kDa) Reference
El 39 G. Millar, unpublished
E2 28 Duncan (1 9 8 5 )
E3 29 This study
E4 20 Ely and Pittard (1979)
E5 46 Duncan £t al. (1984b)
Total:162
NOTE; N.crassa arom subunit m.w. is 165 kDa by SDS PAGE.
from peas has a subunit m.w. of 60 kDa (see Section 1.6.2) 
which also agrees well with the hypothesis that it arose by 
the fusion of two E.coli-like monofunctional activities 
(28 + 29 kDa). Although the bifunctional P.patens E2/E3 
appears to have a subunit m.w. too small (48 kDa) to be 
simply related to the E.coli E2 and E3 polypeptides it should 
be remembered that an E2 with a lower subunit m.w. (20 kDa) 
has been characterised: the catabolic E2 of N.crassa
(20 + 29 kDa = 49 kDa). The 68 kDa proteolytic fragment 
of the N.crassa arom enzyme, which carries the E3 activity 
and at least the active site lysine of E2, can be trimmed 
further to 63 kDa (see Section 1.10.3 ), but it remains to 
be determined whether this fragment carries all sequences 
required for E2 activity.
1.11.4 This pro.ject
One of the long term aims of this laboratory is to find 
out how the arom multifunctional enzyme evolved. The working 
hypothesis is that this protein evolved by the fusion of 
genes for monofunctional activities. To test this idea it 
is planned to compare the amino acid sequence of an arom 
multifunctional enzyme with the amino acid sequences 
of the corresponding monofunctional enzymes from E.coli. The 
finding of homologies between each of the E# coli enzymes and 
the relevant parts of arom would be diagnostic of gene fusion. 
As part of this long term project I describe here the cloning
and sequencing of the E.coli aroE gene encoding shikimate 
dehydrogenase (E3). This route to obtaining sequence 
information also allows the overexpression of the cloned 
gene and the purification of relatively large amounts of 
the encoded protein for detailed study. The technical 
approach used to clone aroE is introduced in the next section.
PART B - INTRODUCTION TO THIS PROJECT
1.12 General approach
The method chosen to clone the E.coli shikimate dehydrogen 
ase gene, aroE, exploited an Aro™ auxotrophic mutant of E.coli 
which is specifically defective in the aroE gene. This strain 
coli AB2834 (Pittard and Wallace, 1 9 6 6). It lacks E3 
activity and will not grow on a minimal medium (lacking 
aromatics) which would support the growth of wild-type E.coli.
A cloned, wild-type, aroE gene should be able to complement 
the auxotrophic mutation of AB2834 cells, thus allowing growth 
on minimal medium and providing a direct selection for the 
presence of this gene. This complementation approach is 
often called cloning by "relief of auxotrophy". One would 
"shotgun” fragments of the E.coli genome into E.coli AB2834 
using a suitable plasmid vector and then plate the transformed 
cells on minimal medium. Any colonies which appeared - 
the "putative positives" - would be studied to see if they 
contained a recombinant plasmid carrying the aroE gene.
Cloning E.coli genes by complementation is a widely 
applicable technique (Clarke and Carbon, 1979) since a large 
number of* wild-type E. coli genes can confer a selectable 
phenotype on the appropriate, and available, mutant. The 
expanding literature testifies to the widespread awareness 
of this fact.
1.13 Shortcuts in cloning E.coli genes by complementation 
The logistics of cloning by relief of auxotrophy can 
be simplified by starting from a known small subset of the 
E. coli genome which is thought to harbor the desired gene.
Such a simplification was possible in this case. There are 
many transducing phages available that carry defined fragments 
of the E.coli genome. The aroE gene is located at about 72 
minutes on the E.coli linkage map (see Figure 1.4). While 
studying E.coli ribosomal protein genes which map very close 
to aroE Nomura and his coworkers isolated the defective 
transducing phage \ spcl (Jaskunas jet al., 1975a; see Figure 
1*9)* This phage carries bacterial sequences from E.coli 
K12 and was thought to carry aroE at its extreme left end.
It seemed worthwhile to see if any restriction fragments of 
\ spcl DNA were able to complement the aroE auxotrophic mutant 
E.coli AB2834 (see Chapter 3)»
It should be noted that the E.coli genomic library 
constructed by Clarke and Carbon (l979)» using the plasmid 












Figure 1.9 The region o f the E. coli genetic map around aroE
From Bachmann (1983)* The approximate extent of the 
E.coli DNA carried in the transducing phage \ spcl is shown. 
The asterisk indicates that the position of tolM with respect 
to nearby markers is uncertain. rrnD represents a ribosomal 
and transfer RNA operon. The trkA gene product is involved 
in the transport of potassium.
genes. Clarke and Carbon initially screened their library 
by testing clones for the ability to complement a wide variety 
of E.coli mutants. This permitted the tentative assignment 
of particular genes, and thus regions of the linkage map, to 
particular recombinant plasmids. They were, however, very 
aware of the dangers of mistaking suppression for complementati 
They identified two recombinant plasmids in their library as 
being able to complement an aroE auxotrophic mutant: 
pLCl6-l and pLC12-24. These are not considered further. An 
important and useful extension of the work of Clarke and 
Carbon is the ”gene-protein index” for E.coli K12 (Neidhardt
CHAPTER 2 MATERIALS AND METHODS
2.1 Materials
2.1.1 Chemicals
General chemicals were obtained from many different 
manufacturers and were of analytical reagent grade or the 
best available quality.
All solutions were made using glass-distilled water, 
except for those solutions used during the annealing and 
synthesis steps of DNA sequencing where deionised, distilled 
water was used.
Fine chemicals and radiochemicals. 3-dehydroquinate 
(ammonium salt) and 3-deliydroshikimic acid were the generous 
gifts of S. Chaudhuri.
Shikimic acid was obtained from the Aldrich Chemical 
Co., Gillingham, Dorset, U.K.
NADP+ (diNa+ salt), NADH (grade II, Na+ salt), and 
PEP (K+ salt) were obtained from Boehringer Corp., Lewes,
East Sussex, U.K.
ATP(A-539^-, essentially vanadium free), ampicillin, 
tetracycline, streptomycin sulphate, chloramphenicol, ethidium 
bromide, Coomassie Brilliant Blue G-250, PMSF, benzamidine, 
and DTT were obtained from Sigma Chemical Co., Poole, Dorset, 
U.K.
2-mercaptoethanol, 99# formic acid (Analar), 30# hydrogen 
peroxide (Analar), concentrated hydrochloric acid (Aristar), 
xylene cyanol, bromophenol blue, nitro-blue tetrazolium, 
phenazine methosulphate, polyethylene glycol 6000, Amberlite 
MB3, CsCl, L-proline, L-leucine, L-phenylalanine, L-tyrosine, 
L-tryptophan, p-aminobenzoic acid, p-hydroxybenzoic acid, 
acrylamide, bis-acrylamide, N, N, N ’ , N ’ ,-tetramethylene diamine, 
SDS, and enzyme grade ammonium sulphate (especially low in 
heavy metals) were obtained from BDH Chemicals, Poole, Dorset, 
U.K.
Thiamine hydrochloride (vitamin B^) was obtained from 
Fluka, Fluorochem Ltd., Glossop, Derbyshire, U.K.
Agarose and low melting point agarose (for DNA gels), 
urea, IPTG, and X-gal were obtained from BRL, Gibco Ltd.,
P.O. Box 35, Paisley, U.K.
Bactotryptone, yeast extract, and "Bactoagar" were 
obtained from Difco, Detroit, U.S.A.
Oxoid nutrient broth powder and Oxoid No.l agar were 
obtained from Oxoid Ltd., London SE1, U.K.
Deoxy- and dideoxy nucleotides (dATP, dTTP, dCTP, dGTP, 
ddATP, ddTTP, ddCTP, ddGTP) and [a“^5s] dATPaS for chain 
termination sequencing were obtained from Amersham International 
pic, Amersham, U.K. The nucleotides were part of a kit 
(see below).
Prior to use in nucleic acid manipulations phenol was 
redistilled and stored in small aliquots at -20°C. Prior to 
use in manipulations involving protein urea was recrystallised 
from ethanol.
2.1.2 Chromatographic media
Sephadex G-75 (superfine grade), DEAE-Sephacel,
Sephacryl S-200 (superfine grade), and 2'3* ADP-Sepharose 4B 
were all obtained from Pharmacia, Milton Keynes, Bucks, U.K.
2.1.3 Enzymes and proteins
The following were obtained from Boehringer Corp., Lewes, 
East Sussex, U.K.: catalase (EC 1.11.1.6) from beef liver, 
glutamate dehydrogenase (EC 1.4.1.3) from beef liver, 
glyceraldehyde-3-pb.osphate dehydrogenase (EC 1.2.1.12) from 
rabbit muscle, aldolase (EC 4.1.2.13) from rabbit muscle, • 
carbonic anhydrase (EC 4.2.1.1) from bovine erythrocytes, 
pyruvate kinase (EC 2.7»l»4o) from rabbit muscle/lactate 
dehydrogenase (EC 1.1.1.27) from rabbit muscle (mixed 
suspension for use as coupling enzymes), and alkaline 
phosphatase (EC 3*l»3»l) from calf intestine (Grade l).
Prior to use in DNA cloning experiments the calf intestinal 
alkaline phosphatase was further purified (to remove residual 
nucleases) by gel filtration on Sephadex G-75 (superfine) as 
described by Efstratiadis _et al. (1977)•
Deoxyribonuclease I (EC 3»l»^-*5) from bovine pancreas, 
bovine serum albumin, proteinase K, RNase A, and lysozyme 
were obtained from Sigma Chemical Co., Poole, Dorset, U.K.
Gelatin was obtained from Serva, Uniscience Ltd., 
Cambridge, U.K.
All restriction endonucleases were obtained from BRL, 
Gibco Ltd., P.O. Box 35, Paisley, U.K., as were T4 DNA ligase 
and nuclease-free bovine serum albumin.
Klenow fragment of E.coli DNA polymerase I was obtained 
from Amersham International pic, Amersham, U.K. as part of 
a kit (see below) which also included the M13 oligonucleotide 
primer.
2.1.4 Bacterial strains and episomes
The bacterial strains used are shown in Table 2.1.
Plasmid vector pAT153 (Twigg and Sherratt, 1980) was the 
gift of R. Krumlauf. The plasmid expression vector pKK223-3 
(j. Brosins, unpublished work) was the gift of J.R. Knowles. 
Further supplies of these two plasmids were obtained by 
exploiting their ability to replicate (see below). The 
sequencing phage vectors M13mp8 and M13 mp9 (Messing and 
Vieira, 1982) were obtained from Amersham International pic, 
Amersham, U.K. as part of a kit (see below).
2.2 General biochemical methods
pH measurements were made with a Radiometer pH probe 
calibrated at room temperature.
Conductivity measurements were made with a Radiometer 
conductivity meter type CDM2e (Radiometer, Copenhagen, Denmark) 
Protein estimations were done by the method of Bradford 
(1 9 7 6), with bovine serum albumin as the standard.
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American Type Culture 
Collection (Rockville, 
Maryland, U.S.A.)
CGSC (E.coli Genetic 
Stock Centre, Dept, of 
Human Genetics, Yale 
University, New Haven, 
U.S.A.) Pittard and 
Wallace (1 9 6 6)
Jaskunas e_t al. (1975a)
Bolivar and Backman
(1979)
Messing and Vieira (1982)
T. Gibson (unpublished)
Gift of D.W. Meek
DNA was determined spectrophotometrically at 2 6 0nm 
(Maniatis ejfc al•, 1 9 8 2). An value of 1.0 (l cm path)
corresponds to 50 )ig/ml of double-stranded DNA. This method 
is only applicable to pure preparations of DNA.
Absorbance (A^ .) values refer throughout to absorbances 
measured in a cuvette having a 1 cm path length; at x  nm.
Dialysis membranes were boiled for at least 15 min in 
ImM Na^EDTA and then rinsed thoroughly with d.w. prior to 
use.
General microbiological techniques
Many of these techniques are described in Maniatis ejb al. 
(1982).
Purification of strains. Before use all new strains were 
streaked on plates for single colonies, usually twice in 
succession. Plate tests were used to check genetic markers 
(see below)•
Preservation of strains. For short term use plates with 
bacterial colonies were stored (sealed) at 4°C. For short 
or medium term use 0/N cultures in Nutrient Broth or L Broth 
remained viable at 4°C up to about six months. For long 
term storage two different methods were employed (usually 
both): stabs and storage at -20°C in medium containing
15# (v/v, final concentration) glycerol (Maniatis et al., 
1 9 8 2). The latter is preferable for strains containing 
plasmids and anyway gives better long term viability 
(several years).
Replica plating was carried out using a "mushroom” 
apparatus and velvets.
Growth of bacteria. Solid and liquid media for the growth 
of bacteria are described in the next section. The growth 
of bacteria in liquid cultures was followed at 650 nm using 
a Gilford-Unicam model 252 spectrophotometer. The linear 
range is from A ^ q  = 0 - 0 . 6  (determined experimentally using 
a culture of E.coli HB101 grown to stationary phase on L broth 
and diluted). The A ^ q  of denser cultures was obtained after 
dilution of a sample in the appropriate medium. Unless 
otherwise stated all bacteria were grown at 37°C. Drug 
selection was always used (except during the expression phase 
of transformations - see below) on strains containing a 
plasmid with a selectable drug resistance marker. Inocula 
for moderate to large cultures were usually taken from a 
10 ml culture in Nutrient Broth or L Broth which had been
grown 0/N without shaking after inoculation from a stock
culture. The inoculum volume was usually 1-5# o f  the volume 
of the new medium.
Harvesting of bacteria for biochemical purposes was done 
by centrifugation, usually in a rotor at 4°C in an MSE High 
Speed 18 refrigerated centrifuge. Larger volumes were spun 
in the 6 x 300 ml angle rotor at 6 krpm (7 0 0 0 g) for 5 - 1 0  min,
while smaller volumes were spun in the 8 x 50 ml angle rotor
at 6 krpm (5 ^ 0 0 g) for 5 - 1 0 min.
2.4 Solid and liquid media for the growth of bacteria
Unless otherwise stated all media (and supplements) 
were sterilised by autoclaving.
2.4.1 Rich media
L Broth contains, per litre of d.w.: 10 g Bactotryptone
5 g yeast extract 
10 g NaCl
After autoclaving add 5 ml sterile 20# (w/v) D-glucose per 
litre (0 .1# final), except when the medium is to be used for 
preparing bacteria for titration of \ phage whereupon the 
glucose is omitted and 0 .2# (w/v, final) maltose is added 
instead.
L agar: add 15 g Bactoagar per litre of L Broth before 
autoclaving. Supplement with D-glucose (as above) before 
pouring, or maltose (as above) for bottom agar to be used 
for \ phage titration. Top agar for \  phage titration 
is the same as bottom agar but contains only 7 g/l Bactoagar.
Nutrient Broth contains per litre of d.w.: 13 g Oxoid 
No.l nutrient broth powder.
Stab medium: add 6 g/l Bactoagar to Nutrient Broth 
before autoclaving.
2xTY medium contains per litre of d.w.: 16 g Bactotryptone
10 g yeast extract 
5 g NaCl
H agar contains per litre of* d.w. : 10 g Bactotryptone
8 g NaCl 
12 g Bactoagar 
H top agar: as for H agar but only 8 g/l Bactoagar.
2.4.2 Defined minimal media
All defined minimal media used were based on one version 
of M9 salts medium. This contains, per litre of d.w.:
1 g NH^Cl
0.13 S MgS04.7H20
3 g . k h 2p o4
6 g Na2HP04
After autoclaving, add vitamin B^ (thiamine hydrochloride; 
final concentration 2 jig/ml), CaCl2 (final concentration 
O.lmM), and D-glucose (final concentration 2 g/l). The 
CaCl2 and D-glucose are autoclaved together while the vitamin 
B^ is filter sterilised. So that the same minimal medium 
would suffice for E.coli HB101 (which requires leucine and 
proline) or K12 the above salts were supplemented prior to 
autoclaving with L-leucine (100 mg/l final) and L-proline 
(1 5 0 mg/l final) to give "minimal medium (MM)n. However, 
for the growth of the host strains for M13 sequencing proline
(and leucine) are omitted because these strains contain an
+  —unstable F* episome carrying the pro marker in a pro
background (see Table 2.1) and one selects for maintenance 
of the episome on a true minimal medium.
For solid defined media the salts must be autoclaved 
separately from the agar to avoid precipitation problems. 
Hence, the M9 salts are made up as a 2 times concentrated 
stock solution and autoclaved separately before being mixed
with the agar solution. For solid defined media Oxoid No.l 
agar was used, rather than Bactoagar, and at 12.5 g/l 
(final). After mixing the two halves and cooling to 55°C 
the vitamin B^, CaCl^ and glucose are added in the same 
concentrations as for minimal medium and the plates are 
poured (M agar)•
For plate tests on aromatic auxotrophs the above solid 
defined medium was supplemented with various compounds to 
the final concentrations given below. For the growth of 
shikimate pathway aromatic auxotrophs plates were supplemented 
with the five end-products: phe (8 0 mg/l), tyr ( 8 0 mg/l), 
trp (40 mg/l), PABA (320 lig/l), and PHBA (320 yg/l). For 
testing auxotrophs with subsets of the above five aromatic 
compounds PABA and PHBA were used at the same concentrations 
but phe, tyr, and trp were used at 20 mg/l. All these end- 
products can be added to the medium prior to autoclaving.
As described in Chapter 3, supplements of the common pathway 
intermediates DHQ, DHS, or shikimic acid were always given 
along with phe ( 2 0 mg/l) + tyr (2 0 mg/l), and were each 
used at 100 mg/l. These intermediates were made up in 
concentrated stock solutions, filter sterilised, and the 
appropriate volume (of the order of 0 . 1  ml) spread on the 
M agar + phe + tyr plates a few hours before use.
2.4.3 Drug supplements
Ampicillin (Amp) was used at a final concentration of 
100 yg/ml. A stock solution of 5 mg/ml was filter sterilised
and stored at -20°C. Hot agar was cooled to 55°C before 
ampicillin was added. L agar + ampicillin = L Amp plates.
M agar + ampicillin = M Amp plates. Plates containing 
ampicillin could be kept for at least 4 weeks if stored at 
4°C.
Tetracycline (Tet) was used at a final concentration of 
15 )ig/ml. A stock solution of 10 mg/ml in absolute ethanol 
was stored in the dark at -20°C. Hot agar was cooled to 
55°C before tetracycline was added. L agar + tetracycline =
L Tet plates, which were used the same day that they were made.
Streptomycin (Str) was used at a final concentration of 
25 Tig/ml. A stock solution of 20 mg/ml was filter sterilised 
and stored at -20°C.
Chloramphenicol for plasmid amplification was used at a 
final concentration of 150 ‘jig/ml. A stock solution of 
34 mg/ml in absolute ethanol was stored at -20°C.
2.5 Crude E.coli cell extracts (for analytical purposes)
For assaying E3 and E2 in crude E.coli extracts: 
grow up 2 x 50 ml bacterial cultures in L Broth (supplemented, 
if appropriate, with ampicillin) each in a 250 ml conical 
flask on an orbital shaker at 37°C. After they reach the 
desired A ^ q  cool on ice, pool, and harvest the bacteria by 
centrifugation at 4°C. Resuspend pellets in sonication 
buffer I:
0..2M KC1
0.2M kh2P04 p^H t0 7*° with K0H)
2mM MgCl2 
ImM PME
Spin down. Resuspend pellet in 3*5 ml sonication buffer I. 
Break cells by sonication: 3-5 x 30 s bursts, each separated 
by a 30 s interval for cooling, using a Dawe soniprobe 
type 7532A at 80 ¥ (output setting 2) with the sample vial 
in a brass cooling block threaded on the probe and immersed 
in iced water. Spin the disrupted cell suspension at b °C
in a precooled rotor for 2 h with 1 9 9 ,0 0 0 g at the maximum
radius (10 x 10 ml MSE aluminium angle rotor (119) in an MSE 
Prepspin 50 centrifuge). The supernatant, which forms the 
crude extract, is removed and kept on ice. E3 and E2
activities are stable in this extract for at least 36 h
but assays were always performed as soon as possible.
In a preliminary experiment in which extracts were
assayed for E4(and E3) the procedure was as above but with
the following modifications: grow the 2 x 50 ml cultures in
minimal medium. Use sonication buffer II which does not
contain P.:
1




(A. Lewendon, unpublished work). Since E.coli E4 activity 
is thought to be unstable 10 mg/ml bovine serum albumin 
was included in the final cell suspension (prior to sonication) 
for a duplicate extract. For the same reason the duration 
of the high speed spin was reduced to 1 h and assays were 
done at once.
2.6 Enzyme assays
Continuous spectrophotometric assays were done at 25°C 
in masked semi-micro quartz cuvettes (l cm path, 1 ml). The 
instrument used throughout was a Gilford-Unicam model 232 
spectrophotometer with a slave chart recorder. One unit of 
activity is defined as the amount of enzyme required to 
catalyse the conversion of 1 ‘jAmole of substrate per minute 
under the defined conditions.
Dehydroquinase (E2) was assayed spectrophotometrically 
at 23^nm (£ = 12,000 M ^cm""^). The assay mixture contained 
(final concentrations) 0.2mM DHQ, lOOmM KP^ pH 7*0. DHQ 
was used to initiate the assay of crude E.coli cell extracts. 
The KP^ was prepared as a two times concentrated stock 
solution (200mM KH2P0^/K0H pH 7«0).
Shikimate dehydrogenase (E3) was assayed in the reverse 
direction by monitoring the reduction of NADP+ at 3^ -0^ m 
( € =  6,200M ^cm’^). The assay mixture contained (final 
concentrations) 4mM shikimic acid, 2mM NADP+, lOOmM Tris-HCl 
pH 9.0. When assaying crude E.coli extracts the assay was 
initiated with shikimic acid after recording any blank rate 
(usually very small).
Shikimate kinase (E4) was assayed spectrophotometrically 
at 3^-Onm (€ = 6,200M Pcm P) by coupling the release of* ADP 
to the pyruvate kinase and lactate dehydrogenase reactions 
(G.A. Nimmo, unpublished work). Assays contained ImM shikimic 
acid, 2.3mM ATP (neutralised with KOH), ImM PEP (neutralised 
with KOH), O.lmM NADH, pyruvate kinase (3U/ml) and lactate 
dehydrogenase (2.3U/ml) in 30mM KC1, 2»3mM MgCl^, 30mM 
triethanolamine.HCl/KOH pH 7«0. The buffer was made up as 
a two-fold concentrated stock solution. The assay of crude 
E.coli extracts was initiated with shikimic acid after recording 
the rather rapid blank rate.
2.7 Polyacrylamide gel electrophoresis of proteins
2.7*1 SDS PAGE
Polyacrylamide gel electrophoresis in the presence of 
sodium dodecyl sulphate was done by the method of Laemmli 
(1970). Separation gels were polymerised from solutions 
containing 375mM Tris-HCl pH 8 .8 , the stated concentration 
(w/v) of acrylamide (at an acrylamide:bis-acrylamide ratio 
of 30:0.8), 0.033% (v/v) N,N,N ' ,N' ,-tetramethylene diamine,
0.03% (w/v) ammonium persulphate and 0.1% (w/v) SDS. Stacking 
gels were polymerised from solutions containing 123mM Tris-HCl 
pH 6 .8 , 3% (w/v) acrylamide (30:0.8), 0.067% (v/v ) N,N,N’,N'- 
tetramethylene diamine, 0 .1% (w/v) ammonium persulphate and 
0.1% (w/v) SDS. Laemmli gels were poured in a slab format
(20 cm x 15 cm x 1.2 mm: Raven Scientific Ltd., Haverhill, 
Suffolk, U.K.). Samples for SDS PAGE were adjusted to at 
least 1% SDS, at least 2% (v/v)0ME, at least 10% (v/v) 
glycerol, and a trace of bromophenol. blue and heated to 
100°C for 2-5 minutes. SDS PAGE was done at room temperature 
The well buffer stock solution is 30 g/l Tris base, 144 g/l 
glycine and is diluted 10-fold and supplemented with 0.1% 
(w/v) SDS for SDS PAGE.
The protocol used for renaturing proteins after SDS PAGE 
is fully described in Section 3*4.4.
The molecular weight markers used in SDS PAGE experiment 
were: bovine serum albumin (6 8 kDa), catalase (60 kDa),
glutamate dehydrogenase (53 kDa), aldolase (40 kDa), 
glyceraldehyde-3-phosphate dehydrogenase (3 6 kDa), and 
carbonic anhydrase (2 9 kDa). See Weber and Osborn (1 9 6 9 )*
2.7*2 Non-denaturing gel electrophoresis
This was done by the method of Davis (1964) but using 
slab gels rather than tube gels. Gels were polymerised as 
described for Laemmli separation gels but without any SDS 
and with O.5M Tris-HCl pH 8.8. The gels are poured in the 
same slab gel apparatus described above for SDS PAGE (after 
cleaning!). The well buffer is a 25-fold dilution of the 
stock Laemmli well buffer (without SDS) supplemented with 
O.lmM DTT. Native gels were pre-electrophoresed (40mA) 
and were run in the cold room (4°C) at 25 mA. Samples for 
non-denaturing gels were incubated with l-50mM DTT on ice 
for 1 h prior to loading (with glycerol).
2.7*3 Staining of polyacrylamide protein gels
Gels were stained for protein with 0.1% (w/v) Coomassie 
Brilliant Blue G-250 in 10% (v/v) acetic acid, 50% (v/v) 
methanol and destained at room temperature in 10% (v/v) 
acetic acid, 10% (v/v) methanol.
Non-denaturing gels, and renatured SDS gels, were stained 
for E3 activity using the nitro-blue tetrazolium (NBT) dye- 
linked method, as adapted by Lumsden and Coggins (1977)*
Gels were first soaked in lOOmM Tris-HCl pH 8.8-9*0 for l/2-l h 
to remove DTT. The (freshly made up) staining mixture 
consisted of 0*5niM NADP+, ImM shikimic acid, 0.62 mg/m 1 NBT, 
300mM Tris-HCl pH 9*0, to which was added 0.0125 volumes of 
0.5 mg/ml phenazine methosulphate. The gel in the staining 
mixture (together with control gel in mixture minus shikimate) 
was incubated at room temperature in the dark until bands 
developed (minutes-hours) whereupon the gel is transferred 
to d.w. and photographed.
Most protein gels were photographed by the author on a 
light box with a Polaroid CU-5 camera and type 665 +ve/-ve 
film. A red filter was used to photograph Coomassie stained 
gels by this method. The gel in Figure 4.7 was photographed 
by the Medical Illustration Unit of Glasgow University. In 
all figures the direction of electrophoresis is from top to 
bottom unless otherwise stated.
2.8 Digestion of DNA with restriction enzymes
2.8.1 Buffers
All restriction enzyme digests were carried out, 
essentially as described in Maniatis €it al. (1 9 8 2), in one 
of four buffers:
’’Low salt” - lOmM Tris-HCl pH 7-5, 10mM , ImM DTT
’’Medium salt” - 50mM NaCl, lOmM Tris-HCl pH 7*5, lOmM MgCl^,
ImM DTT
’’High salt” - lOOmM NaCl, 50mM Tris-HCl pH 7*5, lOmM MgCl2,
ImM DTT
”Smal” - 20mM KC1, lOmM Tris-HCl pH 8.0, lOmM MgCl2, ImM DTT 
These were made up as 5x. stocks. The glass-ware, plastic—ware, 
d.w., stock NaCl, Tris-HCl, KC1, and MgCl2 solutions used 
were all first autoclaved. The stock DTT solution was made 
up in autoclaved d.w. The 5x stocks were stored at -20°C 
in small aliquots. In general, all manipulations involving 
DNA were done using autoclaved materials and implements 
wherever possible.
2.8.2 Conditions
Analytical digests were commonly done in a 20 jil volume.
The appropriate buffer and temperature were selected using 
Maniatis al. (1 9 8 2) or the restriction enzyme supplier’s 
data sheets. Nuclease-free bovine serum albumin was added 
to all restriction digests to a final concentration of 100 jig/ml.
A typical analytical digest would consist of:
b ]il 5x buffer
2 111 1 mg/ml nuclease-free bsa
0.1- 1 ]Ag DNA
restriction enzyme suspension 
(autoclaved) d.w. to 20 Hi 
Most of the restriction enzymes can be used in more 
than one of the general buffers thus facilitating double 
digests. However, where no common buffer was usable the 
lower salt digestion was done first and then the digest 
conditions adjusted. For double digests involving Smal 
the DNA was purified after the first digest (see Section 2.12
2.8.3 Restriction mapping
This was done mainly by using a combination of single 
and double digests and logic. Sequential digests of fragment 
cut out of low melting point agarose gels were also used 
occasionally. These were done exactly as described in 
Maniatis ejt al. (1 9 8 2). Fortuitous partial digestions were 
often very useful. The gel systems used to separate and 
size the products of mapping digests are considered in the 
next section.
2.9 Gel electrophoresis of DNA
DNA was most commonly run in horizontal submerged 
agarose slab gels essentially as described in Maniatis e_t al. 
(1 9 8 2). The dimensions of the agarose gels were either
11 (long) x 13 x 0.7 cm or 22 x 13 x 0.7 cm. The Tris-borate 
(TBE) buffer system was used here, as for all DNA gels.
The lOx stock contains, per litre:
108 g Tris base 
35 S boric acid
9.3 g Na2 EDTA.2H20 
For analysing very small DNA restriction fragments 
polyacrylamide slab gels were used, with the Tris-borate 
buffer system, as in Maniatis jet al. (1 9 8 2). The slab gel 
apparatus used was the same as that described above for 
protein gels. (Polyacrylamide sequencing gels are considered 
in Section 2.14).
Samples for both agarose and polyacrylamide gels were 
loaded after adding 0.1 - 0.2 volumes of Msample loading buffer 
5 0$> (w/v) sucrose, 0.25$ (w/v) bromophenol blue.
After electrophoresis, DNA gels were stained in 1 )tg/ml 
ethidium bromide (in d.w.), destained briefly in d.w., examined 
on a long-wave U.Y. transilluminator (u.V. Products Inc.), 
and photographed (if desired) through a red filter using a 
Polaroid CU-5 camera with type 665 +ve/-ve film. In all 
figures, the direction of electrophoresis is from top to 
bottom unless otherwise stated.
The sizes of restriction fragments were determined by 
running marker fragments of known size alongside the unknown 
fragments. The most commonly used.sets of marker fragments 
were phage X cl857S7 cut with Hindlll, X cut with Hindlll
+ EcoRI, and plasmid pAT153 cut with HinfT. The sizes of4 
these sets are given in the appropriate figure legends. The 
known sequence of pAT153 also allowed precise tailoring of 
markers for sizing particular fragments.
Isolation of restriction fragments from agarose gels was 
initially done by the method of Dretzen e_t al. (1981) in a 
few early experiments. However, this method was soon abandoned 
in favour of the more convenient low melting point agarose 
technique which was performed as described in Maniatis ejb al. 
(1982) with the following modifications:
(i) the diluted molten agarose is cooled from 6 5°C to 
37°C (not room temperature) prior to extraction 
with phenol.
(ii) 3 phenol extractions were performed (rather than 
just l) to reduce contamination of the purified 
DNA with agarose.
2.10 Isolation of plasmid DNA
2.10.1 Large scale isolation of pure plasmid DNA
The large scale isolation of plasmid DNA, in pure form, 
was done using a scaled up version of the Birnboim and Doly 
(1979) alkaline/SDS procedure followed by CsCl/ethidium 
bromide isopycnic density gradient centrifugation.
The isolation was usually done from a 500 ml culture 
(grown in a 2000 ml conical flask on an orbital shaker).
In some early preparations chloramphenicol amplification was
used but it was generally found more satisfactory simply 
to grow the culture to stationary phase. The cell pellet 
from 500 ml of culture is resuspended in 20 ml of lysis 
solution and thereafter the volumes follow the proportions 
used in the Birnboim and Doly (1979) "mini-prep"• Following 
the first precipitation (with isopropanol) the pellet of 
nucleic acids is resuspended in lOmM Tris-HCl pH 8.0,
2mM Na^ EDTA (TE) and subjected to CsCl/ethidium bromide 
isopycnic density gradient centrifugation as described in 
Maniatis et al. (1 9 8 2). The lower of the two bands in the
gradient, which contains supercoiled plasmid DNA, is harvested 
by suction. Ethidium bromide is removed by 5-6 extractions 
with isopropanol (saturated with TE, saturated with CsCl).
The CsCl is removed by dialysis against TE. Purified plasmid 
DNA was routinely stored at k ° C  in TE containing a tiny drop 
of CHCl^. For long term storage (years) the plasmid DNA was 
kept at k ° C in the dark in 1.5M NaCl, lOmM Tris-HCl pH 8.0,
2mM Na^ EDTA plus a tiny drop of CHCl^.
2.10.2 Rapid small scale isolation of plasmids
It is very useful to have a method for quickly isolating 
a small, impure but restrictable sample of a recombinant 
plasmid from a small O/N culture. This permits many clones 
to be screened for the presence of a recombinant with the 
desired insert. The method of Holmes and Quigley (1 9 8I) 
was used for this purpose. This gives DNA which cuts readily 
with restriction enzymes and can also be used successfully
to transform bacteria. These mini-preps are stable when 
stored at -20°C.
2.11 Isolation of phage \  spcl DNA
2.11.1 . Isolation of phage \ spcl
E. coli strain NOI267 was used to prepare phage \  spcl.
This strain (see Table 2.l) is a double lysogen of the defective 
\  spcl and the helper \ c l857S7« The helper phage strain carries 
the standard temperature sensitive allele of the cl immunity 
repressor gene and is also defective in the lysis function, 
having an amber mutation in the S gene. The practical 
implications of this are that;
(i) NOI267 can be grown at 30°C as a stable double lysogen.
(ii) Both types of prophage can be induced to enter the lytic 
cycle by heating the cells to 42°C.
(iii) One must lyse the cells.
(iv) One obtains, initially, a mixture of the two kinds of 
phage from which \ spcl must be separated prior to the 
isolation of \ spcl DNA.
The method used for the isolation of \  spcl phage is a modified 
version of that given in Maniatis e_t al. (1 9 8 2), based on 
advice from D.W. Meek (personal communication); Inoculate 
25 ml Nutrient Broth + streptomycin with a single colony of 
E. coli NOI267 and grow O/N at 30°C. Inoculate 2 x 500 ml 
Nutrient Broth (in 2000 ml conical flasks; prewarmed to 30°C)
each with 10 ml of fresh 0/N. Incubate at 30°C on an 
orbital shaker with vigorous aeration until = 0.45»
Induce by placing the flasks in a 42°C shaking waterbath 
for 35 minutes, then incubate at 39°C with vigorous orbital 
shaking for 2.75 h. Harvest the cells by centrifugation 
at 4°C and resuspend in 20 ml SM phage buffer: lOOmM NaCl,
8mM MgSO^, 30mM Tris-HCl pH 7-5, 0.01# (w/v) gelatin. Add 
0.4 ml chloroform and shake vigorously at 37°C for 10 minutes 
to lyse the cells. Add deoxyribonuclease I (10 jig/ml final) 
and shake for 10 minutes at 37°C. Pellet cellular debris 
(4°C, 10,000 g, 10 min). The supernatant is the crude phage 
suspension. The phage are then partially purified by 
centrifugation on a CsCl step density gradient: 3 steps - 
densities of 1.7, 1*5, and 1.3 g/ml - with the CsCl dissolved 
in SM phage buffer. Layer 1 ml of each step in two 14 ml 
polycarbonate tubes for the MSE 6 x 14 ml Ti swing-out rotor 
(MSE Prepspin 50 centrifuge) or equivalent, then layer 9 ml 
of crude phage suspension in each tube. Spin for 2 h at 
33 krpm, 20°C. The phage band lies at the interface between 
the 1*3 and 1.5 s/m1 steps and is harvested by suction from 
above. It should have a strong bluish-white opalescence.
The X  spcl transducing phage is then separated from the helper 
phage.(and both further purified) by a shallow CsCl equilibrium 
density gradient: adjust the phage suspension from the step
gradient to a density of 1.5 g/ml using CsCl and SM phage 
buffer. Spin at 27 krpm, 20°C for 18-24 h in an MSE 10 x 10 ml 
aluminium angle rotor (119; MSE Prepspin 50 centrifuge). Let
the rotor coast to a halt without braking. Harvest both 
bands individually - the top band is \ spcl. Dialyse the 
phage extensively against SM phage buffer to remove the CsCl.
2.11.2 Determination of phage titre
Preparation of plating bacteria. Inoculate 50 ml of L Broth 
(with 0.2fo (w/v) maltose rather than D-glucose) with a 
single colony of E.coli Ymel (see Table 2.1) and grow for 
10 h in a 250 ml conical flask on an orbital shaker. Pellet 
the cells and resuspend in sterile 0.01M MgSO^. Store at 4°C. 
This plating bacteria suspension can be used for up to 3 weeks 
but better results are obtained if it is used fresh.
Plating the phage. Make serial 10-fold dilutions of phage 
stock in SM phage buffer (see above). Add 0.1 ml of plating 
bacteria suspension to 0.1 ml of each dilution to be assayed. 
Incubate 37°C, 10-20 min. Add 3 ml of \  phage top agar at 
a temperature of 4-5°C, mix quickly but gently, and pour on 
to a plate of bottom agar. Incubate plates at 37°C 0/N.
Count plaques.
2.11.3 Isolation of phage V  DNA
This was done, for both \ spcl and \ cl857S7. hy the 
method given in Maniatis _et al. (1982).
2.12 Construction of recombinant plasmids ("cloning”)
2.12.1 General points
Methods for restriction enzyme digestion of DNA have 
already been described (see Section 2.8). As mentioned 
briefly there, it is necessary when manipulating small 
quantities of DNA (especially when the condition of the 
"ends" is important) to avoid contamination with deoxyribo- . 
nucleases. Thus, all Eppendorf tubes and plastic pipette 
tips should be autoclaved before use. Likewise, all solutions 
should be autoclaved if possible or, where there are labile 
components, made up with autoclaved d.w. All the methods 
considered below can be found, in some form, in Maniatis 
et al. (1982). An accessible Eppendorf centrifuge is essential.
"TE” = lOmM Tris-HCl pH 8.0, 2mM Na2 EDTA.
"Phenol:chloroform" refers to a 24:24:1 mixture of 
(respectively) phenol:chloroform:iisoamyl alcohol which has 
been saturated with TE. "Chloroform" refers to chloroform 
which has been saturated with d.w.
2.12.2 Preparation of vector and insert DNA for cloning 
After restriction enzyme digestion the DNA must be 
purified prior to ligation: adjust the volume of the completed
digest to 150 pT with TE. Extract once with an equal volume 
of phenol:chloroform (unless otherwise stated retain the 
aqueous phase). Back extract the phenol:chloroform with 
80 p,l TE and combine the aqueous phases. Extract with an
equal volume of phenol:chloroform followed by three 
extractions with chloroform. Adjust to 0.25M sodium acetate 
with an autoclaved 4M stock solution, pH 7*4. Precipitate 
the DNA: add 2.15 volumes of absolute ethanol and either 
freeze in dry-ice/methanol (10 min) or leave at -20°C for 
1 h or longer. Spin in the Eppendorf centrifuge for 10-15 min * 
(room temperature). Remove the supernatant carefully - the 
desired pellet is often "invisible”. Dry the pellet very 
briefly under vacuum. Resuspend in a suitable volume of TE 
and store at -20°C until required. It is usually wise to 
run a small sample of the purified DNA on an agarose gel to 
check that the DNA has not been lost. Note that DNA purified 
from low melting point agarose gels is ready for use in 
ligations.
2.12.3 Dephosphorylation of DNA
In some experiments the cut vector was dephosphorylated 
to prevent self-ligation. Calf intestinal alkaline phosphatase 
was used (see Section 2.1.3) and the method employed was that 
given in Maniatis ejb al. (1982) with the changes shown below.
1 unit of calf intestinal alkaline phosphatase (CIP) 
activity is defined as the amount of enzyme which releases 
1 p.mole of p-nitrophenol from p-nitrophenyl phosphate per 
minute at 37°C in 0.1M glycine/KOH pH 10.5, lmM MgCl^,
O.lmM ZnCl^. Vector DNA to be dephosphorylated was purified 
after restriction enzyme digestion as described above.
Spermidine was omitted from the dephosphorylation buffer.
After the heat step the DNA was again purified as described 
above.
2.12.4 Ligations
These were performed, using T4 DNA ligase, in a final 
volume of 20 p.1. The lOx ligase buffer used was 660mM 
Tris-HCl pH 7*6, 66mM MgCl^ and a ligation contained:
vector DNA
insert DNA
d.w. to 20 p.1
2 p.1 lOx ligase buffer
2 ill 5mM ATP
2 p.1 0.1M DTT
T4 DNA ligase
Before adding ligase heat the mixture to 65°C for 1 minute. 
Incubate the completed mixture 2-3*5 h at l4°C followed by
1.5 h at 22°C. Then transform the appropriate host bacteria. 
With phosphorylated vector DNA it is better to use a molar 
excess of insert DNA if possible (say 3-fold)• However, 
with dephosphorylated vector it is better to use a molar 
excess of vector DNA if possible (say 3-fold) since this 
reduces the number of recombinants with multiple inserts.
2.13 Transformation of bacteria with plasmids
The method of Dagert and Ehrlich (1979) was used. Prior 
to plating on media containing ampicillin or tetracycline 
a standard expression period of 90 min was allowed.
2.14 M13/dideoxy sequencing of DNA
2.14.1 Technical procedures
A detailed summary of the M13/dideoxy sequencing method
is given in Section The detailed procedures were
carried out as described in Ajnersham’s ”M13 Cloning and 
Sequencing Handbook” (1 9 8 3). Where a choice of methods and 
materials is possible those actually used are described below. 
The basic materials for M13 cloning and sequencing were 
obtained in the form of kits from Amersham as described in 
Section 2.1. The M13 Cloning Kit N. 4-501 was used together 
with the Ml3 Sequencing Kit N.4502.
When preparing SS M13 template DNA an additional (optional) 
step was used immediately before the ethanol precipitation 
step, namely one extraction with 200 *}i.l of chloroform to 
remove residual polyethylene glycol 6000 since the latter 
gives rise to artefactual bands on the sequencing gels.
When a particular template was found to give artefactual bands 
either a different isolate of the same clone was sequenced 
or the original preparation was re-extracted with chloroform.
The 6jo polyacrylamide sequencing gels used were 20 x 40 x 
0.04 cm and were not poured using the buffer gradient system. 
Different loadings of the same sequencing reactions were used 
to obtain different running times and thus maximise the 
length of sequence that could be determined from each template. 
Usually (but see below) one loading was run for about 1*75 £l
The radioactive label used was
and another for about ^ . 5  h either on the same or separate 
gels. In early experiments gels were run at 25-28 mA without 
any preheating. A number of troublesome "compressions" of 
the band spacing occurred as a result. Later all gels were 
preheated (3 0 min, 33 mA) before the samples were loaded, 
and then run at 30-32 mA. This cured all "compression" 
problems.
After electrophoresis the gels were fixed and then dried 
on Whatman 3^M paper using a Bio-Rad Model 1125 gel dryer 
before autoradiography (l6-48 h) using Fuji RX film.
In one case the technique of clone "turn-around" was 
used (see Chapter 3 ). The DS replicative form was prepared 
from SS template DNA using the in vitro method.
For extended sequencing up to 400 bases the concentration 
of ddNTP was reduced to 0.75 of that normally used and the 
period of electrophoresis was extended to 5 * 5 h.
2.14.2 Compilation of the sequence
At every stage between reading the sequencing gel 
autoradiographs and the final print-out from the computer 
a system of multiple checks was used in an effort to prevent 
errors. However, by far the best line of defence against 
mistakes was the sequencing of both strands.
The primary data from the sequencing gels were recorded 
on specially designed sheets. While reading the autoradiographs 
attention was paid to the following possibilities:
(i) weak bands (in the upper reaches of a gel) especially 
the first C of a doublet or an A at the end of a run 
of A* s
(ii) artefactual bands
(iii) compressions, especially in the vicinity of C/G 
rich regions.
A ruler was used very frequently to check the spacings between 
bands by comparison with adjacent sets of tracks. It was 
often useful to measure the spacing between bands well above 
and below a suspect region and to compare the total number 
of bands within that wide region with the expected total.
Overlapping sequences and complementary strands were 
quite easily identified by visual inspection of the auto­
radiographs.
All doubtful regions were so indicated on the primary 
data sheets. It was always possible to deduce the sequence 
of a region, using both strands, even in areas of bad 
compression. However, as a precaution, where there was 
ambiguity in the same vicinity on both strands this region 
was sequenced again on both strands using gels run at a higher 
current (hence higher temperature) until the sequence could 
be read unambiguously on both strands. Even where there 
was only ambiguity on one strand and the other strand was 
unambiguous both strands were sequenced again (except in 
cases where the original ambiguity was clearly a faint 
artefactual band with no trace of a complementary band in 
the other strand, and no anomalies in the spacing). The 
original "consensus" sequence proved correct in all cases.
When a fully overlapping sequence had been obtained 
the consensus sequence for each strand was entered into a 
Digital PDP 11-34 computer using part of the program BATIN 
(Staden, 1980). The sequence of each strand was entered 
as segments (each into a separate file). A print-out of 
each file was subsequently checked against the original 
consensus sheets. As the main check on the accuracy of the 
computer files the files containing complementary strands 
were compared using the program TTEM (R. Eason, unpublished).
A perfect match was found in all cases. Each file was 
entered beginning and ending with half a restriction site.
This greatly facilitated the final merger of files (in the 
correct order) to construct the complete sequences of both 
strands of the Hindlll-Clal fragment. The total number of 
bases in the files for each whole strand were equal, and 
equal to the number expected from the sum of the component 
files.
Although all sequences had been checked visually for 
double inserts the program CUTSIT was used to locate all 
restriction sites in the final sequence. All known sites 
were found but no unexpected ones.
2.14.3 Analysis of the sequence data
Except for the DOTPLOT program (see below) all programs 
were run on a Digital PDP 11-34 computer.
The program TRNTRP (Staden, 1978) was used to translate 
DNA sequences in any desired reading frame. The relative 
positions of stop codons in all six frames were plotted manually.
The program HAIRPN (Staden, 1978) was used in a limited 
search for palindromic structures. Only those structures 
with !,loopM sizes ^ 3 and 4 10 bases would have been found 
by this search and, furthermore, only those where the symmetry 
related elements immediately flanking the central ’’loop” 
were ^  4 bp long. A print-out of the positions of palindromic 
structures meeting these conditions was obtained. Each one 
was examined with a view to extending it.
The DNA sequence was examined for speculative promoters 
in two ways. Firstly, the region upstream from aroE was 
checked manually using a print-out of the sequence and a 
double (sliding) card system to accommodate the variable 
spacing between the ”-35” region and the Pribnow box. The 
assumption was made that the final T in the Pribnow box 
would be conserved (see Section 5*9*1)* This assumption is 
valid for 108 of the 112 well-established promoters listed by 
Hawley and McClure (1 9 8 3 )* Only promoters acting in the 
BamHI to Hindlll direction were searched for. Each T 
upstream from aroE was checked to see if the sequences 
further upstream loosely fitted the consensus E.coli promoter 
sequence (see Section 5*9*1)•
Secondly, a SEARCH program was used to look for sequences, 
in the Clal-Hindlll sequence, differing from the Pribnow box 
consensus by only a single base and for sequences differing 
by no more than one base from the first five bases (the 
most conserved) of the ”-35” region consensus sequence. All 
"finds” were examined manually to see if anything approximating
the other region/box was present.
The amino acid sequences of E.coli shikimate dehydrogenase 
and N.crassa catabolic quinate/shikimate dehydrogenase were 
compared using the DOTPLOT program from the WISGEN software 
package (Devereux ejfc al., 1984). This package was devised by 
the Wisconsin Genetics Computer Group and was available on 
the Edinburgh Regional Computing Centre’s VAX 11/750, from 
where DOTPLOT was run with the assistance of A. Coulson.
2.15 Large scale purification of overproduced E.coli E3 
from pIA32l//AB2834
2.15*1 Growth of cells
7 x 50 nil L Broth plus ampicillin, in 250 ml conical
flasks, were each inoculated with 2.5 ml of an 0/N culture
of pIA32l//AB2834 (grown in L Broth + ampicillin) and incubated
on an orbital shaker for 2 h at 37°C. Then 13 x 500 ml
prewarmed L Broth + ampicillin, in 2000 ml conical flasks
were each inoculated with 25 ml from the 50 ml cultures and
shaken at 37°C for 5*25 h. 1.25 h after this inoculation the
lac inducer IPTG was added to each 500 ml culture to a final
-4concentration of 5 x 10 M. After 5*25 h of growth the 
cultures had reached stationary phase (A^q = 3*7 - 3*8) and 
were removed to ice prior to harvesting by centrifugation 
(MSE 6 x 750 ml rotor, 10°C, 15 min, 5 krpm). The cells 
were stored at -20°C until required.
2.15*2 Purification of E3
This was carried out almost exactly as described in 
Chaudhuri and Coggins (1 9 8 5) with a few minor changes which 
are described below. The method is summarised in Chapter 4 
and further details are given in the figure legends.
Buffers were prepared from a stock of 1M Tris-HCl 
pH 7*5 without any adjustment to the pH after dilution.
Buffer 1 (extraction): lOOmM Tris-HCl pH 7r5, lmM Na^ EDTA,
0.4mM DTT, 1.2mM PMSF.
Buffer 2 (post-ammonium sulphate dialysis, equilibration and 
washing of DEAE-Sephacel column): 50mM Tris-HCl 
pH 7*5, 50mM KC1, 0.4mM DTT, 1.2mM PMSF. The salt 
gradient was based on this buffer.
Buffer 3 (post-gradient dialysis, equilibration of 2 ml mini- 
DEAE-Sephacel column for concentrating enzyme):
50mM Tris-HCl pH 7*5, 0.4mM DTT, 1.2mM PMSF. This 
. is twice the concentration of Tris-HCl used by 
Chaudhuri and Coggins•
Buffer 4 (elution from 2 ml DEAE-Sephacel column) = Buffer 3 
containing 1M KC1.
Buffer 5 (equilibration and running of Sephacryl S-200 superfine 
column): 500mM KC1, 50mM Tris-HCl pH 7*5, 0.4mM DTT. 
Buffer 6 (post-Sephacryl dialysis and equilibration of ADP- 
Sepharose column): 25mM Tris-HCl, 0.4mM DTT.
Buffer 7 (elution from ADP-Sepharose column) = Buffer 6. 
containing lmM NADP+.
Buffer 8 (first post-ADP-Sepharose dialysis, to remove NADP+): 
50mM Tris-HCl pH 7*5, 0.4mM DTT, lmM benzamidine. 
Buffer 9 (storage dialysis buffer): 50$ (v/v) glycerol.,
50mM KC1, 50mM Tris-HCl pH 7*5, 0.4mM DTT, lmM 
benzamidine. The storage buffer used by Chaudhuri 
and Coggins (1 9 8 5) did not contain any KC1.
PMSF (in ethanol) and DTT were added just before use.
Due to the limited capacity of ADP-Sepharose and the 
large quantity of E3 present a 20 ml bed volume was used 
for this column rather than the 5 ml used by Chaudhuri and 
Coggins.
2.16 Protein sequencing
2.16.1 Reduction and carboxymethylation
This was carried out essentially as described by Lumsden 
and Coggins (1978). All glass-ware used was acid-washed.
100 nanomoles (3 mg) of pure E.coli E3 was dialysed 
exhaustively (3 days, 7 changes) against 0.5$ (w/v) ammonium 
bicarbonate. The dialysed material was freeze-dried, re­
suspended in h ml d.w. and freeze-dried again. The dry E3 
was dissolved in 2 ml of 0.1M Tris-HCl pH 8.2, 8M urea 
(recrystallised), 2mM DTT and incubated in the dark, under N^, 
at room temperature for 1 h. The solution was then made 
15mM in iodoacetic acid (from a fresh 300mM stock solution, 
pH adjusted to 7*5 with NaOH) and incubated in the dark for 
a further 1 h. The reaction was terminated by the addition of
DTT to a final concentration of 30mM. The solution was 
then dialysed exhaustively against 0.5$ ammonium bicarbonate. 
The dialysed material was freeze-dried, taken up in d.w., 
and freeze-dried twice more.
2.16.2 Automated N-terminal amino acid sequencing
This was done in collaboration with J.E. Fothergill,
L.A. Fothergill, and B. Dunbar at the SERC funded protein 
sequencing facility at Aberdeen University. The determination 
of the N-terminal amino acid sequence was carried out using 
a Beckman Model 89OC automatic liquid phase sequencer operated 
by B. Dunbar as described in Smith at al. (1982). Thiazolinone 
samples were collected into tubes containing 0.2 ml of 
freshly prepared 1M HC1 containing 1% (v/v) ethanethiol, 
thus readily permitting the detection of serine and threonine 
residues. The phenylthiohydantoin samples were analysed by 
high pressure liquid chromatography on a Waters 5 "Resolve” 
Cig reverse phase column with a pH 5*00 Na acetate-acetonitrile 
buffer system (Carter e_t al• , 1983)* S-carboxymethylcysteine 
was used as an internal standard.
2.17 Amino acid analysis of E.coli E3
2.17*1 General points
The starting material was E.coli E3 purified to homogeneity 
from the overproducing strain pIA32l//AB2834 (see Section
2.15 and Chapter 4). The E3 was almost homogeneous by the 
criterion of SDS PAGE after the penultimate stage of the 
purification. The last step (affinity chromatography on 
ADP-Sepharose) is a powerful one (giving more than a 40-fold 
purification during the purification of E3 from wild-type 
E. coli) thus one might expect the purified, overproduced 
E3 to have an unusually low percentage of residual contamination 
with other proteins. This was possibly an important factor 
in the good agreement between the observed amino acid 
composition and that predicted from the gene sequence.
Great care was taken at all stages of the analysis to 
prevent contamination with extraneous proteins or amino acids. 
All glass-ware used was soaked overnight in concentrated nitric 
acid before being rinsed exhaustively with tap water followed 
by d.w., drained and then dried in an oven. The clean glass­
ware was stored in a new seal-top plastic container which 
had been thoroughly scrubbed. Two pairs of disposable plastic 
gloves (from a dedicated box) were worn at all times and 
changed regularly. Plastic pipette tips were taken from a 
dedicated, unpunctured bag normally kept sealed.
2.17* 2 Performic acid oxidation
30 nanomoles (0.9 mg) of pure E.coli E3 was dialysed 
exhaustively against 0.5$ (w/v) ammonium bicarbonate.
DL-nor-1eucine was then added as an internal standard and 
the material was freeze-dried, redissolved in a few ml of
d.w., and lyophilised again.
Performic acid oxidation was then carried out (to convert 
the cysteine and methionine residues to derivatives stable 
under the subsequent acid hydrolysis conditions) by the method 
of Hirs (1 9 6 7). The oxidation was terminated by dilution 
with d.w. followed by lyophilisation. After redissolving in 
d.w. and further lyophilisation the "oxidised" protein was 
dissolved in 200 ]il 99$ formic acid, diluted up to 2 ml with 
d.w., divided equally between 4 pyrex test-tubes (avoiding 
contact with the sides) and freeze-dried once more prior to 
acid hydrolysis.
2.17*3 Acid hydrolysis
Each of the above tubes received 500 )il of 6M HC1 
(Aristar) containing 0.17$ (v/v) 2-mercaptoethanol, without 
any of the acid touching the sides of the upper part of the 
tube. The tubes were then sealed under vacuum (with the 
assistance of J.R. Coggins) and placed in a 105°C heating 
block. One tube was removed after 23*9, 47*8, 72.1, and 
94.9 hours. Tubes were stored at -20°C until all were ready, 
whereupon they were opened and desiccated over concentrated 
H^SO^ and NaOH pellets, under vacuum. After resuspension in 
d.w. and further desiccation as before the samples were left 
0/N under simple vacuum prior to resuspension in 125 anc* 
analysis.
2.17.4 Analysis and data processing
The protein hydrolysates were analysed on an LKB Model 
4400 amino acid analyser (with integrator) operated by J. 
Jardine. Data processing was performed by the author except 
for integration of the proline peaks from the original chart 
recorder traces which was done by J. Jardine.
Standards were run immediately before and after every 
set of 3 03? 4 experimental runs. Although there was not 
usually much difference an average value of the nmol/area 
figure was calculated for each standard amino acid (in all 
cases).
For a given loading, the 95 hour timepoint values were 
all about 3*3 times lower than those for the 24, 48, and 72 
hour timepoints. However, the DL-nor-leucine values were, 
incomprehensibly, very similar in all four cases. For this 
reason the 95 hour timepoint data were discarded.
For each of the other three timepoints two 5 ,ii i oadings, 
one 10 ji.1 loading, and one 25 >tl loading were run. Data 
from the 25 *1 1 oadings were not used except for cysteic 
acid (see below) because many of the peaks were overloaded 
and merged with adjacent peaks.
Considerable problems were encountered with the integrator 
Peaks were often misassigned by the machine so print-outs 
were examined by eye and the appropriate calculations performed 
manually (in all cases) using correctly assigned areas for 
each peak. More seriously, for unknown reasons the integrator 
sometimes made errors in deciding which points to integrate
between and with what baseline. Thus, the integration 
markers were examined for every peak in every print-out 
(including the standard runs) and data from peaks with 
obvious integration errors were discarded. This was done 
before calculating the predicted amino acid composition 
from the gene sequence and before calculating the experimental 
composition.
Except for threonine, serine, valine and isoleucine (see 
Chapter 4) the values, in nmol, for the three different runs 
with each of the three different timepoints (minus integrator 
error values) were simply averaged (but see below). Each 
average was based on the following number of values: 
asx(9), methionine sulphone(9), glx(5), gly(9), ala(9), leu(9), 
tyr(8), phe(9), his(9 ), lys(9), arg(7)« The values, in 
nmol, for each amino acid within a given run were summed and 
from this figure the values for each a.a. were normalised 
to give a total of 100 nmol of amino acids per run. This 
allows one to average a different number of values for 
particular amino acids, without distorting the time experimental 
ratio, where two different sizes of loading have been used.
With the cysteic acid peak the integrator made an error 
in every run (including standard runs), starting the integration 
from the bottom of a sharp, shallow valley of roughly constant 
size which always preceded the main peak. This error was 
clearly of least significance for values calculated from the 
largest (2 5 j-tl) loadings. Fortunately the cysteic acid peak
is well isolated so merging of peaks is not a problem. Also, 
with the 25 Til loading the experimental peaks were about the 
same size as the standard peaks thus effectively removing 
the error. However, since the 25 1*1 loadings (for all three 
timepoints) always tended to give slightly higher values 
for all the other amino acids the value for cysteic acid, 
calculated from the average of the 24, 48, and 72 hour 25 1*1 
runs, was normalised using the values for arginine.
CHAPTER 3 SUBCLONING AND DNA SEQUENCING OF THE E.COLI
AROE GENE 
h i  Preliminaries
3*1.1 Isolation of phage Xspcl DNA
Xspcl was prepared from E.coli strain N01267 (Jaskunas 
et al., 1975a)• This strain is a double lysogen of the 
defective Xspcl and of the helper Xcl857S7* In Chapter 
Two there is a detailed description of the isolation of 
the two kinds of phage, of their separation, and of the 
extraction of their DNA. Xspcl is known to form the upper 
band in the CsCl equilibrium density gradient which is used 
to separate the two types of phage (D.W. Meek, personal 
communication). The two phage bands in the equilibrium 
gradient were of approximately equal intensity. The 
infective titre of the Xspcl band was much lower than that 
of the helper band, as expectedj-
upper band: 1.1 x 1 0 ^  plaque-forming units per ml.
12lower band: 3*3 x 10 plaque-forming units per ml.
Thus, it appears that the defective Xspcl phage were 
slightly contaminated with approximately 3$ of helper phage 
a negligible amount. The identity of the two phage DNAs 
was confirmed by analysis of restriction fragment patterns. 
A restriction map of Xspcl was available (R. Hayward, 
personal communication). It had been compiled from the 
work of many people in different laboratories (C. Ma,
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et al. , 1975t>) • Figure 3*1 shows the sites relevant to 
the initial subcloning of aroE. Single digests of the 
presumptive Xspcl DNA with the restriction enzymes Hindlll, 
EcoRI, Sail, and Bglll gave DNA fragments of the sizes 
expected from the map (data not shown). Digestion of the 
presumptive Xcl857S7 DMA with the same enzymes gave 
patterns identical to those of the standard Xcl857S7 DNA 
that was used to make the restriction fragment size 
markers. These latter patterns are readily distinguishable 
from those of Xspcl.
3.1.2 E.coli AB2834
We tested our stock of E. coli AB283^- to confirm that 
it was still an aroE auxotrophic mutant. In plate tests 
the strain behaved as expected (see Table 3»l)» Minimal 
medium must be supplemented with all three aromatic amino 
acids plus p-aminobenzoate and p-hydroxybenzoate to allow 
E.coli AB283^ to grow well. This implies a block in the 
common pathway. The failure of AB283^- to respond to a 
DHS supplement together with its good response to a 
supplement of shikimic acid strongly suggest that the defect 
is in the aroE gene. These common pathway intermediate 
supplements were given together with phenylalanine and 
tyrosine. DHQ, DHS, and shikimic acid alone can be growth 
factors for suitable mutants. However, some mutants 
respond poorly to these compounds if they are given alone 
but very well if the intermediate is given along with 
tyrosine and phenylalinine (Davis and Weiss, 1953 > Ely
Table 3«1 Growth of B« coli strains AB283^~ and K12 on
solid media







trp + PABA + PHBA - ti
phe + tyr - it
phe + tyr + trp - i
phe + tyr + trp + PABA + it
phe + tyr + trp + PHBA +/- it
phe + tyr + trp + PABA + PHBA +++ it
phe + tyr + DHQ - it
phe + tyr + DHS - it
phe + tyr + shikimic acid +++ ii
NOTES: 1. In all cases the supplements were added to
minimal medium.
2. Details of the various media are given in Chapter 
Two •
3« Key: +++ = wild-type growth
++ = moderate growth 
+ = slight growth 
+/- = barely detectable growth 
- = no growth detectable 
k, E.coli K12 is taken as wild-type.
and Pittard, 1979)* For an aroE mutant the following 
scheme was elucidated: the strain accumulated DHS heavily
and this competitively inhibited utilisation of shikimic 
acid. With increasing inhibition the various end products 
of aromatic synthesis were eliminated in a fixed order, 
tyrosine and phenylalanine being the first to be lost 
(Davis and Weiss, 1933)* As a control for the stability 
of DHS in plates an E2- aroD auxotrophic strain was tested. 
This strain, E. coli AB28^-8, responded well to a DHS 
supplement which confirmed the stability of DHS in plates.
As a further check crude cell extracts were made from 
E.coli strains AB283A-, AB2848, and K12. Each of these 
extracts was assayed for E3 activity. The results are 
shown in Table 3*2. There was no detectable E3 activity 
in AB2834 in contrast to the activities of the AB2848 and 
K12 control strains. Thus it was concluded that our stock 
of AB283^ was almost certainly a genuine aroE mutant.
h .2 Initial subcloning of aroE from Xspcl
3.2.1 Isolation of the first putative positives
The available restriction map of Xspcl (Figure 3»l) 
showed a Bglll site at the extreme left end, outside the 
region of transduced bacterial DNA. The next Bglll site 
to the right was over 28 kbp away. The distance from the 
left end to the first EcoRI site was 13 kbp and this site 
was known to be in the RNA polymerase/ribosomal proteins 
operon (jaskunas _et al. , 1973^)* This operon lies to the
Table 3.2 E3 specific activities of* crude cell extracts
of E.coli strains AB283^-« AB2848 and K12
Strain Specific activity of E3 in crude extracts (units/mg)
K12 0.05
AB2848 0 .1 3 2
AB2834 none detectable
NOTES: 1. The limit of detection was less than 0.0006 u/mg
2. Mixing experiments (e.g. K12 extract + AB283^ 
extract) were not done but later work involving 
the activity staining of SDS gels, after 
renaturation, effectively rules out the 
possibility of some inhibitory species in the 
AB283^- extracts.
right of aroE when the E.coli linkage map is orientated 
with the phage. Thus, the 12.6 kbp Bglll-EcoRI fragment 
from the left end of Xspcl was expected to include the 
aroE gene. This fragment was cloned in a suitable plasmid 
vector so that its ability to relieve the auxotrophy of 
E. coli AB283^- could be tested.
The multicopy plasmid vector pAT153 (Figure 3*2) 
was used for this experiment (Twigg and Sherratt, 1980; 
the details of the construction of pAT153 given in the paper 
are now known to be slightly in error - Old and Primrose, 
198l). The copy number of pAT153 is 1.5 to 3 times higher 
than that of pBR322 so that higher levels of plasmid 
specified gene products are obtained. The pAT133 used was 
prepared from a strain (E.coli AB2829) with a functional 
EcoK host modification system because AB283^- has a functional 
EcoK host restriction system and the pAT153 sequence contains 
an EcoK site which if left unmethylated would result in 
about a 20-fold reduction in the efficiency of transformation 
of AB2834 by pAT153.
There are no Bglll sites in pAT153* However, Bglll 
sticky ends can be ligated with BamHI sticky ends (though 
the resulting hybrid site is cleavable by neither of the 
two enzymes). Xspcl DNA was digested with Bglll and then 
with EcoRI, whereas pAT153 was digested with BamHI and 
then with EcoRI. After purification the DNA from the two 
digests was ligated and used to transform competent AB283^ 
cells. (This is, in effect, a "mini-shotgun" experiment).
EcoRI








Figure 3.2 Plasmid vector pAT153
The origin of DNA replication is marked "Ori”. The 
two drug resistance markers Amp and Tet-^ , specifying 
resistance to ampicillin and tetracycline respectively, 
are hatched and the direction of transcription is shown 
for each. Some useful restriction sites are marked and 
the cleavage coordinates are shown. The total length of 
pAT153 is 3657 base-pairsi pAT153 is derived in a known 
way from pBR322 (Twigg and Sherratt, 1 9 8 0) and the complete 
DNA sequence of the latter plasmid is known (Sutcliffe,
1979)-
The cells were plated onto L agar + ampicillin to select 
for transformed cells. After overnight growth about 
970 colonies were replica plated onto minimal agar. 27 
colony replicas grew well on the minimal plates whereas 
the remainder showed no signs of growth. These 27 colonies
g
constituted the putative positives. As a control 3 x 10 
AB2834 cells were plated directly on minimal agar after 
CaCl^ treatment and transformation with pAT133» No colonies 
appeared on these control plates which implied that the 
reversion rate of AB283^ is rather low. The replica 
plating step was used, rather than direct plating onto 
minimal medium, to ensure that any cloned aroE genes would 
have had sufficient time to be expressed in the cell. This 
was later shown to be an unnecessary precautions Aro+
AB283^ cells carrying aroE recombinants can be recovered 
after plating directly on minimal medium, provided the 
cells are suspended in rich medium.
3.2.2 “Ways in which false positives could arise
There are a number of ways in which one could be 
misled by false positives
(a) The most obvious danger is AB283^- cells reverting to
prototrophy. As mentioned above this is a very rare event.
Also, since the initial selection is for ampicillin resistance
and since only a tiny proportion of the cells are actually
transformed by any kind of plasmid, the chances of getting 
R +an Amp , Aro revertant are very remote. However, it is
+
still wise to check that the Aro phenotype of a putative
positive is due to a plasmid. This can be done by preparing 
plasmid on a small scale from several positives and back
transforming into AB283^-* One would then expect that all
R +Amp colonies would also be Aro •
(b) AJB283^ carries the wild-type recA gene. If4 a recombinant 
plasmid carried an inactive version of the aroE gene it is 
conceivable that complementation might arise from recombination 
between the nonfunctional plasmid-borne allele and the 
(different) nonfunctional AB283^ allele. In this case it
is very unlikely that all cells which became Amp , in a 
back transformation experiment, would also become Aro+.
(c) It is possible that the plasmid in a putative positive 
does not carry the desired gene but rather a gene which 
suppresses the mutant phenotype of the host cell (e.g. a 
suppressor tRNA gene could suppress a nonsense mutation
in a gene). This possibility can be effectively ruled out, 
where one is using a high copy number vector, if one can 
show that cells transformed with the recombinant plasmid 
express much higher levels of the gene product than are 
found in normal cells.
3.2.3 Evidence that some of the recombinant plasmids 
carry aroE
Plasmids isolated from putative positives 4L and 8L 
and a control sample of pAT153 were used to transform 
AB283^+. The cells were initially plated on L agar + 
ampicillin and colonies were then replica plated onto both




• o f  colonies
LTet(replicas) MAmp (replicas)
+ve 4L 69 0 69
+ve 8L (39 not done 39
(52 0 52
pAT153 410 410 0
L agar + tetracycline and onto minimal agar + ampicillin.
The results are shown in Table 3*3» The two putative 
positives, 4L and 8L, both yielded plasmids that conferred 
the Aro+ phenotype on all transformed cells. Positive 4L 
was then studied in more detail.
The sensitivity to tetracycline suggested that the 
plasmids were recombinant. Restriction analysis of the 
plasmid from 4L showed that it contained the expected 
12.6 kbp Bglll-EcoRI insert. This recombinant was designated 
pIA306.
When subcloning from Xspcl by the ”mini-shotgun” 
approach one must be alert to the following possible 
complications:
(a) cloning a partial digest product of A-spcl and/or 
cloning into a partial digest of the vector.
(b) Cloning more than one fragment into the one recombinant 
plasmid.
(c) Cloning a hybrid fragment of Ispcl formed by ligation 
of the \  cohesive ends. Hence, when considering the 
possible complete (and partial) restriction digest products 
of Ispcl it is essential to consider both the linear and 
the circular forms of the phage.
The shikimate dehydrogenase specific activities of 
crude cell extracts were determined for the following 
E.coli strains: K12, AB2834, AB2834 transformed with
PIA306 (=pIA306//AB2834), HB101, and pIA306//HB101. 
Dehydroqiuinase specific activities were also determined as
an internal control. The results are shown in Table 
Cells carrying pIA306 show much higher levels of shikimate 
dehydrogenase than normal. In contrast, dehydro<||uinase 
specific activities are fairly constant between comparable 
strains. It could be argued that our K12 strain has an 
abnormally low level of E3 but this criticism is not 
applicable to the comparison between HB101 and pIA306//
HB101. The cultures used to make the latter two crude 
extracts were taken at almost identical values and
they grew at almost equal rates. The final -A-^ q values 
were not determined for the other three cultures but there 
were no great differences between them as judged by eye. 
(Factors that can influence the expression of a gene 
carried by a particular multicopy plasmid are discussed 
in Section 3*3*5 below). It was concluded that E3 was 
being overexpressed due to the presence of aroE on the 
multicopy recombinant plasmid pIA306. Hence, aroE must 
be present on Xspcl between the Bglll and EcoRI sites 
previously described. Later results demonstrate unequivocally 
that aroE has been cloned but the findings described above 
justified proceeding further.














AB283^ 0 0 .0 3 2 not
determined
K12 0 .0 8 6 0 .0 3 2 not
determined
pIA306//AB2834 1.7 0.03^ not
determined
HB101 0 . 1 2 0 .0 1 8 0 . 8 2
pIA306//HB101 1.3 0 .0 1 8 0 . 7 8
NOTES: 1. E3 s.a.(pIA306//HB101) - E3 s.a.(HB101)
E3 s.a.(HB101)
2. E3 s.a, (p IA306//AB2834) _ g
E3 s.a.K12
3. All crude extracts were made from cells grown 
in L  Broth supplemented, in the case of strains 
containing pIA306, with ampicillin to maintain 
selection (see Chapter Two for details).
3*3 Further subcloning of* aroE
3.3»1 Isolation of plasmids pIA305. 307* and 304
Further subcloning experiments were performed to 
locate the aroE gene more precisely (see Figure 3»3 
Table 3*5)• Initially the same approach was used as for 
pIA306 namely a "mini-shotgun” of a particular Xspcl digest 
into AB2834 followed by restriction analysis of plasmids 
isolated from Aro clones. In this way plasmids pIA305,
307, and 304 were obtained. The 2.47 kbp Hindlll-BamHI 
fragment was the only region of Xspcl DNA common to all these 
recombinants thus implying that aroE was located on this 
fragment•
3» 3> 2 Construction of pIA303
The 2.47 kbp common denominator fragment was now 
cloned specifically. A two stage isolation procedure was 
used since a Hindlll + BamHI digest of Xspcl would yield 
several fragments of about 2.5 kbp. Xspcl DNA was digested 
with BamHI and the fragments separated by electrophoresis 
in a 0.6$ agarose gel. The 4.7 kbp fragment (see Figure 
3.1) was isolated from the gel by the method of Dretzen 
et al. (1 9 8 1) and digested with Hindlll. The products of 
this second digest were separated by electrophoresis in 
a 1$ agarose gel and the 2.47 kbp.fragment was isolated 
and then ligated with cut (Hindlll + BamHl) and phosphatased 
pAT153 vector. The ligation mix was used to transform
E.coli HB101 and the cells were plated on L Amp. 9 Amp
H*
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pIA306 12.6 kbp Bglll-EcoRI 
from Xspcl
BamHI + EcoRI
pIA305 10.6 kbp Hindlll 
from Xspcl
Hindlll
pIA307 6.2 kbp Bglll-Aval 
from Xspcl
BamHI + Aval
piA304 4.3 kbp Bglll-BamHI 
from Xspcl
BamHI





-3-•CM kbp Hindlll-BamHI 
from Xspcl (gel)
Hindlll + BamHI
pIA301 1.82 kbp Hindlll-Clal 
from pIA307 (gel)
Clal + Hindlll
NOTES: 1. Fragments in the lower section were cloned
specifically after isolation from agarose gels 
whereas those in the upper section were cloned 
by the "mini-shotgun" approach.
2. Since the Aval recognition sequence is degenerate 
(CPyCGPuG) the isolation of pIA307 was fortuitous.
3. The Structures of -these subc/ones are. shown in Figure 5.8 .
colonies were tested and shown to contain the desired 
recombinant by restriction analysis. This recombinant 
was called pIA3 0 3. Six of these pIA303 plasmid isolates 
were shown to confer the Aro+ phenotype on AB2834. These 
results confirmed the suggestion from earlier subcloning 
experiments that aroE is located on the 2.47 kbp Hindlll- 
BamHI fragment•
3.3.3 Further restriction mapping of the pIA307 insert
The available compilation of Xspcl restriction sites
did not include any sites within the plA303 insert region 
nor any sites closely flanking this region. Further 
mapping of restriction sites in the insert of pIA307 was 
carried out. It was hoped that new sites might allow the 
position of aroE to be better defined. The results are 
shown in Figure 3*4 while Figures 3»5> 3*6, and 3*7 show 
examples of the data used to construct the new restriction 
map.
3.3.4 Construction of pIA301 and pIA302
The newly mapped Clal site in. the 2.47 kbp Hindlll- 
BamHI region was used to construct pIA301. This contains 
the 1.82 kbp Hindlll-Clal fragment cloned into Hindlll + 
Clal cut, and phosphatased, pAT153* In addition, the 4.4 
kbp Hindlll-AVal fragment was cloned into Hindlll + Aval 
cut, and phosphatased, pAT153 to give pIA302. In both 
cases the desired insert fragments were isolated from
? kbp ,1
N P V N N V C  V V N C  X
B/G I H H B A
Insert In PIA303
Figure 3*^ - Restriction sites in the insert of4 pIA307
Key to restriction sites; B/G = BamHI-Bglll hybrid site,
H = Hindlll, B = BamHI, C = Clal, A = Aval, P = PstI,
N = HincII, V = PvuII, X = Xbal, I = Hpal.
Sites labelled underneath the bar are from the previously 
described R. Hayward compilation. As well as the sites 
in Figure 3«1 this compilation also gave sites For Sail, 
Hpal, Kpnl, Smal, and Xhol. However, of these only Hpal 
has a site in the region under consideration. Sites 
labelled above the bar were identiFied during1 this project. 
2 AccI sites and an SstI site have not been mapped. There 
are no sites For Sstll.
Figure 3« 5 Agarose gel analysis of restriction digests of
PIA307
Lane: 1• EcoRI cut pIA307
2. Clal cut pIA307
3. PvuII cut pIA307
4. PstI + BamHI cut pIA307
5. HincII + BamHI cut pIA307
6. HincII cut pIA307
7. Aval + Hindlll cut pIA307 (incomplete digest
8. Hindlll + Clal cut pIA307 (incomplete digest
9. Xcl8 57S7 cut with Hindlll (size markers)
10. pATl33 cut with Hinfl (size markers)
11. pIA307 (undigested)
In each case 0.8p.g of pIA307 was digested and subsequently 
loaded on the gel. A 1 °fo agarose gel was used. DNA fragments 
were stained with ethidium bromide and the gel photographed 
with a Polaroid camera on a U.V. transilluminator. The 
original photograph shows the fainter low m.w. bands better 
than the copy above.
X/HindIII fragments (kbp): 23*6, 9*64, 6.64, 4.34, 2.26,
1.98, O.36, 0.14 .
pAT133/HinfI fragments (kbp): I.63I, 0.317, 0.396, 0.298,
0.221 and 0.220, 0.134 and 0.143,
Figure 3.6 Polyacrylamide gel analysis of restriction
digests of pIA30?
Electrophoresis was through an 8% polyacrylamide gel which 
was subsequently stained with ethidium bromide.
Lane: 2. Clal cut pIA307
3. HincII cut pIA307 
k . PvuII cut pIA307
3» pATI33 cut with Hinfl (size markers)
6. HincII + PvuII cut pIA307 
7- BamHI + PvuII cut pIA307 
8. as for 3*
9» BamHI + HincII cut pIA307
10. Hindlll + PvuII cut pIA307
11. as for 3
12. Clal + PvuII cut pIA307
pAT133/HinfI markers (kbp): 1.631, O.317, O.396, 0.298,
0.221 and 0.220, 0.13^, 0.1^3, 
0.073
This gel was run to look for small fragments that would have 
escaped detection on agarose gels (e.g. bottom of lane 3)»
Figure 3*7 Agarose gel analysis of restriction digests
of pIA307 - precise sizing of particular fragments
1.5% agarose gel.
The relevant marker fragments are underlined. Sizes are
in kbp.
Lane: 2. BamHI + Hindlll cut pIA307 - for sizing of the 
2.47 kbp fragment (second from top)
3. pAT153/BamHI + PstI - markers (2.532, 1.125)
4. Xcl857S7/Hindlll - markers (23.6, 9*64, 6.6k,
4.34, 2 . 26 , 1 .98. O.56, 0.14 )
5. Hindlll + Clal cut pIA307 - for sizing of the
1.82 kbp fragment (second complete digest product 
from the top)
6. IcI857S7/Hindlll + EcoRI - markers (21.7, 5*24,
5.05, 4.21, 3-41, 1.98, 1.90, 1.57, 1.32, 0.93,
0.84, 0 .58. 0.14 )
7* Clal + BamHI cut pIA307 - for sizing of the 0.60 kbp
fragment (fourth from top)
8. pAT153/Hindlll + Sail - markers (3*036, 0.621)
Figure 3*8 Agarose gel analysis of restriction digests
of piA301 and pIA302
Electrophoresis was through a 1 °fo agarose gel which was 
subsequently stained with ethidium bromide.
Lane: 2. Clal cut pIA301 (isolate 3/l/+l)
3 . m  r. it ( tt 3/1/+3)
Hindlll + Clal cut pIA301 (isolate 3/l/+l)
3. " " " " M ( M 3/1/+3)
6. Xcl8^7S7/HindiII markers
7» pAT133/HinfI markers
8. HincII cut pIA301 (isolate 3/l/+l)
9. " " ( " 3/1/+3)
11. Aval + Hindlll cut pIA302
X/Hrnjm m„rk < r s ( k l ?)  :23-4, H4, «4, I U ,  MS, 0-54, 0-14
J\TI?3 /HtnJ-I marker? (W>|.) -. 1-431, 0*17 , 0-316, 0-Z11,0-22I 0-2Z0, 0 • I54,0-l(?r 0-07J-
digests of pIA307 by electrophoresis in a 1 °[o low melting 
point agarose gel. This method of isolating bands from 
agarose gels proved much more convenient than that of 
Dretzen e_t al. The desired band is simply cut out of the 
low m.p. gel, the agarose melted and extracted with phenol, 
and the DNA purified (see Chapter Two for further details). 
Figure 3*8 shows pIA301 and pIA302 restriction digests 
analysed on a 1% agarose gel. Both these subclones confer 
the Aro+ phenotype on AB283^» Hence, it appeared that 
aroE was contained within the 1.82 kbp Hindlll-Clal region.
3«3* 5 E3 specific activities in strains carrying particular 
subclones
In an experiment like that described in Section 3*2.3 
the E3 specific activities of crude cell extracts were 
determined for the following E.coli strains:- K12, AB2834, 
pIA307//AB283^ and pIA30l//AB2834. Three independent 
isolates of pIA301 were tested since the cloned insert DNA 
had been exposed to the combination of ethidium bromide and 
long-wave U.V. during the isolation procedure and this 
slightly increases the remote chances of picking up a 
mutant DNA fragment. E2 specific activities were also 
determined, again as an internal control. The results are 
shown in Table 3*6. The cultures grew at similar rates , 
(data not shown), after being inoculated to identical 
initial turbidities, and their final values covered
a narrow range (1.17 - l«3l)* The E2 specific activities 
were all very similar and were comparable with those in
Table 3»6 E3 specific activities in crude cell extracts














K12 0 . 0 9 2 0 . 0 2 6 1.24
AB2834 0 0 . 0 2 6 1 . 2 6
pIA307//AB283^ 1.7 0.029 1.17
pIA301(l)//AB2834 0 . 0 7 8 0 . 0 3 0 1.30
pIA301(2)//AB2834 0.089 0.031 1.31
pIA301(3)//AB2834 0 . 0 7 6 O.O3O 1.24
NOTES: 1. All crude extracts were made from cells grown 
in L broth, supplemented with ampicillin in 
the case of strains carrying subclones, as in 
Section 3.2.3*
2 B3 s.a.(pIA307//AB2834) _ 1^7_____ , 0  -
E3 S.a. K12 “ 0 . 0 9 2  “ ^
3* Three independent isolates of pIA301 were tested.
Section 3*2.3* The specific activity of E3 in pIA307//
AB2834 was the same as that observed previously for 
pIA306//AB2834. However, although all three isolates of 
pIA301 confer the Aro+ phenotype on AB2834 the E3 specific 
activity in strains containing pIA301 was, in all three 
cases, slightly less than the K12 wild-type value and was 
thus about 21 times lower than that obtained with the 
larger subclone. It seemed possible that the small insert 
of piA301 did not span all the sequences required for the 
proper expression of aroE. Experiments analogous to the 
one described above were done using the other subclones.
The aim was to define the minimum region of DNA required 
for maximal aroE expression.
Results for three independent isolates of pIA303, iti 
HB101, are shown in Table 3*7* The cultures were grown 
from different initial turbidities, hence the much greater 
spread of the final -A-^ q values: (a), (c), and (d) are
roughly comparable whereas (b) is about two times higher.
Note that (b) also shows higher E2 and E3 specific activities, 
piA303 clearly gives overexpression of E3 but about three 
times less than that originally observed with pIA306.
Table 3*8 shows the results for another experiment 
with HB101 as the host for various subclones. Row (g) 
again shows that a higher final -A-^ q correlates with higher 
E2 and E3 specific activities.
Table 3*9 contains data from an experiment in which 
AB2834 was the host for a variety of subclones. Row (c)
Table 3*7 E3 specific activities in crude cell extracts














HB101 0 . 0 7 8 0 . 0 1 1 0 . 6 2
piA3 0 3 (8 ) //hbioi 0.50 0.019 1.3
piA303(20)//HB101 0.31 0 . 0 1 0 O . 5 8
pi A303 ( 28 ) / /HB101 0.40 0 . 0 1 3 0.79
NOTES: 1. All crude extracts were made from cells grown 
in L broth, supplemented with ampicillin in 
the case of strains carrying subclones.
E3 s.a. pIA303( 20) //HB101 - E3 s.a. HB101 „
E3 s.a. HB101 J
3* Three independent isolates of pIA303 were tested: 
(8), (20), and (28)•
Table 3»8 E3 specific activities in crude cell extracts














HB101 0.12 0.018 0.82
pIA306//HB101 1.3 0.018 0.78
pIA307//HB101 1.3 0.019 O . 8 5
pIA304//HB101 0 . 6 2 0.017 0.72
pIA305//HB101 1.0 0.020 O . 7 6
pIA303(8 )//HB101 0.40 0.017 0.90)
V
pIA303(8)//HB101 0 . 6 1 0.027 2.6 )
NOTES: 1. Values in the upper section (rows (a) and (b)) 
are from Section 3.2«3«
2. All crude extracts were made from cells grown 
in L broth, supplemented with ampicillin in 
the case of strains carrying subclones.
3» Samples of the final cultures were taken for 
the small scale preparation of plasmid. This 
was done to check that no gross deletions had 
occurred. None were detected.
Table 3*9 E3 specific activities in crude cell extracts













AB2834 0 0 . 0 3 2 1.2
pIA306//AB2834 2.1 0 . 0 3 6 1.2)
pIA306//AB2834 5-4 0 . 0 5 2 2.9)
pIA307//AB2834 1.6 0.033 1.2
pIA304//AB2834 0.48 0.037 1.3
pIA305//AB2834 1.7 0 . 0 3 6 1.2
pIA303(8)//AB2834 o.4l 0.038 1.2
pIA307//AB2834 2 . 5 0 . 0 3 6 1.0
pIA302(2)//AB2834 1.9 0.023 1.0
pIA302(6)//AB2834 1 . 8 0.019 0.92
NOTES; 1. The values in the lower section are from a
separate experiment (rows (h), (i) and (j))»
2. All crude extracts were made from cells grown 
in L broth supplemented with ampicillin in 
the case of strains carrying subclones.
3» Two independent isolates of pIA302 were tested; 
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once more demonstrates that E2 and E3 specific activities 
are elevated when the cultures are grown to higher cell 
densities.
The main results of this group of experiments are 
summarised in Table 3*10.
3 * 3 * 6  Preliminary interpretation of the specific activity 
results
Before considering the differences between the various 
subclones two general conclusions should be noted. Firstly, 
if two otherwise identical cultures are grown to different 
final values then the culture with the higher -A-^ q^
will show higher E3 and E2 specific activities. Hence, 
one should only compare the specific activities of different 
cultures if they have been grown to roughly similar -A-g^  
values. Secondly, overexpression of E3 is less marked in 
HB101 than in AB2834. The reason for this is unknown.
Plasmids pIA306, 307 > 303> and probably 302 can be 
classed as giving "high" E3 specific activities - class I. 
Plasmids pIA304 and 303 - class II - give E3 levels which 
are rather lower than those of class I. pIA301 - class III • 
shows much lower levels than class I. These results must 
be interpreted cautiously because many factors may be 
involved.
The size of the insert and/or its location in the 
vector might influence gene expression. For example, the 
size of the insert might affect plasmid replication and 
thus the copy number. However, the size of the insert 
in pIA302 (4.4 kbp, class i) is almost the same as that
of the insert in pIA304 (4.3 kbp, class II). This makes 
insert size less plausible as a way of explaining the 
differences between the subclones. None of the subclones 
have lost vector fragments which are known to affect plasmid 
replication or partition.
Particular insert sequences, or hybrid vector-insert 
sequences created at the ligation sites, could influence 
plasmid functions. It is known that strong constitutive 
promoters often cannot be cloned in the absence of a down­
stream transcriptional termination signal (G-entz ejb al. , 
1 9 8 1) presumably because high levels of transcription 
interfere with plasmid replication. If the insert of, say, 
pIA301 spans aroE and also a highly transcribed gene but 
does not include the latter’s terminator then this might 
cause some plasmid instability and thus effectively reduce 
the copy number.
It is unlikely that interactions between the trans- 
cription of the plasmid Tet gene and transcription of aroE 
could alone explain the data. In both pIA307 (class i) 
and pIA304 (class II), for example, the aroE gene must have 
the same position and orientation relative to Tet 
transcription.
A simple hypothesis is that class II and III insert 
fragments do not span all the sequences required for full 
expression of the aroE gene. Sequences required for maximal 
aroE expression are unlikely to be to the left of the 
Hindlll site which forms one end of the inserts in pIA305,
3 0 2, 303t and 301 since both pIA303 and pIA302 are in 
class I. However, one could imagine that part of the 
aroE promoter straddles the BamHI site at one end of the 
pIA304 and pIA303 (class XI) inserts. Cleavage here might 
leave only a partially functional sequence. Cleavage 
at the Clal site when cloning the pIA301 (class III) insert 
would give total loss of the sequence. However, this 
hypothesis is not without difficulties. For instance, 
one must postulate a messenger RNA which has an unusually 
long leader sequence if cleavage at the Clal site is not 
to remove the ribosome binding site (and N-terminal portions 
of E3). The Clal site is 0.6 kbp from the BamHI site 
(see Figure 3*^)* Most prokaryotic mRNAs have 3 f un­
translated leader sequences of less than 200 bases (reviewed 
by Kozak, 1983)* At this stage in the work it seemed 
sensible to postpone further consideration of the specific 
activity results until after the relevant region of DNA 
had been sequenced. Further discussion will be found in 
Chapter Five.
Before starting to sequence the aroE gene and the 
surrounding DNA it was desirable to check that the E3 
produced in the various subclone carrying strains was 
similar to that produced in E.coli K12. These comparisons 
are described in the next section. There was the possibility 
not considered above - that the E3 polypeptide had a 
partially redundant C-terminal portion which was slightly 
truncated in pIA303 and 30^ and drastically truncated 
in pIA301.
3 * 4 Analysis by PAGE of E3 from different subclones and
from E.coli K12
3.4.1 Background
The experiments described in this section exploit a 
specific gel stain for shikimate dehydrogenase activity - 
the nitro-blue tetrazolium (NBT) dye-linked method, as 
adapted by Lumsden and Coggins (l977)» The technique is 
very sensitive. When some crude extract of wild-type 
E.coli K12 is run on a polyacrylamide gel under nondenaturing 
conditions it is easy to detect the band of E3 activity.
This seemed a suitable way of comparing E3 in wild-type 
E.coli K12 with that produced in the various subclone 
carrying strains.
3.4.2 Analysis by nondenaturing PAGE of E3 from different 
s trains
Crude cell extracts of E.coli K12 and of a selection 
of subclone containing strains were made in the same way 
as for the determination of specific activities. Samples 
of these extracts were run on nondenaturing polyacrylamide 
slab gels. To allow precise comparisons between lanes the 
salt concentration, glycerol concentration, and final 
volume were kept constant between different samples on a 
particular gel. For each strain duplicate samples were 
loaded on opposite halves of the gel. After electrophoresis 
one half was stained normally for E3 activity. The other 
half was stained in a mixture lacking the specific substrate
shikimic acid. This served as a control against nonspecific 
reduction of the NBT. The results obtained using crude 
cell extracts of E.coli strains AB2834, K12, pIA30l//AB2834 
(class III), pIA303//AB2834 (class II), and pIA307//AB2834 
(class I) are shown in Figure 3*9»
The minus shikimic acid control half shows no bands 
but does have three very faint diffuse regions which stretch 
horizontally across the upper part of the complete gel.
The nature of these is unknown. In the plus shikimic acid 
half AB2834 gives only a very faint activity band and even 
this could simply be ”splashover” from the adjacent K12 
lane where there is a very prominent band.
The three subclone containing strains each give only 
one prominent band and the intensities of these increase 
in the expected order. These three bands, together with 
the K12 band, all have the same mobility. This supports 
the view that the (putatively) cloned aroE gene produces 
an E3 at least superficially identical to that found in 
E.coli K12. The mobility of a protein in this gel system 
is a function of both its net charge and of the Stokes 
radius. Thus it is conceivable, but unlikely, that two 
bands of identical mobilities represent different proteins 
whose Stokes radii and charges combine to give identical 
mobilities. (However, a single experiment at a different 
gel concentration (896) also showed all bands to have the 
same mobility). The faint bands above the main activity 
bands are probably due to aggregates that have become 
linked by intermolecular disulphide bonds which survive,
Stained +SA Stained -SA
7 g q 10 I]
Figure 3. 9 Comparison of E3 in K12 with that in subclone 
carrying strains.
Nondenaturing PAGE was carried out in a 10% slab gel.
The two halves were stained for E3 activity as shown 
above. Identical amounts of protein were loaded in 
each lane (103 V-g) and the samples were treated with 
50mM DTT for 1 hour at 0°C prior to loading. The 
samples were of crude cell extracts of particular strains





Note that the crude extract of pIA30l//AB283^- was made 
from a culture with a higher final than that of
the K12 culture and, as expected, had a slightly higher 
than usual relative specific activity.

as some do, the treatment with DTT prior to loading.
The faint bands underneath might be the result of 
proteolysis or of intramolecular disulphidle linkages.
3*4.3 Recovery of enzyme activity after treatment with 
SDS-introduction 
More evidence that the E3 from subclone carrying 
strains is outwardly indistinguishable from that in E.coli 
K12 came from experiments in which samples of crude cell 
extracts were subjected to SDS PAGE by the method of 
Laemmli (1970). After treatment designed to renature 
enzymes these gels were stained for E3 activity. It 
proved possible to detect specific bands. This work was 
prompted by diverse reports in the literature which describe 
the successful renaturation of proteins from SDS-protein 
complexes. Weber and Kuter (l97l) incubated a variety of 
enzymes with 2-mercaptoethanol and 1% SDS for 1 h at 
room temperature. This is rather different from the pre- 
loading treatment used for SDS PAGE samples. Nonetheless, 
they showed that the SDS could be removed in the presence 
of 6M urea (using an ion-exchange resin) and that various 
enzymes could subsequently be renatured from the urea 
solution. Rosenthal and Lacks (1977) demonstrated that 
certain extra- and intracellular nucleases could be re­
natured in gels, after SDS PAGE, by prolonged washing in 
40mM Tris-HCl pH 7*6, 2mM MgCl^, 0.02% sodium azide.
No urea was used at any stage. They assert that the pore
size of a 10% separating gel should allow SDS micelles 
to diffuse out and they emphasise that the purest available 
SDS should be used since some contaminants appear to bind 
very tightly to the proteins. Dottin ejfc al. (1979) showed 
that alcohol dehydrogenase (Drosophila) and lactate 
dehydrogenase (Fundulus), amongst other enzymes, could 
be renatured in gels (and activity stained) after SDS PAGE 
followed by isoelectric focussing in the presence of 7M 
urea and 2% NP4-0. Early work on protein blotting provides 
further examples of proteins, such as the lac repressor, 
which can be renatured (using the criterion of restored 
function) after SDS PAGE (Bowen et: al. , 1980): SDS is
removed from the gel by washing firstly in 4M urea, 1% 
Triton X-100, 50mM NaCl, 2mM Na2 EDTA, O.lmM DTT, lOmM 
Tris-HCl pH 7*0, and secondly in the same buffer minus 
Triton X-100. (The urea itself is removed during the later 
blotting stage). It was also known that a tryptic fragment 
(subunit m.w. = 68kDa) of N.crassa arom could regain E3 
activity after denaturing PAGE in the presence of 8M urea 
(Smith and Coggins, 1 9 8 3)*
Thus, it seemed that it might be possible to renature 
E. coli (and N.crassa) E3 in gels after SDS PAGE and to 
stain the resulting activity bands specifically. As well 
as permitting further comparisons of the E3 in various 
strains it was also hoped that the renaturation approach 
would yield a preliminary estimate of the E.coli E3 subunit 
m.w. which was unknown at this stage in the work since the 
enzyme had not yet been purified to homogeneity.
3*4.4 Recovery of E3 activity after SDS PAGE - results 
and discussion 
A protocol for renaturing E3 after SDS PAGE was 
designed on the basis of the work cited above. It was 
initially tested using purified N.crassa arom which was 
the generous gift of M.R. Boocock (arom preparation ,IA211’; 
Boocock, 1 9 8 3)* The first protocol used was as follows: 
Buffer A = 50mM sodium phosphate pH 7*0> ImM DTT.
1.Samples were boiled for 2 minutes exactly in > 1% SDS,
> 2% 2-mercaptoethanol, prior to loading. More 
prolonged boiling should be avoided due to the potential 
risk of trans-cis rotation of peptide bonds. After 
electrophoresis:
2. Soak the gel with gentle agitation at room temperature 
in Buffer A + 8M urea (freshly recrystallised), ImM 
glycinamide, 0.1% Triton X-100: use 150 ml over about
4 h.
3.Continue for another 3 h using 100 ml of the same 
buffer but without Triton X-100.
4.Soak in a total of ^ 0 0 ml of Buffer A ( 2 changes) 
for 12 h .
5*Remove DTT prior to staining by soaking for 1 h in a 
total of 500 ml of lOOmM Tris-HCl pH 9*0 (two changes).
6.Stain for activity (at least 1 h ).
This protocol was successful in that one could see 
activity bands for A21 arom but these were rather faint.
It also permitted the detection of a faint activity band 
for a crude extract of pIA307//AB2834. However, M.R. Boocock
greatly improved the protocol by introducing the following 
modifications (Boocock, 1 9 8 3):
(a) Include 0.01% 2-mercaptoethanol, O.lmM EDTA in the 
well buffer used for electrophoresis.
(b) Do not use urea; proceed as follows:
Soak the gel with gentle agitation at room 
temperature in Buffer A + 0.1% Triton X-100, O.lmM 
EDTA - use a total of 1 I in several changes over 
7-12 h .
(c) Continue for about 12 h using a further 1 I of 
the same buffer but without Triton X-100.
(d) As for 3 . above.
(e) Stain for activity.
This improved version was used in all the experiments 
described below. Figure 3*10 shows the E3 activity bands 
detected after SDS PAGE (and renaturation) of crude cell 
extracts of E.coli K12, AB2834, pIA30l//AB2834, and pIA307// 
AB2834. A similar experiment is shown in Figure 3»H*
The fainter details of the photographs were much more easily 
seen when the original gels were viewed on a light box.
The following reproducible features should be noted:
1. All activity bands are dependent on shikimic acid
(or at least on something in the shikimic acid bottle).
2 . AB2834 shows no bands.
3 . K12, pIA30l//AB2834, and pIA307//AB2834 each show 
(i) an activity band of m.w. about 29kDa (all three 
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Figure 3«10 Detection of E3 activity bands in crude 
cell extracts after SDS PAGE - (l)
Crude extracts of various E. coli strains were run, 
plus a sample of pure A21 arom "("some of which is proteo- 
lytically nicked, hence the doublet) as an internal control 
for the efficiency of renaturation. Gel ( l O f o )  was cut into 
sections prior to staining as shown above each section.
Lane: 1. pIA30l//AB2834 (96 P-g total protein)
2. molecular weight markers (see Chapter Two)
3. K12 (68 p.g total protein)
4. AB2834 (84 ]ig total protein)
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Figure 3»H Detection of E3 activity bands in crude 
cell extracts after SDS PAGE - (2)
10# gel • Lane: 1. AB283A-
2. AB283^
3. blank to prevent splashover into 1. & 2. 
k .  pIA30l//AB283^
5. K12 + pIA30l//AB2834
6. pIA307//AB283^
7. pIA302//AB2834
8. molecular weight markers (see Chapter Two)
9. pIA307/AB2834
10. pIA302//AB2834
activity band of m.w. about 49 kDa (all three 
bands having identical mobilities).
4. The upper band is always fainter than the lower band.
5. Both the upper and lower bands are much more intense 
in the pIA307//AB2834 lanes than in the K12 or 
pIA30l//AB2834 lanes.
Leaving aside momentarily the surprising presence of 
two bands, these experiments again fail to reveal any 
differences, other than of quantity, between the E3 from 
K12 and that from a large or the smallest subclone. This 
implies that pIA301 must carry most (if not all) of the 
aroE coding sequence. Hence, the initial DNA sequencing 
work (see Section 3*5) concentrated on the 1.82 kbp Hindlll- 
Clal fragment which forms the insert of pIA301.
Returning to the finding of two activity bands in 
place of the anticipated single band, the following 
conclusions can be drawn. The points listed above suggest 
that both bands are, in a loose sense, "encoded” by even 
the smallest subclone. The question then arises of whether 
the smaller m.w. band is, in some way, a subset of the 
larger. The data presented do not permit a definite answer. 
However, for a number of reasons it seems unlikely that 
there are two separate genes giving independent polypeptides 
with E3 activity. Firstly, the maximum coding capacity of 
the pIA301 insert is 607 amino acids and thus is unlikely 
to code for more than 120 Da x 607 = 73kDa worth of 
polypeptide(s). ”29” kDa + ”49” kDa = ”78” kDa which would
be a tight squeeze. Secondly, AB2834 lanes lack both 
bands. There are two obvious ways in which the smaller 
band could be a subset of the larger band. The smaller 
could be a proteolytic fragment of the larger. Alternatively, 
oxidation could lead to disulphide crosslinking of the 
smaller species to another protein: there are (rare)
precedents for such linkages surviving boiling in SDS/ 
2-mercaptoethanol, for example, between the P and P* sub­
units of E.coli RNA polymerase (J.R. Coggins, unpublished 
results).
It should be emphasised that the relative intensity 
of the two bands is not a safe guide to the relative 
abundance or activity of the two species since their 
respective efficiencies of renaturation might be quite 
different. Hence, the presence of only a single major 
band on nondenaturing gels is not necessarily at variance 
with the SDS PAGE results.
Since the problem of the two bands could not be 
simply resolved no conclusions could then be drawn about 
the E.coli E3 subunit m.w.(s). Further discussion will be 
found after the DNA sequencing work has been described 
(Chapter Five).
2 l1 DNA sequencing of aroE
3. 5•1 Introduction
3» 5«1A Choice of sequencing method
All rapid DNA sequencing methods exploit polyacrylamide 
gel systems which can resolve single-stranded DNA fragments, 
of up to several hundred nucleotides, which differ in length 
by a single nucleotide. Also, the available methods (with 
the exception of the recently developed "genomic sequencing" 
technique of Church and Gilbert, 1984) all feature nested 
sets of radiolabelled DNA fragments having one. end in common. 
The fragments are made in four groups and the members of 
each group all end randomly at a particular type of base.
Two major DNA sequencing techniques are currently in 
use. The method of Maxam and Gilbert (1977) relies on 
base-specific chemical cleavage of DNA fragments radio­
labelled at one common end. The method of Sanger afc al. 
(1977) involves copying the DNA to be sequenced, using 
the Klenow fragment of DNA polymerase I starting from a 
uniquely hybridising primer (see Figure 3*13) which provides 
the common end; base-specific endpoints are obtained by 
using specific chain-terminating dideoxy nucleotide 
analogues•
The dideoxy method was chosen for this project mainly 
because it can be used in a shotgun fashion when combined 
with the phage Ml 3 cloning system developed by J. Messing 
and his coworkers (Messing, 198 3 )* This obviates the
need for a highly detailed restriction map of the DNA 
to be sequenced, a normal requirement when using the 
Maxam and Gilbert method. Overall the M13/dideoxy approach 
is probably the most efficient one available, especially 
for sequencing many kilobases of DNA as was the eventual 
aim in this laboratory.
3» 5«IB M13/dideoxy sequencing
A single-stranded (SS). DNA template is an essential 
prerequisite for sequencing by the dideoxy method. This 
requirement is easily met by exploiting the life cycle of 
the single-stranded filamentous phage M13« The key stages 
in M13/dideoxy sequencing are set out below and are 
summarised in Figure 3*12. Further details are given in 
Chapter Two - the procedures used were essentially those 
given in Amersham’s "Ml 3 Cloning and Sequencing Handbook" 
(Amersham, 1 9 8 3)*
Stage 1 - M13 cloning:
(a) Ligate the double-stranded (DS) DNA fragment(s) to be 
sequenced with cut DS Ml 3 replicative form (RF).
(b) Transform competent E.coli host cells with ligation 
mix. In this project E.coli JM101 was used initially but 
later E.coli TGI was substituted since the latter, unlike 
JM101, is EcoK restriction minus. (The recombinant plasmid 
which provided the source material for sequencing was 
isolated from the EcoK modification minus strain E.coli 
HB101)•
Figure
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3»12 M13/dideoxy sequencing 
(After Messing, 1 9 8 3)
There are a wide variety of M13mp vectors and 
E. coli host cells (see text). oc-^S dNTPaS can be
used as the label (see text).
(c) Plate out the transformed cells in the presence of 
X-gal and IPTG and grow up plaques. Blue plaques are 
almost always nonrecombinant although very occasionally a 
particular insert will still allow complementation of the 
lacZ M15 deletion (Close et al., 1 9 8 3)* Colourless plaques 
are usually, but not always, recombinant. 
stage 2 " Preparation of SS templates:
(a) Pick and grow up individual colourless plaques, in 
1.5 ml cultures.
(b) Remove cells from the culture and precipitate the phage 
from the supernatant with PEG.
(c) Extract the SS template DNA from the phage and purify it
(d) Run samples of the templates on a 1 fo agarose gel to 
check that DNA is present in each case and to see if any 
of the templates are contaminated with material from a 
different plaque.
Stage 3 - Sequencing reactions:
(a) Anneal each template with the "universal" primer.
(b) Carry out the four different sequencing reactions with 
each annealed template/primer as summarised below:
"A"-template/primer + Klenow + ddATP/dNTP’s + label (see bel 
"C"- " + " + ddCTP/ " + " .
"G"- " + " + ddGTP/ "  + ” .
"T"- " + "  + ddTTP/ " + " .
(c) Chase the reaction with a mixture of all four dNTP’s. 
Stage 4 - Electrophoresis and autoradiography:
(a) Add formamide (+ dye mix) to each reaction and heat 
in order to denature the DNA.
(b) Electrophorese samples on a thin polyacrylamide gel 
at high temperature (use two separate loadings so as to 
obtain a long run and a short run).
(c) Fix the gel and dry it down.
(d) Autoradiograph the gel.
Stage 5 - Data processing:
This is discussed further on and in Chapters Two and
Five.
The radioactive label used during this project was
deoxyadenosine 5 ,_(<*” thio)triphosphate (Biggin e_t al. ,
1983)» The main advantage of the analogue over dATP
is that the bands on the autoradiographs of the sequencing
gels are much sharper due to the lower energy of the electrons 
3 5emitted during S decay. It is therefore possible to read
the sequence further up the gel. Also, even above where
the sequence can be read reliably it is usually still
possible to count the bands (especially T*s and to a lesser
extent A ’s) and to estimate the spacing between them. This
"unreadable" pattern of bands can often be used to match
up two different clones even if they are complementary
35strands. Other advantages of using S for sequencing
include its logistically more convenient half-life and the
lower radiation dose received by the user. The only
disadvantage is a minor one: prior to autoradiography one
must dry down the gel as the radiation is less penetrating 
32than from P. Although not essential drying the gels
32also improves the resolution obtained with P.
3« 5»1C Potential pitfalls in DNA sequencing
It is important to sequence across every restriction 
site that is used to make fragments for sequencing because 
closely adjacent restriction sites of the same kind may 
have been mistaken for single sites during restriction 
mapping.
A particular template insert may represent an artefactual 
ligation of two (or more) fragments of DNA which are not 
normally contiguous. When fragments for sequencing are 
generated by digestion with a restriction enzyme that cuts 
frequently, as in this project, it is straightforward to 
examine the sequence for internal sites of the enzyme 
used initially. Internal sites should always be assumed to 
be artefactual and not the result of partial digestion.
It is dangerous to sequence only one strand of a region 
of DNA due to the risk of missing a base. Such a frameshift 
error would have a catastrophic effect on the amino acid 
sequence deduced from a gene sequence. Normally the spacing 
between bands declines gradually up the gel and this 
regularity is useful when reading the sequence, for example, 
in prompting one to look for a faint band where the spacing 
implies that one should exist. However, certain stretches 
of sequence, especially G/C rich ones, can give rise to 
the "compression effect" (also known as "pile-up") where 
the spacing between successive bands is reduced abruptly, 
sometimes to zero (Fiddes, 1976; Sanger jet al. , 1977)*
This effect, which is a general problem with all rapid 
DNA sequencing techniques, is due to the DNA forming
base-paired loops during electrophoresis despite the 
denaturing conditions (urea and high temperature) that 
are normally used. The spacing of bands above a compression 
is often expanded. Usually compressions are obvious but 
there are insidious cases which can escape notice (see 
Figure 3*2.0). Fortunately the position of a compression 
is generally shifted by a few bases when the complementary 
strand is sequenced. Thus, the whole of both strands 
should be sequenced, as was done in this project.
3.5>ID Outline of the sequencing strategy used in this project
This section provides a brief overview of the DNA 
sequencing work. The initial aim was to obtain the protein 
coding sequence of the aroE gene. Evidence presented in 
Sections 3*3 and 3*4 suggested that the desired region of 
DNA was probably contained within the 1.82 kbp Hindlll-Clal 
fragment which forms the insert of pIA301. Hence, the 
objective became the sequence of this 1.82 kbp fragment.
All material for sequencing came from a class I plasmid, 
pIA307, which had been prepared on a large scale.
At the start defined restriction fragments from the 
region of interest were isolated and then cloned specifically 
using suitably cut M13 mp 8/9 vectors. This work exploited 
available restriction sites from the map given in Figure 
3.4 and generated islands of sequence whose locations were . 
known•
In the second round of sequencing the 1.82 kbp 
fragment was digested with the frequently cutting restriction 
enzyme Hpall. The resulting small fragments were cloned 
into M13 in. a shotgun fashion. Templates were prepared 
from many plaques and screened by "T-tracking” (see Section 
3.5«2) to eliminate redundant clones. Unique clones, 
which include those with complementary strands, were then 
sequenced. Complementary strands were readily identified 
by visual inspection of the gel autoradiographs as were 
matches to the regions of sequence obtained from the first 
round.
Another set of small fragments, overlapping those 
generated by Hpall, was then required so as to allow the 
whole sequence to be pieced together. The third round of 
sequencing was therefore analogous to the second except 
that the 1.82 kbp fragment was digested with a different 
restriction enzyme - Taql.
Due largely to the unfavourable distribution of 
Taql sites a fourth stage was required to complete the 
sequence of the 1.82 kbp fragment. A more selective 
cloning strategy was used in this final stage to span 
a gap in the sequence.
3.5.2 First round of M13/dideoxy sequencing
The sequencing vectors M13mp8 and M13mp9 were used 
throughout this project (Messing and Vieira, 1 9 8 2 ). Each 
contains a "polylinker" which facilitates the insertion 
of a wide variety of restriction fragments (see Figure 
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Table 3*11 The versatility of the mp8/9 cloning sites
Vector site Some restriction enzymes 
giving ends compatible 
with the vector site
AccI GT'CGAC Clal ATf GGAT 
Hpall C »CGG 
TaqI T»CGA
BamHI G 1GATCC Sau3A ’GATC
Smal CCC *GGG ) 






NOTES : 1. All the restriction enzymes listed in the
right half of* the table were used during 
the DNA sequencing work.
2. The recognition sequences are written 5 1 
to 3'* The site of cleavage is indicated 
thus: *•
polylinker in mp8, relative to the primer hybridisation 
site, is the opposite of that in mp9« It is therefore 
possible to select either strand of a double digest 
restriction fragment for cloning and sequencing since 
one can choose the orientation of the insert.
Defined restriction fragments, of known location, 
were cloned individually for the first round of sequencing 
of the 1.82 kbp Hindlll-Clal region. Particular fragments 
were purified from low m.p. agarose gels, after electro­
phoresis of the appropriate restriction digests of pIA307• 
The isolated fragments were either cloned forthwith,or, 
in some cases, cleaved further. For the latter the M13 
vectors were cut so as to accept only the desired secondary 
digest product (in the correct orientation). For example, 
to clone the 0.6 kbp Clal-BamHI fragment (which flanks 
the 1.82 kbp Hindlll-Clal fragment), in both orientations 
with respect to the primer, the previously isolated 2.47 kbp 
Hindlll-BamHI fragment was digested with Clal. The 
resulting mixture of fragments was ligated both with AccI + 
BamHI cleaved M13mp8 and, separately, with AccI + BamHI 
cut M13mp9* The templates derived from these two ligations 
carried complementary strands of the Clal-BamHI fragment. 
Thus one could sequence into this fragment from opposite 
ends. There is no danger of ambiguity provided that the 
vector-insert junction is as expected.
When, as here, purified single digest fragments are 
cloned it is necessary to prepare templates from many 
plaques to have a good chance of obtaining at least one
Table 3«12 First round of* Ml3 cloning - defined fragments
Template name Insert Fragment Vector
3-4 0.6 kbp Clal-BamHI AccI + BamHI cut 
mp8
4-2 ii AccI + BamHI cut 
mp9
1 3 - 2 0.84 kbp PvuII Smal cut mp8
17-4 1.08 kbp HincII - 
BamHI
HincII + BamHI 
cut mp8
18-8 1.27 kbp Hindlll- 
HincII
HincII + Hindlll 
cut mp9
1 6 - 3 1.6 kbp Hindlll- 
PvuII
it
15-5 1.7 kbp PvuII Smal cut mp8
21-3 0.090 kbp HincII n
NOTES: 1. The insert Fragments are shown in Figure 3*14.
2. The template name is given For the one which 
was sequenced From a particular class.
•d ^  




P* O*0 H 
00
{3* VJ O •
Si H 
P






















P g• 4 H
b 4 00o 0 \
H d- < a
P* C+ 0 H-
0 0 &
& P- 0H P 0• H & W00 H- H-
JO P O
0 P 0PT 0 d- 0
O* 0 £4 P
0 rt 0p1 P
p* 4 0 O
P 0 H-
a 0 & P
H 0 P* CH3







P 0 OH P
H- 4 PP P P
0 eng &




































00 £. X  cr
















































-o [ °L O
H
representative of both possible orientations (e.g. six 
plaques give a 1 in 64 chance of not getting both 
orientations). Thus, it is helpful to screen the 
templates, prior to sequencing, by MT-tracking” in which 
only the ”T” sequencing reaction is performed and the 
products run on a gel. Clones with the insert in different 
orientations can be selected by inspection of the auto­
radiographs.
Table 3*12 describes the first round M13 clones and 
Figure 3*14 shows the runs of sequence obtained using 
these clones. E.coli JM101 was used as the host strain 
for this stage.
3.5» 3 Second round of M13/dideoxy sequencing
It was planned to digest the 1.82 kbp Hindlll-Clal 
region with a restriction enzyme which cuts frequently 
(one with a tetranucleotide recognition sequence). The 
resulting fragments would then be cloned in M13 using a 
shotgun approach. The 1.82 kbp fragment was purified 
from a low m.p. agarose gel after electrophoresis of a 
Hindlll + Clal digest of pIA307 (see Figure 3«15)« A 
sample of the fragment was digested with Hpall (see Table 
3.11) and analysed by agarose gel electrophoresis. Figure 
3 . 1 3  shows the pattern of fragments obtained; one of 
the seven visible fragments is inconveniently large 
(0 . 6 8  kbp) but, overall, digestion by Hpall offered a 
useful way of obtaining pieces of the 1 . 8 2  kbp region 
for sequencing.
I ^  ^
Figure 3»15 Digestion of the 1.82 kbp Hindlll-Clal 
fragment with Hpall
Lane: 3* pAT153 cut with Hinfl, markers (kbp):- I.63I, 0.517>
O.396, 0.298, 0.221 and 0.220, 0.15^ and 0.1^5, 0.075* 
5. 1.82 kbp Hindlll-Clal fragment cut with Hpall.
Estimated sizes of the digestion products (kbp):- 
0.68, O.33, 0 . 2 k ,  0.18, 0.15, 0.13, 0.092 (total = 
1.80 kbp).
7» Purified 1.82 kbp fragment.
8. pIA307 cut with Hindlll + Clal.
Electrophoresis was through a 2°fo agarose gel which was 
subsequently stained with ethidium bromide.
A complete Hpall digest of4 the 1.82 kbp fragment 
was cloned randomly (”shotgunned”) into AccI cut M13mp9»
E. coli TGI (r”nf”) was used as the host strain from here 
on. It was expected that the Hpall-Clal fragment would 
be cloned (Table 3*ll) but that the Hindlll-Hpall fragment 
would be lost. Templates were prepared from 60 colourless 
plaques so as to give a reasonable probability of getting 
all possible strands. 57 templates were analysed by T- 
tracking. Systematic examination of the T-track auto­
radiographs revealed, unexpectedly, 15 different classes 
of clone. Representatives of all the classes were sequenced.
From the sequencing autoradiographs five pairs of 
complementary strands were identified by inspection and 
all of these pairs could be localised by comparison with 
first round sequences. Another strand could be matched 
to a first round sequence (18-8) and was clearly one 
strand of the large 0.68 kbp fragment. (The complementary 
strand was identified very tentatively by the "unreadable” 
pattern of residues).
One of the three remaining classes contained a tiny 
Hpall-Clal fragment with three bases between the two sites. 
This fragment, which formed part of a larger insert, was 
presumed to be the Clal end.
The two sequences that were still unaccounted for 
remain so to this day. A computer search program failed 
to locate segments of these last two sequences in the 
final contiguous sequence of the 1.82 kbp fragment. They 
presumably originate from incomplete digestion of the
pIA307 during the initial isolation of the 1.82 kbp 
fragment, causing the latter to be slightly contaminated 
with partial digest product(s).
The contribution of the second round Hpall clones to 
the overall sequencing strategy is shown in Figure 3 ,1 6  
which is drawn partly with the benefit of hindsight. 
Figure 3*17 shows an example of a sequencing gel auto­
radiograph.
3« 5. ^  Third round of M13/dideoxy sequencing
Digestion of the 1.82 kbp fragment with TaqI gave 
fragments of sizes 0.98, 0.53* 0.18 and 0.12 kbp. This 
enzyme was thus unsuitable for generating a comprehensive 
set of small fragments, overlapping the Hpall fragments, 
for sequencing. However, three TaqI sites had been found 
(with their potential use in mind) during the sequencing 
of the Hpall clones. All three lay in the half nearest 
the Clal end. Their distribution implied fragments of 
the sizes observed and was such as to allow completion 
of the Clal half of the sequence. For this reason the 
TaqI fragments were cloned using AccI cut M13mp9 even 
though it was realised that the largest fragment (which, 
from 1 5 - 5 first round sequence data, extended to the 
Hindlll site) would not be cloned and would anyway have 
left a large gap in the sequence.
Templates were prepared, sorted by T-tracking and 
representatives of the useful individual classes were 
sequenced, all in a manner analogous to that described
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Figure 3.17 An example oi a sequencing gel autoradiograph.

for the HpaXI clones. The contribution of these TaqI 
clones to the overall sequencing strategy is shown in 
Figure 3*16 . The presence of a Hpall site three bases 
from the Clal site was confirmed.
3 . Fourth round of M13/dideoxy sequencing
After the third round the right hand half of the 
1.82 kbp fragment1s sequence was essentially complete.
It was possible to sequence rightwards from the Hindlll 
site, past the start of 19-2 (see Figure 3*16) by ’’turning- 
around" (see below) the insert in the first round clone 
18-8. Also, a Haelll site had been found just after the 
start of 1 9 - 2  and so the complementary strand back to the 
Hindlll site could be obtained by cloning the small 
Hindlll-Haelll fragment in the correct orientation. Figure 
3 . 1 6  shows clearly the crucial problem that remained: 
how to span the major gap in the left hand half of the 
sequence. Sequencing leftwards from the TaqI site end of 
the large O . 9 8 kbp Hindlll-TaqI fragment would clearly 
gain a little ground. A potentially useful Sau3A site 
was found very near the end of the 1 9 - 2  sequence.
To investigate the extent of useful Sau3A, Alul, 
and Haelll sites in the vicinity of the gap these enzymes 
were used to digest the 0.68 kbp Hpall and the 0.98 kbp 
Hindlll-TaqI fragments (see Figure 3*16). These two 
fragments were obtained by electrophoresing suitable 
digests of purified 1.82 kbp fragment on a low m.p. agarose 
gel. The desired bands were cut out of the gel in the
usual way. However, the subsequent analytical digests 
were performed in molten low m.p. agarose at 37°C without 
further purification of the DNA (see Chapter Two). Haelll 
cleaved off the expected 0.13 kbp fragment from the Hindlll 
end of the O . 9 8 kbp material but made no other detectable 
cuts in this nor in the 0.68 kbp Hpall fragment. Alul 
cut the 0.68 kbp Hpall fragment into 2 pieces of O . 3 6 and 
0 . 3 0  kbp. This would prove a very useful site. No 
additional Alul sites were detected in the O . 9 8 kbp fragment. 
Sau3A digestion of the O . 9 8 kbp fragment revealed four 
subfragments of 0«33> 0.25> 0.21, and 0.12 kbp. These 
Sau3A sites would also prove very useful in completing 
the sequence.
It proved possible and convenient to cut both the 
0.60 kbp Hpall-TaqI (see Figure 3*16) and the O . 9 8 kbp 
Hindlll-TaqI fragments directly from gels of the correspond­
ing digests of pIA307* These two fragments provided most 
of the raw material for the fourth round of M13 cloning 
work which is summarised in Table 3»13*
A Haelll digest of the O . 9 8 kbp fragment was ligated 
with Hindlll + HincII cut M13mp9» Only the sought after 
small Hindlll-Haelll fragment was expected to be cloned 
(and in the correct orientation).
The first round clone 18-8 insert (the 1.27 kbp 
Hindlll-HincII fragment cloned in Hindlll + HincII cut 
M13mp9) was Mturned-around” (see Chapter Two) by synthesising 
a replicative form in vitro and cutting out the insert 
from the now double-stranded molecule by an EcoRI + Hindlll
Table 3*13 Fourth round of M13 cloning
Ligation Insert Vector
2k Hindlll-EcoRI insert 
from first round clone 
18-8
Hindlll + EcoRI 
cut mp8
25 0.60 kbp Hpall-TaqI Accl cut mp9
26 Alul cut 0.60 kbp 
Hpall-TaqI
Accl + Smal cut 
mp9
27 Sau3A cut 0.98 kbp 
Hindlll—TaqI
BamHI cut mp8
28 t BamHI + Accl 
cut mp9
29 Haelll cut 0.98 kbp 
Hindlll-TaqI
Hindlll + HincII 
cut mp9
digest. The products of this digestion were separated 
by electrophoresis in a low m.p. agarose gel and the 
insert band was cut out, purified, and ligated with Hindlll + 
EcoRI cut M13mp8, thus placing the Hindlll site of the 
insert adjacent to the primer.
The 0.60 kbp Hpall-TaqI fragment was ligated into 
AccI cut M13mp9» One of the possible orientations permits 
sequencing in from the TaqI end.
The 0.60 kbp Hpall-TaqI fragment was digested with 
Alul and ligated with AccI + Smal cut M13mp9» Both of 
the expected inserts would be orientated to permit sequencing 
in from the Alul ends (i.e. outwards, in both directions, 
from the middle of the 0 . 6 0  kbp fragment).
A Sau3A digest of the O . 9 8 kbp fragment was ligated 
with BamHI cut M13mp8, to clone Sau3A fragments, and also 
with BamHI + AccI cut M13mp9 to clone the Sau3A-TaqI 
fragment in the correct orientation for sequencing in 
the direction of the TaqI site.
Templates derived from these ligations were screened, 
where necessary, by T-tracking and then sequenced. The 
runs of sequence obtained from these fourth round clones 
are shown in Figure 3*18, and they proved sufficient to 
complete the sequence.
3« 5» 6 The overall sequencing strategy
Figure 3*19 shows the overall strategy used to sequence 
the 1.82 kbp Hindlll-Clal fragment, and the sequence itself 
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strands were determined and all the restriction sites 
used were overlapped.
The weakest overlap is that between the sequence of 
the Hpall clone 19-2 and the sequence of the small Sau3A 
clone 27-13 (see Figure 3*18). The sequence at the end 
of the 19-2 run reads (3» to 3 1)•••GATCGCCG(G), the last 
base being inferred from the fact that the insert in 1 9 - 2  
is a Hpall fragment. Only a single base separates the 
GATC Sau3A site from the CCGG Hpall site and the effective 
overlap is thus five bases. However, error could only arise 
from a very unlikely possibility; the existence of another 
unsuspected pair of Sau3A and Hpall sites, separated by a 
G residue, and lying within about 30 bases of the known 
pair. A greater separation would make it almost certain 
that the hypothetical Hpall fragment would have been 
detected amongst the products of the analytical Hpall digest 
of the 1.82 kbp fragment shown in Figure 3«15« Even a 
separation of 30 bases would have led to a marked discrepancy 
between the observed - 1.82 kbp - and predicted sizes of 
the HindUI-Clal fragment. The sequence shown in Figure 3*21 
contains 1,826 bases.
An experiment was done to confirm the sequence of 
this region, despite the low probability of being misled 
by the short overlap. Clone 24-2 (see Figure 3*18 and 
T bles 3.13 and 3*12) permits the 1.27 kbp Hindlll-HincII 
fragment to be sequenced from the Hindlll end. This clone 
was resequenced using conditions biased towards being able
Figure 3*20 An example of a "compression"
In panel (iii) the sequence around the arrow can be 
read unambiguously as ...ATGCCCTGA... Panel (i) shows the 
complementary strand of the same region; here the three 
G residues corresponding to the three C*s in panel (iii) 
are compressed, making it impossible to count the number 
of G's (although measurements of the spacing of widely 
flanking bands and comparison with adjacent, uncompressed 
sequences - not shown - allow an estimate of three to be 
made). Panel (ii) shows the same strand as in panel (i) 
but from a gel run at a higher temperature (hence the 
"fuzziness" of the bands ) to check the conclusions from 
the complementary strand. Here it seems more plausible 
that there are indeed three G residues although clearly 
the conditions were not yet fully denaturing.
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to read the sequence at long distances from the primer site 
(up to 400 bases; the ratio of dideoxynucleotides to 
deoxynucleotides is reduced and the period of electrophoresis 
is extended - see Chapter Two for details). This extended 
2k -2 sequence matched the 1 9 - 2  sequence as far as the 
Hpall site and continued (with slight uncertainty at those 
positions underlined):-
.... -A-A-T-A-T-C-A-C-C-A- ( ? ) -T-G-A-T- ....
This matches the sequence of 27-13 after the Hpall site:- 
.... - A-A-T-A-T-C-A-C-C-A-C-T-G-A-T- ....
Hence, the extended 2^ — 2 sequence provides a much more 
reliable overlap.
Conclusion
The cloning and sequencing of a region of DNA able to 
complement an E.coli aroE~ mutant has been described. Only 
after further work described in the next chapter was it 
certain that the aroE structural gene lay within this region.
CHAPTER 4 LOCALISATION OF THE AROE CODING SEQUENCE AND
CONFIRMATION OF THE DNA SEQUENCE BY ANALYSIS 
OF THE OVERPRODUCED POLYPEPTIDE
4.1 Localisation of the aroE coding sequence
4.1.1 Open reading frames in the 1.82 kbp Hindlll-Clal sequence 
As a first step towards locating the aroE coding region,
within the sequence of the 1.82 kbp Hindlll-Clal fragment, 
the computer program TRNTRP (Staden, 1978) was used to 
translate both strands of the sequence in all three possible 
reading frames. For each of the six frames the positions 
of stop codons were plotted (see Figure 4.l). The two 
largest open reading frames (ORF!s) are both found in the 
Clal(31)-Hindlll(3 *) strand.
The second largest ORF has 624 bases between stop 
codons, 613 bases from the start of the first plausible 
initiation codon (GTG), and 44l bases from the start of 
the first methionine codon (ATG). Even the 615 base 
stretch is unlikely to encode a polypeptide larger than 
about 23 kDa, taking 110 Da as the average m.w. of an 
amino acid residue.
The largest ORF has 846 bases between stop codons,
843 bases from the first plausible initiation codon, and 
8l6 bases from the first ATG. From the first methionine 
this ORF would encode a polypeptide of about 30 kDa. At 
about this time E3 was purified to homogeneity from 
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and the subunit m.w. observed on SDS Laemmli gels was 
30 kDa. Hence, it appeared that the largest ORF was 
much more likely to contain the aroE coding sequence than 
the second largest one.
4.1.2 Further subcloning of aroE using pAT153
Further subcloning experiments were performed to 
confirm that only the largest ORF could contain the aroE 
gene. The 1.27 kbp Hindlll-HincII fragment (see Figure 
4.2) carries the whole of the largest ORF but includes 
only the latter 250 bases of the second largest ORF. This 
fragment was cloned by ligating Hindlll + Nrul cut, and 
phosphatased, pAT153 with a HincII digest of the purified
2.47 kbp Hindlll-BamHI fragment of pIA307, transforming
— RE.coli AB2834 (aroE-), and screening Amp transformants
for the Aro+ phenotype in the way described previously. 
Five of the six independent isolates were found to contain 
the desired insert - this construct was called pIA309«
(The sixth isolate contained the very small 0.090 kbp 
HincII fragment in addition to the 1.27 kbp Hindlll-HincII 
fragment). Back transformation confirmed that pIA309 
can complement E.coli AB2834. This rules out the 624 base 
ORF as a possible location for the aroE gene, leaving 
the largest ORF as the only candidate. How this might 
relate to the specific activity results discussed in 
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4.I.3 The need for analysis of the E3 polypeptide
That only the largest ORF could contain the aroE 
coding sequence is not conclusive evidence that it actually 
does. As mentioned in Section 3*2.2 there was the 
possibility (remote, given the observed overexpression) 
of4 being misled by a suppressor gene. Also, assuming 
that the largest ORF did represent aroE, there was the 
need to locate the translational initiation codon. This 
need could be met by determination of the N-terminal amino 
acid sequence of purified overproduced E3 and this approach 
also offered a way of showing definitively that the ORF 
sequence encodes E3* It was also decided to determine 
the amino acid composition of the purified overproduced 
E3 since this would confirm the overall sequence.
4.2 Construction of a strain which greatly overproduces 
E.coli E3
4.2.1. Justification
The procedure developed by Chaudhuri and Coggins 
(1985) for the purification of E3 from wild-type E.coli K12 
yields about 0 .0 1 3 mg of homogeneous polypeptide from 20g 
(wet weight) of cells. Thus, it would have been tedious 
to purify enough wild-type E3 for determination of the 
N-terminal amino acid sequence (using a conventional 
liquid phase sequencer) and for determination of the amino 
acid composition. The levels of E3 overexpression 
obtainable with subclones, such as pIA307, would have
overcome this difficulty. However, the wish to raise 
antibodies against E.coli E3, and especially the long 
term aim of obtaining crystals suitable for high resolution 
X-ray crystallography, all prompted consideration of ways 
of obtaining rather higher levels of E3 overexpression 
than could be gained from the copy number of the vector
pAT153«
4.2.2 Expression vector pKK223-3
In seeking higher levels of E.coli E3 overexpression 
the approach adopted was to place the putative coding 
sequence downstream, in the correct orientation, from a 
powerful promoter. The expression vector pKK223-3 was 
used for this purpose (J. Brosius, unpublished results; 
this vector is available commercially from Pharmacia P-L 
Biochemicals Inc. but for this study it was obtained 
through the generosity of J.R. Knowles). This vector 
contains the strong trp-lac hybrid tac(i) promoter (De Boer 
et al., 1 9 8 3) which has the ”-3 5 ” region of the E.coli 
trp promoter and the ff—10” region of the E. coli lacUV5 
promoter; the lacUV5 segment also contains the lac operator 
and the Shine-Dalgarno sequence although the latter is 
irrelevant here. As shown in Figure 4*3 there is an 
M13mp8 polylinker situated downstream from the tac promoter, 
thus facilitating the positioning of genes behind the 
promoter. The polylinker is followed by a DNA segment 
containing the strong rrnB ribosomal RNA transcription
Sail 6  am HI 








Figure 4.3 Expression vector pKK223-3. This
vector carries the Amp-^  selectable marker.
terminators. The position of these terminators stabilises 
the plasmid (Gentz e_fc al•, 198l), the remainder of which 
consists of pBR322 sequences. The tac promoter is 
controllable by the lac repressor and can be induced by 
IPTG. However, transcription from the tac promoter of 
pKK223-3 is only partially inhibited in uninduced cells 
carrying the wild-type lacI gene due to the multiple 
copies of the plasmid titrating out the lac repressor.
pKK223-3 has been used by Frost _et al. (1984) to 
overexpress the E.coli aroB gene which encodes dehydroquinate 
synthase. They obtained about one thousand times the 
normal wild-type level of enzyme.
4.2.3 Construction of pIA321
The 1.27 kbp Hindlll-HincII fragment (see Figure 4.2) 
was cloned into pKK2 2 3 -3 so that it would be transcribed 
in the HincII to Hindlll direction, the correct orientation 
for overexpressing the product of the largest ORF. A 
HincII digest of the purified 2.47 kbp Hindlll-BamHI 
fragment of pIA307 was ligated with Smal + Hindlll cut 
pKK223-3> E.coli AB2834 was transformed, and Amp trans-
S 'X Independent
formants were tested for the Aro /isolates were examined 
by restriction analysis and found to be identical. None 
contained the very small 0.090 kbp HincII fragment. This 
construct was called pIA321 (see Figure 4.4).
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4.2.4 Specific activity of E3 in pIA32l//AB2834
Table 4.1 summarises the E3 specific activity values 
observed in crude cell extracts of pIA32l//AB2834 grown 
to various final cell densities in L Broth medium. IPTG 
gives a worthwhile improvement in the specific activity 
(increases of 3 7 and 4 8 in the two cases shown in 
Table 4.1). Prom earlier results the correlation between 
higher final A ^ 0 values and higher E3 specific activities 
is not unexpected. However, the specific activity of 
pIA32l//AB2834(l) grown to Ag^Q = 3•08 shows a useful 
three fold increase over that of pIA306//AB2834 grown to 
■^650 = ^*9’ "k*10 most similar A ^ q  available from previously 
described results (see Table 3*9)* Thus, pIA321 is 
significantly better than any previous subclone.
"When pIA32l//AB2834 was grown to higher final Ag^Q 
values than had been tried previously (A^q = 4 or 4*7> 
where the culture is almost stationary) the E3 specific 
activity, 3 0 - 3 3 u/mg, was almost double that obtained at 
■^650 ~ Although no E. coli K12 cultures were grown to
such high cell densities it is worth noting that a specific 
activity of 33 u/mg is three hundred times greater than 
the E3 specific activity in crude extracts of E.coli K12 
grown to a final A ^ q  of 3 » 1 (0.11 u/mg). This is not as 
good as the one thousand fold factor obtained by Frost 
et al. (1984), but there are many possible explanations 
for this. For example, it is conceivable that there is 
a weak transcriptional terminator between the HincII site 
and the start of the ORF.
Table 4.1 E3 specific activities in crude cell extracts
of* E.coli AB2834 carrying pIA321







in crude cell 
extract
pIA32l//AB2834(l) I .6 3 7.3
it it it +  I P T G I .6 3 1 0 . 0
it n it +  I P T G 3 .O8 16.4
it ti it +  i f t g 4.15 3 1 . 0
n ii n +  i P t g 4.75 33-0
pIA3 21 //AB2834 ( 2 ) 1 . 6 2 6.4
it it it +  I P T G 1.38 9-3
n it it +  I P T G 3.95 3 0 . 0
it it n +  i P t g 4.7 33.0
NOTES: 1. All crude extracts were made from cells grown
in L Broth supplemented with ampicillin.
2. The inducer IPTG was used to obtain maximal 
expression from the tac promoter of pIA321.
It was added to a final concentration of 
3 x 1 0"^M 1-J hr after inoculation of the 
cultures (see Chapter Two).
3* Two independent isolates of pIA321 were used: 
(1) & (2).
The specific activity of E.coli E3 purified to homo­
geneity is 1200 u/mg (Chaudhuri and Coggins, 1985). Thus,
E3 constitutes about 3% of the total protein in small 
scale crude cell extracts of pIA32l//AB2834 grown almost 
to stationary phase.
4.3 Large scale purification of overproduced E.coli E3 from 
PIA321//AB2834
4.3.1 Ob.jectives and approach
The need to determine the N-terminal amino acid sequence 
of E3 was discussed in Section 4.1.3 as were the advantages 
of determining the amino acid composition of the protein.
For the accomplishment of these two tasks a total of about 
3 mg of homogeneous E3 was required. The experiments 
described in Section 4.2.4, together with the previous work 
on the purification of E3 from E.coli K12 (Chaudhuri and 
Coggins, 1985), suggested that the required amount of 
pure E3 could be obtained easily from 20g (wet weight) of 
cells of the overproducer strain pIA32l//AB2834.
The method developed by Chaudhuri and Coggins (1985) 




3. Ion-exchange chromatography on DEAE-Sephacel
4. Gel filtration on Sephacryl S-200
3* Affinity chromatography on ADP-Sepharose 
6 . Ion-exchange chromatography on a Pharmacia Mono Q 
FPLC column.
The degree of purification afforded by this procedure 
(approximately 2 0 ,0 0 0 fold) is greater than that required 
when an overproducing strain such as pIA32l//AB2834 is used 
as the starting material. The procedure used was therefore 
a simplified version in which the final step was omitted.
4. 3» 2 Growth of cells
The medium used was L Broth plus ampicillin, as for 
the specific activity experiments. IPTG was added as an 
inducer. For small scale analytical crude extracts cells 
were always grown in 50m l cultures in 230ml conical flasks 
on an orbital shaker. For the production of pIA32l//AB2834 
cells on a larger scale 13 x 3 00ml cultures were grown up 
in 2000ml conical flasks on an orbital shaker. Perhaps 
due to inferior aeration the growth of these large scale 
cultures levelled off at a somewhat lower than
expected. The cultures were eventually taken for harvesting 
at = 3»7-3«8. A total of about 40g (wet weight) of
cell paste was obtained from the 6 . 3  I of culture.
4.3» 3 Purification of E3 from pIA32l//AB2834
Further details are given in Chapter Two. The starting 
material was 20g (wet weight) of pIA32l//AB2834 cells and 
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The cells were broken by two passages through a 
French pressure cell. This was Followed by deoxyribonuclease 
treatment and centrifugation at 3 0 ,0 0 0  x g for 30 min: the
supernatant represented the crude extract. The specific 
activity given for the crude extract in Table 4.2 is not 
directly comparable with those given in Table 4.1 because 
all small scale crude cell extracts were prepared in a 
different way - cells were disrupted by sonication which 
was followed by a high speed spin at 1 9 9 ,0 0 0 x g for 2 h : 
the supernatant formed the crude extract. Chaudhuri and 
Coggins (1985) obtained a specific activity of 0.039 units/ 
mg for their crude extract of E.coli K12 (grown on minimal 
medium) compared with 19*9 units/mg for the pIA32l//AB2834 
crude extract here, a 337-fold difference.
After (NH^)2S0^ fractionation of the crude extract 
the E3 activity was found in the 30-55%-saturation fraction.
The third step was ion-exchange chromatography on 
DEAE-Sephacel (Figure 4*3)« The peak fractions that were 
pooled from the DEAE-Sephacel column contained a total of 
only 60% of the activity originally loaded - this deliberate 
paring of the yield was done in the hope of minimising the 
number of chromatographic steps required to obtain pure 
overproduced E3* The pool, which contained 17,800 units 
at a specific activity of 284 units/mg, was then concentrated 
prior to the fourth step. (An accident during the 
concentration procedure resulted in only about 83% of the 
material being carried forward to the next step, although 
the author’s loss was the cold room floor's gain.) In 
Table 4.2 the yield after the fourth step (Sephacryl S-200)
Figure k » 5 Chromatography of overproduced E.coli 
E3 on DEAE-Sephacel (step 3 of the 
purification scheme).
Enzyme from step 2 (29,100 units in 36ml) was 
loaded onto a column of DEAE-Sephacel (1 6 . 5  cm x 2.1 cm) 
equilibrated in buffer 2, as described in Chapter Two. 
The column was washed with this buffer until the -A-P80 
of the eluate reached a constant value of about 0 .2 .
The column was then eluted with an 800ml linear gradient 
of KC1 (50-350mM) in buffer 2. The flow rate was 
36 ml/h and 5»5m 1 fractions were collected. 0 , -A-2 8O’
# , E3 activity (units/ml); ---- , conductivity
A280
o  —* —1 ro ro w w x- 
o l n o v n o v n o v n  o
vn - o
— J — f — 1 i— r T" T “1 1 "T“nro vn —» —» o ro Xr cno vn o o oo o o
Conductivity Enzyme activity
(mmho) (units ml”1 )
r800
Figure k »6 Chromatography of overproduced E. coli 
E3 on Sephacryl S-200 (step b o f  the 
purification scheme).
Enzyme from step 3 (l7>800 units in 33 ml) was 
concentrated (to 2.7 ml) and applied to a column of 
Sephacryl S-200 (8 5 cm x 2.1 cm) equilibrated in 
buffer 3 (see Chapter Two). The enzyme was eluted 
with the same buffer. The flow rate was k ml/h and 
1 ml fractions were collected. 0, Apon. • > E3 
activity (units/ml). 9
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is therefore slightly lower than it would otherwise have 
been.
The fourth step was gel filtration on Sephacryl S-200 
(Figure 4.6). The E3 activity elutes late in a peak of 
activity which corresponds clearly to a large peak of 
protein. This step in the purification is particularly 
effective because the enzyme is monomeric (Chaudhuri and 
Coggins, 1985). Fractions 200-213 inclusive, those having 
more than 400 units/ml, were pooled. This pool contained 
10,400 units (71% of the 14,800 units loaded) at a specific 
activity of 638 units/mg.
The fifth and final step was affinity chromatography 
on ADP-Sepharose (elution profile not shown). Due to the 
limited capacity of this chromatographic medium a 20ml 
bed volume was used rather than the 3 ml specified in 
Chaudhuri and Coggins (1985). The pool from the fourth 
step was loaded onto the column which was then washed to 
remove unbound material. The E3 activity was then eluted 
from the column with ImM NADP+ in buffer 6 (see Chapter Two) 
The final pool of activity contained 9»040 units at a 
specific activity of 860 units/mg. The total amount of 
protein was 10»3nig. This material was homogeneous by the 
criterion of SDS PAGE, as shown in Figure 4.7 - in the 
original gel a barely detectable contaminant band (of 
greater mobility than E3) was visible in the lane loaded 
with 23pg of E3. Polyacrylamide gel electrophoresis under 
native conditions, after incubation of the sample in 30mM 
DTT at 0°C for 1 h prior to loading, revealed two barely 
detectable minor bands when of E3 was loaded (gel not
shown).
Figure 4.7 The purification of overproduced E.coli E3«
Samples were subjected to SDS PAGE in a 12.yfo 
gel. After electrophoresis the gel was stained for 
protein.
Lane; 2. (N.B. not from the purification) sample of a
small scale crude extract of pIA32l//AB2834 
(grown to = 4.l), 100 jig total protein
in sample.
3. post-DEAE-Sephacel pool, 13 HS total protein
4. post-Sephacryl S-200 pool, 6.7 V-g total protein
3* post-ADP-Sepharose final pool, 3
6. molecular weight markers (see Chapter Two; BSA,
catalase, GluDH, aldolase, GAPDH, carbonic
anhydrase)•
7* 0.43 PS pure E.coli K12 E3
8. 1 p,g, final pool
9. lOiig, final pool
10. 25p S t final pool
Lanes 3 , h ,  and 3 were loaded with equal amounts of E3 









Overall, the overproduced E3 had to be purified about 
43-fold to give homogeneous material. This compares with 
20,000-fold for E.coli K12 E3 (op.cit.). The final yield 
of overproduced E3 was 29$>« One may speculate that it 
might be possible to obtain homogeneous overproduced E3 
using only the first four steps by sacrificing yield. This 
could be useful for obtaining gram quantities of E3 for 
crystallisation experiments since otherwise the cost of 
the ADP-Sepharose might be limiting.
4.3*4 Specific activity of overproduced E.coli E3
The overproduced E3 appears to be effectively homo­
geneous yet its specific activity of 860 units/mg is 
significantly lower than the value of 1200 units/mg (see 
footnotes to Table 4.2) obtained by Chaudhuri and Coggins 
(op.cit.) for the specific activity of pure E.coli K12 E3*
In both cases protein concentrations were estimated by 
the method of Bradford (1976) using bovine serum albumin 
as the standard. However, the extremely small amounts of 
K12 E3 required the use of the "micro" assay rather than
the standard assay, and discouraged repetitions. These
difficulties, and the fact that traces of glassware 
detergent can cause anomalously high "values with the
Bradford system, might be responsible for the higher K12 
value (a trace of detergent in the buffer control "blank" 
tube could generate an artefactually low protein concentration 
hence higher specific activity). The specific activity of 
the overproduced E3 was calculated using the average of
four activity determinations and the average of two 
protein determinations done with two different buffer 
controls; volumes were measured either using Hamilton 
microsyringes or Gilson Pipetmen whose calibration had 
been checked by weighing; removal of samples at 4°C was 
done after precooling the Pipetmen.
Clearly such precautions are to no avail if, despite 
the contrary evidence from two different gel systems, the 
overproduced E3 is significantly impure. Further evidence 
is available which argues against contamination. During 
the later N-terminal sequencing of the overproduced E3 
there was no trace of heterogeneity. It could be argued 
that the putative contaminant(s) did not have an accessible 
N-terminus but the later amino acid analysis of the over­
produced E3 gave a composition which matched very closely 
the composition predicted from the DNA sequence. All these 
different strands of evidence make it implausible that 
the overproduced E3 is sufficiently impure to explain the 
discrepancy in the specific activity values.
4.3.5 Comparison of purified E3 from E.coli K12 with that 
from pIA32l//AB2834
The results obtained from gel analysis of small scale 
crude extracts (Section 3*4) suggested that there would be 
no detectable differences between purified E3 from E.coli 
K12 and that from pIA32l//AB2834. Further data tend to 
confirm this view. At a gross level both display similar
Figure 4.8 Comparison of purified K12 E3 with purified 
pIA32l//AB2834 E3 by nondenaturing PAGE
Samples were subjected to nondenaturing PAGE in a 
10% gel after incubation for 1 h at 0 C in the presence 
of 30mM DTT. The gel was stained for E3 activity.
Lane: 1. 0.4 pig pure E. coli K12 E3
2. 0.4 pig pure pIA32l//AB2834 E3
The salt concentration, glycerol concentration, and final 
volume were the same in both samples. Pure E.coli K12 E3 
was the generous gift of S. Chaudhuri.

chromatographic behaviour on DEAE-Sephacel and on Sephacryl 
S-200 during purification* Lanes 7 and 8 in Figure 4*7 
show that the two purified enzymes have identical mobilities 
during SDS PAGE. In addition, Figure 4.8 shows that they 
also have identical mobilities during PAGE under non­
denaturing conditions.
It would perhaps be worthwhile to compare the over­
produced and K12 versions by one-dimensional peptide mapping, 
and by their kinetic parameters, as in Duncan e^fc al. (1984a)..
4.4 Determination of the N-terminal amino acid sequence of
the overproduced E.coli E3
This work was done in collaboration with J.E. Fothergill, 
L.A. Fothergill, and B. Dunbar in the SERC funded protein 
sequencing facility at Aberdeen University. The determination 
of the N-terminal amino acid sequence was carried out using 
a Beckman Model 8 9OC automatic liquid phase sequencer.
Details of the methodology are given in Chapter Two. The 
resulting sequence is shown in Figure 4.9* Table 4.3 shows 
the yield (in nmol) obtained for each residue and Figures 
4.10a and 4.10b present the same data graphically. The 
identification of the first thirty amino acids was unambig­
uous. Residues ,31 and 35 were almost certainly histidine 
and arginine respectively but there was an element of doubt 
due to the HPLC retention times being shorter than usual. 
Residue 36 could not be identified. Residue 40 was 
definitely isoleucine even though no yield could be calculated.
I I w
1 10
Met - Glu - Thr - Tyr - Ala - Val - Phe - Gly - Asn - Pro -
11 20
lie - Ala - His - Ser - Lys - Ser - Pro - Phe - lie - His -
21 30
Gin - Gin - Phe - Ala - Gin - Gin - Leu - Asn - lie - Glu -
31 40





Asn - (— ) - Phe - lie - Asn - (--) - Leu - Asn - Ala - Phe -
(Asp)
60
Phe - (--) - Ala - Gly - Gly - Lys - Gly - Ala - Asn - Val -
Figure 4.9 The N-terminal amino acid sequence of E.coli 
shikimate dehydrogenase
The repetitive yield from residues 1-60 
was 94io by regression analysis (correlation 
coefficient O.9 6 ) and the initial amount of 
protein sequencing was 53 nmol. The gaps 
are discussed in the text.
I I / jaun<$
Table 4. Yield obtained of each residue during 
N-terminal amino acid sequencing of 
overproduced E.coli E3»
RESIDUE NO. AMINO ACID YIELD(nmol}
1 M  30.5
2  E 46.0
3 T  11.5
4  Y 31.5
5 A 34.7
6 _  V 42.5
7 F 35.1
0 G 31.8
9 N  33.7
10 P 22 .8
11 I  31.8
12 A  23.8
13 H 14.5
14 S 4.1
15 K  28.3
16 S 3.9
17 P  18.4
18 F 24.3





24 A  14.1
25 Q 13.9




30 E  12.5
31 -  00
32 P 7.2
33 Y  8.8
34 G 8 .4
35 —  00
36 -  00





42 -  00
43 F 4.5
4 4  I 00
45 N  4 .2
46 -  00
47 L  3.2
48 N  2 .8
49 A  2.7
50 F 5.2
51 F 5.0




56 K  1.2
57 G 0 . 8 ^
58 A  1.5
59 N 1.1
60 V  1 .4
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Residue 42 was probably aspartic acid but the preceding 
asparagine residue made it impossible to rule out another 
asparagine residue at position 42. Residue 44 was un­
doubtedly isoleucine even though no yield could be calculated. 
Residues 46 and 52 could not be identified.
4.5 Definitive identification of the E.coli shikimate
dehydrogenase coding sequence
The N-terminal amino acid sequence of overproduced 
E.coli E3 was compared with the amino acid sequence predicted 
for the longest open reading frame in the DNA sequence of 
the 1.82 kbp HindlXI-Clal fragment (see Sections 4.1.1 and 
4.1.2), starting from the first methionine residue in the 
ORF. A perfect match was found (compare Figures 4.9 and 
4.1l), thus definitively locating the coding sequence for 
shikimate dehydrogenase. Figure 4.11 shows the complete 
nucleotide sequence of the E.coli aroE gene and the 
corresponding amino acid sequence of E.coli shikimate 
dehydrogenase.
From the DNA sequence the residues which could not be 
identified during the N-terminal amino acid sequencing - 
residues 3 6 , 46, and 52 - are valine, threonine, and serine 
respectively. Failure to detect threonine and serine after, 
many cycles is not surprising since the anilinothiazolinone 
derivatives of threonine and serine are relatively unstable. 
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at residue 36 . The identities of amino acid residues 31>
359 and 42, which had been slightly in doubt after the 
protein sequencing, were confirmed by the DNA sequence.
The relationship of the E3 coding sequence to the 
restriction map of the 1.82 kbp fragment may be seen in 
Figure 3*19»
4.6 Determination of the amino acid composition of the
overproduced E.coli B3
As a final check on the complete aroE sequence the 
amino acid composition of overproduced E.coli E3 was 
determined so that it could be compared with the amino acid 
composition predicted by the DNA sequence.
Purified E.coli E3 was oxidised by performic acid and 
samples were analysed after hydrolysis with 6M-HC1 at 105°C 
for 24, 48, and 72 h, as described in Chapter Two. The 
amino acid composition obtained is shown in Table 4.4 
alongside the predicted composition. Tryptophan is destroyed 
by the procedure used. Since asparagine and glutamine are 
hydrolysed quantitatively to aspartic and glutamic acid 
respectively the abbreviations Asx and Glx have been used 
in Table 4.4 to indicate the ambiguous origins of the aspartic 
and glutamic acid residues. Some serine and threonine is 
destroyed in a time dependent manner during hydrolysis so 
for these two amino acids the data from the three timepoints 
were extrapolated to zero time.
Table k.k The amino acid composition of overproduced
E.coli E3 compared with the amino acid composition 




Relative amino acid com­























ct Determined as cysteic acid
Determined as methionine sulphone
Q
Experimental values were extrapolated to zero time
Values were calculated using only data from the 72 h timepoint.
Valine and isoleucine are often released more slowly than 
other amino acids due to steric hindrance of hydrolysis 
by the ^-branched sidechains. A plot of the data for the 
three timepoints showed that the amounts of valine and 
isoleucine had reached a plateau by 72 h, hence only data 
from the 72 h timepoint were used. Performic acid oxidation 
of cysteine and methionine, to cysteic acid and methionine 
sulphone respectively, allowed quantitative determination 
of these two amino acids.
The relative amino acid composition was calculated 
using the assumption that there are 8 lysine residues in 
the polypeptide. (Each of glycine, alanine, leucine, lysine 
and arginine was tried - using the number of residues predicted 
by the DNA sequence - and lysine gave the closest fit to the 
predicted total number of amino acids - 272). The overall 
agreement between the observed and predicted values in 
Table 4.4 is good. It is thus very unlikely that there is 
a frameshift error anywhere in the aroE sequence.
4.7 Conclusion
The match between the DNA sequence of the longest ORF 
in the 1.82 kbp Hindlll-Clal fragment and the N-terminal 
amino acid sequence of purified E.coli E3 formally locates 
aroE, the gene for shikimate dehydrogenase. The accuracy 
of the aroE sequence is confirmed by the finding that the 
amino acid composition of purified E.coli E3 fits very
closely with that predicted from the DNA sequence.
The location of the aroE gene so far from the ClaX 
site reopened the issue of the wide variation in E3 
specific activities in strains carrying different aroE 
subclones. "Whether the sequence data might shed light on 
this and other questions is considered in the next chapter.
CHAPTER 5 ANALYSIS OF THE SEQUENCE DATA
5.1 Subunit molecular weight of* E.coli E3 and the
t!2 bandst! problem
The subunit molecular weight for E3 predicted by the 
sequence is 29,380 daltons. This agrees well with the 
size of 30 kDa obtained by SDS PAGE of the purified enzyme 
(Chaudhuri and Coggins, 1 9 8 5 ; this study).
In Section 3*4.4 it was shown that E3 activity could 
be recovered after SDS PAGE. However, SDS PAGE of E.coli 
crude cell extracts unexpectedly gave two bands with E3 
activity: one of about 29 kDa, which from the sequence
data can now be said to represent uncorrupted E3, and 
another of about 49 kDa. The reproducible features of 
these two bands can be summarised as follows
(i) both are shikimate-dependent
(ii) neither is detectable in E.coli AB2834
(iii) both are present in pIA30l//AE2834 extracts
(iv) both are increased in intensity in extracts
of strains overproducing E3«
These observations strongly suggest that both bands are 
dependent for their existence on the region of the 
genome represented by the 1.82 kbp Hindlll-Clal fragment. 
There is no need, therefore, to invoke the idea of some 
other dehydrogenase nonspecifically catalysing the E3 
reaction. The sequence data for the 1.82 kbp fragment 
show no ORF capable of encoding a 49 kDa polypeptide.
It seems likely, as mentioned in Chapter Three, that the 
species giving rise to the 49 kDa band contains, in some 
way, the E3 polypeptide. This matter was not pursued 
further experimentally so the origin of the 49 kDa band 
remains unclear. Application of the renaturation protocol 
to an SDS Laemmli gel of homogeneous K12 E3 gives a single 
30 kDa activity band (S. Chaudhuri, unpublished results).
In Chapter Three it was hypothesised that the 49 kDa 
band might be an artefact due to the formation of refractory 
disulphide linkages between E3 and some other protein.
One can speculate further in this direction though the 
ratio of data to ideas is unfavourable. The existence of 
only one putatively artefactual band need not imply that 
there would have to be only one particular polypeptide to 
which E3 crosslinks since possibly only one partnership 
out of many would survive the sample preparation procedure 
used for SDS PAGE. However, it is perhaps more plausible 
that the hypothetical crosslinking would occur to some 
species with which the E3 polypeptide was already associated, 
conceivably another E3 polypeptide. E3 purified to homo­
geneity from E.coli K12 is a monomer (Chaudhuri and Coggins, 
1 9 8 5) but it has been noted (Fulton, 1 9 8 2 ) that the protein 
concentrations found in cytoplasm are so high that non-ideal 
effects become very important. Thus observations made at 
low protein concentrations may not accurately reflect the 
in vivo situation. The 49 kDa molecular weight of the 
putatively crosslinked species is not at variance with the 
idea of a crosslinked E3 dimer since the apparent m.w. 
would depend on the positions of the crosslinked groups
within the polypeptide chains.
The sequence data suggest an alternative hypothesis 
to explain the 49 kDa band. Examination of the open 
reading frames in the 1.82 kbp Hindlll-Clal sequence (see 
Figures 4*1, 4.2, and 5*l) shows that upstream of the aroE 
gene and in the same orientation there is a substantial ORF 
(624 bases between stop codons) whose termination codon is 
only 4 bases before the initiation codon of aroE. This ORF 
immediately upstream of aroE will be referred to as UPSORF 1. 
It is possible, as discussed later, that UPSORF 1 is a 
functional gene and that it is part of an operon which 
includes the aroE gene. If this is the case, and there is 
as yet no direct evidence to support it, then the 49 kDa 
band could arise from ribosomes occasionally frameshifting 
during translation of the C-terminal part of UPSORF 1 thus 
resulting in readthrough into the aroE gene and the production 
of a fusion protein. Precedents for this situation are 
known (Grosjean and Fiers, 1982; Atkins ejt al. , 1979)*
Perhaps some feature of the sequence at the end of UPSORF 1 
predisposes ribosomes to shift frame sometimes rather than 
to terminate translation.
Various experimental approaches could be used to pursue 
this problem. The readthrough hypothesis would predict 
that an extract of pIA309//AB2834 should not give a 49 kDa 
band since in pIA309 UPSORF 1 is drastically truncated (see 
Figure 4.2). Also, it should be possible to lyse cells 
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The possibility that UPSORF 1 is a gene, in an 
operon containing aroE, is relevant to the discussion of 
another problem: the wide variation in E3 specific activities
obtained for strains carrying different subclones of aroE 
(Sections 3«3«5 and 3*3*6)# This problem will be discussed 
later. In the next sections preliminary sequence data are 
presented for the 0.6 kbp Clal-BamHI region (see Figure 3*14), 
thus extending the available sequence further upstream from 
aroE. This new information permits the identification of 
another large ORF whose amino acid sequence has interesting 
features.
5.2 Locations of large open reading frames upstream of aroE
5.2.1 Large ORF's in the 1.82 kbp Hindlll-Clal sequence 
The stop codons in all six reading frames of the 
Hindlll-Clal sequence were shown in Figure 4.1. The precise 
position and extent within the sequence of each of the two 
largest ORF’s (aroE and UPSORF l) is shown in Figure 
Upstream from, and slightly overlapping, UPSORF 1 is a 
segment of ORF which continues uninterrupted to the Clal 
site: this segment was found to join in frame with a
segment of ORF in the sequence of the Clal-BamHI region 
(see below) giving a large ORF which will be referred to 
as UPSORF 2.
3* 2.2 Sequence of the 0.6 kbp Clal-BamHI fragment on one 
strand
The Hindlll-Clal fragment was sequenced on both strands 
The abutting Clal-BamHI piece was sequenced mainly on one 
strand during the first round of M13 sequencing (see Figure 
3*14 and Table 3*12) by sequencing in from either end of 
the fragment. The use of altered ratios of dideoxy- to 
deoxynucleotides and extended periods of electrophoresis 
were required to obtain runs of sequence long enough to 
overlap. An overlap of 49 base-pairs was obtained. The 
sequence is shown in Figure 3*2. It must be emphasised 
that this sequence should be regarded as preliminary since 
being mainly on one strand it may harbor insidious errors, 
as discussed in Section 3*5*1C* However, it is worth noting 
that the overlapping sequences agree perfectly and also that 
very unusually, there are no ambiguities or doubtful regions 
in the two runs of single strand sequence.
The overlap across the Clal site was obtained by 
extended reading of the 13-2 template (see Figure 3*14 and 
Table 3*12). This permitted the tentative Clal-BamHI 
sequence to be fused with the Clal-Hindlll sequence thus 
extending the distance upstream from aroE for which DNA 
sequence.was available.
The stop codons in all six reading frames of the Clal- 
BamHI sequence were plotted as an extension to Figure 4.1. 
This enlarged ORF diagram for the whole Hindlll-BamHI region 
is shown in Figure 3*3* As mentioned above in Section 3*2.1
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there is a large open reading frame, UPSORF 2, which 
straddles the Clal site.
5*2.3 The amino acid sequences of UPSORF 1 and UPSORF 2 
Table 5*1 gives the rough sizes of the polypeptides 
which would be expected if UPSORF 1 and UPSORF 2 are 
expressed genes. The amino acid sequences predicted from 
the DNA sequences are shown in Figures and 5 .6 . Figure
5*5 sketches the arrangement of large ORF’s and some putative 
initiation codons in the Hindlll-BamHI region.
5*3 Are UPSORF 1 and UPSORF 2 genes?
It is not known whether UPSORF1s 1 and 2 are expressed 
as polypeptides. Further work is required to test this 
idea, however, considerable indirect evidence points to 
UPSORF 1 and UPSORF 2 being genes. This evidence is outlined 
below, prior to detailed discussion in the following sections:
1. The codon utilisation within the two ORF's shows 
the bias found in genes.
2. For UPSORF 2, the striking pattern in the deduced 
amino acid sequence makes it very likely that this 
ORF encodes a protein.
3* The E3 specific activities in strains carrying
different aroE subclones suggest that the level of 
aroE expression is affected.by sequences far upstream 
from aroE. One plausible explanation is that UPSORF*s 
1 and 2 are genes in an operon which includes aroE.
J
Table 5.1 Polypeptide sizes predicted from the sequences of
UPSORF 1 and UPSORF 2
Number of Estimated
amino acids m.ui. (kDa)
(a ) UPSORF 1
In i t ia t io n  codon: 1st GTG 205 23
2nd " 200 22
3rd M 190 21
1st ATG 147 16
(b ) UPSORF 2
In i t ia t io n  codon: 1st ATG 180 20
NOTE: m .u .’ s estimated on the assumption of an average m.u. per 
amino acid residue of 110 Da.
p U r O H3
o • d - H* H*
H* o n  p * 4
p . • CD CD P
0 H  4 d - 4
V---' 0
p Q  P 1
4 p 0 1-3 CD Ln
® 4 P O •
0 d - O ■P*
H - P O 121
P P 4 O >
&  H  0 Pa
H- CD CD 0 0 3
O 0 p 0 H*
P O • £ P
Cf 3 4 ) P O
CD P 0
p P
K* o 0 0 0
Cf 0 CD p 0 H-
Pa CD 4 P i
•  • H* O
p . a * y 4) 0
0 H 0 0
d - f *  CD CD C | ►9
CD o CD 4d P
p CD H* cn 0
p  era H- o 1 0 P
P 05 H td O
a 4 P 0 0
p H*
S  13 H> P - h» 0|P  CD H* P H)
CD O H- 3
O P c+ P <P
H j H j 0 H* 0 hd
H O P tfl
P P CD d - d - O
P 0 H* 4
£ P O p
H* d - d - P p
P 0 0 H
era P O H
H  O ' 0 P
o  \ ® P i d -
p  % O 0
p  *< P i P Pa
4 Pa H- 0
era 4 CD
CD 0 O P 0
P 4 d -
ST CD 0 Pfl 0 CD 4
3 o 1 CD H d -
H- H- P i P H*
p O a* P
0 H- 0 ora
p P H
p 3 H  H j
0 H- Cfi 0 4
H- P CD Pi O
a  O O 3
CD d - H










a n o -4 -H o n n n ©
x X 3 -H X —  ® r X ©
O  X . n x •n  p O  X -4 X -4 PI Cl X >  p -H
o o 3 X PI ^  c C o z
—4 3 -4 o -4 © © 2> X ©
© n -4 -1 -4 n -4 o
© X p r~ to o r >
© p ♦ o x • -im h  m O  PI X 1“ -4 PI n x ©  X n
•< o c c X X C X ©
-I o o o © © © > >
© -i H > n o © o o ©
© o n —4 > r © © 3>
2> |“ * o -< »© -c O  X O X -4 © 2> r 3> r 3>> © -4
c cn tn X o C c c X
> * H *-o U  Cl w n tO -4 © > o >
<0 w NJ tfi •0 04 NJ ►-
> o  o © o ©  Q © -4 © X © -4 © © o © ©  2>
-1 3 o o -4 f“ > X
o  x • 3 p ci r • Q X >  *< -4 PI o  r O  P >
X ~  © X •< X to C 3>
© 3 © n O > Cl •H O
© 3 © o o n X» © 3> 2>
o -4 3 > X X r © H
© r O X •o  r o  x • O X n x > *< -t > -4 P 3>
«< X 3 o o o tn PI
© 3 -4 n x> Cl 2> -4 O -4
© © -4 -i © ■ -4 n -4 © ©
© c —4 X o o X 3>
© r -4 3 • 3 K -4 X • ©  r » -< >  r -4 X n p -4
«< p X PI -< X z Pi 3>
© 3 -* -4 -4 -4 © O
> ©
n U © * © UJ Q u n IO 2> K3 n © © O
3> O > «* o CD 3> hS X CS •-« © 2> © © 3> to
© x © 3 © o © P © > tn © n  x ©  -4 r* © © X © ©  r © n p © 2>
© X •< X • - o pi o ~< 3»
H n -4 -4 ■H -4 -4 -4 IV
© 3 O © n © © 3>
P o P to © > X © 3>
-f n 3 r 3  ■< n  m • -4 2> > tn n x -4 2> Cl p ©
c c (0 X 1“ X o P 3>
i» 3 3 o n -4 © —4 © n
3 © O o o © © 3>* n
3 C X n -4 !>■ © ©
3 (0 -4 3 n  x -4 m • © X 2> CO -4 > ©  P -1 P ©
X p o c X X n -< P
-4 -4 Cl -4 n o •>4 © > ©
n si/ n o O -4 3- . © —4 © • —4
X #  3 p > X —4 3> O »
n x m  ci x > -4 p 04 n r W-4I to n x to cn © *< 3» © -4
o ►- o Cf c ND > Ui m NJ X X C»1 © X w
-4 o n o o © •H ©  <H © n © -4 © n © -< c
-4 © o O © > 3> © © n
tn 3 © © © X r > ©
o p • o r • -4 3 -4 > • -4 3> -4 PI > -< 3> © -4 > ©
X 3 r r r~ tn X P
3 3> H > o © © -4 ©
© O -4 n -4 -4 n n n n
c o tn > X n o X p
3 r • 3 r n m o x • -4 X -4 PI © r n x -4 P ©
c X X o PI C -< o C
3 3 -4 2> -4 o Cl -4 Cl ©
3 -4 > O n > a © 3> 3>
X -4 © X -4 c > 3>
-h r • -4 X n x O X n  x -4 p| > © > © 3v
p m X r* o X C X Z
n W -4 * n o 04 n K) -4 to o -4 ^ “4 —4
tO O' © CD to cs © Jt
n c © © 3 © © © © C © X- © © © © 3>
3 Cl cn -4 > © ©
© * * © p o m n x n r > to -4 r ©  PI 3> P 3v
© -< X X > X pi X C
O o n © n n -H
O o a o n © -4 © © 3>
3 3 3> > X © r © ©
3 (f? • n r « n r > tn • n x -t > • -»m > r~ 3> p Jv
3 X* X . o r c C C
H o n n -4 Cl 3^ > n
© o > n o Cl 3> n Cl
3 3 > X > c. -4 3»-
n p • o r • > (A 2> *- • n >  r • -4 r n x © X —4
3 3 X X tn 3> z m X ©
n © n —« © Q n -4 ©
Cl t* -4 4*-4 > n U > to n to o © ^ © 3>
p U X NJ r X u -4 < 3> u > NJ 3* h  © m
-4 m © -4 X © -4 m © n x © n x © © X © © r* © Cl P © -4 > © 3>
c ' • m c • o • X o • > > P
© n o Q > X- > r.
3 o > -4 3> © o © > 2>
X tn r* © > ©
n x • O X • a  m • -4 m •n x 3> r • n r -4 2> -H P 3>
X o 1 x c X c > P P
© © i-* a » > X © Cl -4
© o o c n 2> 3> 3> © >
o c o © X —< X 3>
©  p • -4 3 9o r* • -i S> •n x n z • 3> tn -4 P n p 3*
K p •< r o X z -4 3>













3 p trt -4 3 a  -4 m A -4 > Im O X U’H T to 3> -< ©  X h  >  < —I
c >. r cr c to r P* © ©  P*. > X X © K) X c
























P Cf- p 0
• 0 bd d  O
d di-b § O 0 do S 4 M4 H d 0d  0
P 0 d  -4 PH* tn h- 4
0 cf- O  3 0H- 0
CP? d  P 4
P d- c+ 0H- O H P d
d H 4H- P P H 00 0 P ^ 0
S P Pi 0P 4 p
cf- cj 0 d-
d- h j 0 0
Pi P  cn 0 PiH- 0 O
0 M O P
cf- 0 d  p ^
P cf- p
P p i\3 d d-o 4 • cf- P
0 cf- 0 0
p >  4
0 4 
P P
§P CP? p 0 
4 3 














d  d- d  O P0 4 P
p d H* P H- Pi
0 d 0 4 N
cn 0 d
P  O  P P Po d  o P cf- cf-
4 d  cf- P P P
H- Pi H cf-
N ro p H-
O P d- P <1
P i 0 P  o 0
rf- 3 0
P H  P 0 d
H  0 d 0 P
P  3 0 • d
P 0 P  0 c+
4 H 0 H- d
4 H  d- d- d P
O 0 P  H- P cf-
* Pi 0 O 0 d
0 4 P O3 0 H- P
3 d  d- Pd d  P  o H* O
cf- cn 0 d cf- O
P  O H- Pi
H- d  0 0 P 0
P d  0 o cf- p
CR? 3 H* 0
cf- Lo 3 0 O
P  -0 0 P d
0 = P d  cf- P O
P
P 1 cf- o d-
0 O P Pi P
X 0 d  d- 0 0
0 o H- p0 p O  <j K
d- bd 0 d d0 H- d o P
p  p H- 4 Pi
0 P 3 P H
0 P  H- p H0 H- d- 4 H
d- O H- 0 1
P  P  P  P m bd
0 0 cr P
0 H- P
U r o 0 P d
— p cf- P 0 H
Pi 0
rf- P 0 P 4
O d- Pi O 0 0
P  0 Pi 0 cn?









4. The pattern of putative transcriptional and trans­
lational control sequences within the Hindlll-BamHI 
sequence is consistent with the operon hypothesis 
mentioned above, although this is tenuous evidence 
at best.
There are thus two separate but interwoven questions 
to be considered. Are UPSORF*s 1 and 2 genes and, if so, 
do they form an operon which includes aroE? There is also 
a short segment of ORB) labelled ’’UPSORF 3?” in Figure 5»5; 
which is truncated by the BamHI site and which may constitute 
a third putative gene (see below).
5.4 Patterns of codon utilisation in aroE, UPSORF 1, and 
UPSORF 2
5.4.1 Background
Codon utilisation in E.coli genes is not random (Gouy 
and Gautier, 1982; Grosjean and Fiers, 1982). All genes, 
except for those which are only expressed at extremely low 
levels, tend to use codons corresponding to major species 
of tRNA’s in the cell and the degree of this bias is greater 
in genes for highly expressed proteins. Another component 
of the observed bias is that in genes for very abundant 
proteins the choice between synonymous codons NNU and NNC 
is such as to favour intermediate values of codon-anticodon 
binding energy but for weakly expressed genes this rule 
does not hold. The expected biases for moderately/weakly
expressed B.coli genes, such as the shikimate pathway genes, 
are shown in Table 5*4.
5.4.2 Codon utilisation in aroE and comparison with some 
other common pathway E.coli aro genes
The codon usage of* aroE is shown in Table 5*2. Alongside 
it are the codon usages for aroA and aroD (Dunean et al., 
1984b; Duncan, 1 9 8 5)* In Table 5*4 the observed biases 
are. compared with the expected biases. The patterns for 
the three aro genes are all very similar and are in good 
agreement with the expected pattern.
5.4.3 Codon utilisation in UPSORF 1 and UPSORF 2
The codon usages of UPSORF 1 and UPSORF 2 are shown 
in Table 5*3 alongside the codon usage for aroE. The codon 
utilisation of UPSORF 1 was calculated on the assumption 
that the translational initiation site is the third GTG 
codon which is the first plausible initiation codon after 
the end of UPSORF 2; the pattern is the same if one starts 
from the first ATG. Note that the polypeptide sequence 
predicted for UPSORF 2 contains 16 cysteine residues out 
of a total of 180 amino acids. In Table 5*4 the observed 
biases are compared with those expected for moderately/ 
weakly expressed E.coli genes. For both UPSORF 1 and UPSORF 2 
the agreement is reasonably good, although poorer than in 
the case of the aro genes. However, this less satisfactory 
agreement will be at least partly due to UPSORF1s 1 and 2 
being smaller than the aro genes and thus their codon usage 
patterns being more vulnerable to statistical fluctuations.
Table 5 .2  Codon u t i l is a t io n  in  aroE. aroA, and aroD. 
_____________ aroE aroA aroD _______________ aroE aroA______ aroD
ARG CGA 1 0 0
CGC 5 7 2
CGG 3 2 0
CGU 3 12 7
AGA 1 0 0
AGG 0 1 1
LEU CUA 1 0 0
cue 5 3 5
CUG 13 26 11
CUU 4 4 1
UUA 4 10 1
UUG 8 5 1
SER UCA 2 2 0
UCC 4 5 5
UCG 2 2 2
UCU 2 6 3
AGC 2 5 4
AGU 5 1 2
THR ACA 3 7 0
ACC 3 10 8
ACG 2 10 4
ACU 4 7 3
PRO CCA 4 2 2
CCC 2 3 0
CCG 3 9 3
ecu 4 4 2
ALA GCA 6 15 6
GCC 3 7 13
GCG 10 18 7
GCU 11 6 3
GLY GGA 4 2 0
GGC 7 18 8
GGG 1 4 0
GGU 13 13 5
UAL GUA 4 4 4
GUC 0 4 6
GUG 5 9 5
GUU 4 7 2
LYS AAA 6 14 . 16
AAG 2 3 1
ASN AAC 2 9 2
AAU 9 9 2
GLN CAA 3 5 2
CAG 7 7 4
HIS CAC 3 5 2
CAU 5 3 4
GLU GAA 11 16 11
GAG 6 6 7
ASP GAC 5 3 6 ,
GAU 8 23 11
TYR UAC 0 4 1
UAU 5 9 5
CYS UGC 1 4 3
UGU 2 2 0
PHE UUC 4 4 3
UUU 10 9 5
ILE AUA 3 0 0
AUC 6 9 7
AUU 9 17 9
MET AUG 5 14 11




Table 5.3 Codon utilisation in aroE, UPSORF 1, and UPSORF 2
______________ aroE UPSORF 1 UPSORF 2________________ aroE UPSORF 1 UPSORF 2
ARG CGA 1 4 1
CGC 5 5 5
CGG 3 0 1
CGU 3 4 3
AGA 1 1 0
AGG 0 0 0
LEU CUA 1 0 1
cue 5 1 1
CUG 13 6 6
CUU 4 2 2
UUA 4 3 1
UUG 8 7 0
SER UCA 2 1 3
UCC 4 1 3
UCG 2 1 1
UCU 2 1 2
AGC 2 1 0
AGU 5 2 1
THR ACA 3 4 3
ACC 3 5 2
ACG 2 4 2
ACU 4 1 0
PRO CCA 4 3 1
CCC 2 2 2
CCG 3 5 6
ecu 4 6 4
ALA GCA 6 5 4
GCC 3 4 2
GCG 10 5 5
GCU 11 5 2
GLY GGA 4 1 5
GGC 7 2 3
GGG 1 5 3

















U S AAA 6 3 10
AAG 2 1 3
ASN AAC 2 2 2
AAU 9 5 3
GLN CAA 3 2 3
CAG 7 5 5
HIS CAC 3 0 3
CAU 5 1 4
GLU GAA 11 9 8
GAG 6 2 4
ASP GAC 5 5 2
GAU 8 7 3 -
TYR UAC 0 1 3
UAU 5 3 3
CYS UGC 1 2 8
UGU 2 1 8
PHE UUC 4 2 2
UUU 10 6 6
ILE AUA 3 1 1
AUC 6 4 3
AUU 9 3 5
NET AUG 5 2 2








N.B. For UPSORF 1 codon u t i l is a t io n  
was calcu lated  s ta r tin g  from 
the 3rd GTG (190 a . a . 's ) .
180 a .a * f s in  UPSORF 2.
Table 5 .4  Expected biases in  codon usage fo r  m oderately/ueakly  
expressed E .c o li  genes and comparison w ith observed 
biases in  aroE, arofl, aroD, UPSORF 1 , and UPSORF 2
Expected biases aroE aroA aroD UPSORF 1 UPSORF 2
*LEU CUG most favoured + + + V - +
CUA le a s t favoured + + + + + / -
*LYS AAA > AAG + + + + +
*ILE AUU > AUC »  AUA + + + V - +
*GLN CAG > CAA + + + + +
*GLU GAA > GAG + + + + +
ARG CGC & CGU favoured + / - + + + / - +
GLY GGC & GGU favoured + + + V - -
ASP GAU > GAC + + + + +
TYR UAU >  UAC + + + + + / -
PHE UUU > UUC (o fte n ) + + + + +
NOTE; 1 . The most c le a r cut expected biases are asterisked .
2. Good agreement w ith the expected bias is  ind icated  by "+” , 
marginal agreement by "+ /-">  and disagreement by
If the data for UPSORF1s 1 and 2 are pooled then the match 
with the expected biases is as good as for aroE. Hence, 
the codon utilisation data support the hypothesis that 
both UPSORF 1 and UPSORF 2 are genes.
Although the small truncated "UPSORF 3?” (see Figure 
5 .5 ) contains only 92 known codons its codon usage is heavily 
biased in the manner expected for a gene. Only two amino 
acids occur more than 6 times, leucine and glutamic acid.
Of the l6 leucine codons 7 are CUG and none are CUA. Of 
the 14 glutamate codons 10 are GAA. This suggests that 
UPSORF 3 may also be a gene.
5*5 Analysis of UPSORF1 s 1. 2. and 3 by the method of Fickett
3.5.1 Background
Fickett (1 9 8 2) devised the "TESTCODE" procedure to 
distinguish protein coding regions from fortuitous ORF’s 
in DNA sequences. This test depends mainly on finding 
statistical order in the base sequence (together with a 
small contribution from the base composition). Statistical 
order in protein coding regions is due to non-random codon 
utilisation. One consequence of biased codon utilisation 
is that the number of bases separating (e.g.) T's is much 
more likely to be 2,5>8...(2 + 3a) than it is to be 3a o r  
1 + 3n. Although Fickett fs method does not provide a line 
of evidence independent from that adduced in the previous 
section it does provide a more quantitative assessment of
a particular ORF. It is applicable to stretches of DNA 
sequence greater than 200 bp.
The Fickett method was originally tested on 400,000
v
bases of sequence. It gave "no opinion" in 20$> of cases 
and was wrong in 5$> of cases (although the latter include 
cases with an assigned "probability of coding" as low as 
0.84).
5.5*2 Results
TESTCODE gave a "probability of coding" of O . 9 8 for 
the whole of UPSORF 1 and predicted that this region encodes 
a protein. However, starting from the first ATG in UPSORF 1 
the verdict was "no opinion" ("probability of coding" = 
0.77).
For UPSORF 2 the verdict was "no opinion" ("probability 
of coding" = 0 .5 8 ).
The most categorical result was obtained for the 
truncated UPSORF 3 where TESTCODE gave a "probability of 
coding" of 1.00 (TESTCODE indicator value of 1.25). If 
thus seems likely that UPSORF 3 is a gene.
5 . 6  Preliminary examination of the deduced amino acid 
sequences of UPSORF 1 and UPSORF 2
5.6.1 UPSORF 1
On the uncertain assumption that UPSORF 1 encodes a 
protein the deduced amino acid sequence was examined by eye
for any prominent features. This must be regarded as a 
highly tentative exercise.
One possible initiation site for translation is the 
first ATG(Met) codon. The a.a. sequence following the 
first Met shows some similarity to an E.coli signal sequence 
(Watson, 1984). This feature is labelled "A" in Figure 
5.4. Many E.coli polypeptides with signal sequences begin 
(in their tie novo form) either with Met Lys... or else 
have one or more lysines and/or arginines within the first 
six amino acids. Also, in most cases the run of uncharged/ 
hydrophobic amino acids characteristic of a signal sequence 
is preceded by a lysine or arginine residue. Both these 
features are found in UPSORF I. However, the run of 
uncharged/hydrophobic amino acids in UPSORF l's putative 
signal sequence (9 residues) is unusually short, and the 
run's distance from the initiation codon is rather long, 
compared to most known precedents thus casting doubt on 
this idea.
Much of the latter part of UPSORF 1 consists of relatively 
long runs of uncharged/hydrophobic amino acids. These are 
marked on Figure However, the overall polarity of
the hypothetical polypeptide (as defined by Capaldi and 
Vanderkooi, 1972), calculated from the first ATG, is 40$>, 
the same as for E3*
There are some interesting sequence patterns within 
the neutral/hydrophobic runs but these may be completely 
fortuitous. The first (marked "B" in Figure 5*4) is as follows
LIKo
.••Arg Trp Pro Gly Pro Val Thr Phe Val Phe Pro Ala Pro Ala Thr 
Thr Pro Arg • • •
in which, a hexapeptide sequence is closely followed by a 
very similar hexapeptide sequence. The second (marked "C" 
in Figure 5*4) consists of two neutral/hydrophobic inns, 
separated by a lysine residue, which both begin Pro Leu Val.
The small size of the putative UPSORF 1 polypeptide 
(l6-23 kDa) led to the suggestion that UPSORF 1 might be 
the missing gene for shikimate kinase (E4) I (see Chapter One). 
The estimated molecular weight of E4l is 20 kDa (Ely and 
Pittard, 1979)* To test whether there was any E4 gene(s) 
in the vicinity of aroE, crude extracts were made of E.coli 
AB2834 carrying the largest aroE subclone pIA306 (and of 
pIA307//AB2834) and assayed for E4 activity as described 
in Chapter Two. No sign of E4 overexpression was seen.
However, this preliminary experiment must be interpreted 
with caution since both forms of E4 are known to be unstable. 
There is no trace in UPSORF 1 of the weak homologies between 
ATP using enzymes that were found by Walker ejb al_. (1 9 8 2 ).
5.6.2 UPSORF 2
5.6.2A Four-fold repetition within the UPSORF 2 amino acid 
sequence
Inspection of the UPSORF 2 amino acid sequence revealed 
a very interesting structure; the 180 amino acid sequence 
(approximately 20 kDa) contains 4 imperfect repeats each of
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27-29 amino acid residues. The positions of the h repeats 
within UPSORF 2 are shown in Figure 5*6 - they have been 
named A, B, C, and D. Repeats A and B lie within the 
BamHI-Clal region which was sequenced mainly on one strand, 
while repeats C and D lie within the Clal-Hindlll region 
which was sequenced on both strands. Figure 5»7 shows the 
homologies between the k repeats.
The strongest homology is between repeats A and B.
No ’’gapping" is required to achieve optimal alignment of 
these two repeats and there are 16 perfect matches out of 
27 amino acids. There are also h mismatches between very 
similar amino acids: 2 Leu/lle, 1 Lys/Arg, and 1 Gln/Asn. 
Although the overall homology between A, B, C, and D is 
poorer than that between A and B alone the basic structural 
motif is preserved:
...Cys Pro — !— Cys < 16-18 a. a. 's--- >Oys < 5(^)a«a»-1s  ^Cys
Note that there are four cysteine residues in each repeat, 
seemingly in two pairs. There are a few constant residues 
in addition to those in the basic motif.
The sequences which flank the repeats are of variable 
length being (in order from pre-A to post-D) l4, 22, 15> 12, 
and 7 residues long. There is no obvious homology between 
these flanking segments nor between them and the repeats, 
however, it may be significant that each of the four repeats 
is followed, at a variable distance, by ...Lys/Arg Pro...
The repeats presumably arose as the result of gene 
duplication events perhaps as a consequence of unequal 
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within proteins are known, for example, in anaerobic 
bacterial ferredoxins (Tsunoda and Yasunobu, 1968), 
Pseudomonas oleovorans rubredoxin (Yasunobu and Tanaka,
1973) and mitochondrial ADP/ATP translocase (Walker at al., 
1982). The case of immunoglobulin heavy chains was 
mentioned in Chapter One.
The UPSORF 2 repeats and, in particular, the conserved 
pairs of cysteine residues initially suggested comparison 
with the small iron-sulphur proteins. The results of these 
comparisons will be considered in Section 5*6.20. The 
intervening section contains a brief summary of the structure 
and role of iron-sulphur proteins.
5.6.2B Iron-sulphur proteins
Iron-sulphur (= nonhaem iron = FeS) proteins have 
been reviewed in the series edited by Lovenberg (1973)• 
in particular, much of the amino acid sequence data 
discussed below is contained in the chapter by Yasunobu 
and Tanaka (l973)» Bacterial FeS proteins have been 
reviewed by Yoch and Carithers (1979)*
The simplest prosthetic group in FeS proteins is an 
/ 2 + 3 + \iron ion (Fe or Fe ) tetrahedrally coordinated to the 
sulphydryl groups of four cysteine residues in the poly­
peptide backbone (an "FeS centre"). Only in rubredoxins, 
however, are the FeS centres this simple. In the vast 
majority of cases inorganic sulphide is also liganded to 
the iron, either as an Fe^S^ centre (2 Fe, 2 sulphides,
4 backbone cysteines) or as an Fe^S^ centre (4 Fe, 4 
sulphides, 4 backbone cysteines). Other more complex 
types also exist.
FeS proteins play crucial roles in a wide variety of 
biological redox processes, for example in:
(i) mitochondrial electron transport (NADH-Q reductase, 
succinate dehydrogenase)
(ii) photosynthesis (e.g. ferredoxin)
(iii) fixation
(iv) hydrogenase systems of many anaerobic bacteria
(v) oxygenase systems (e.g. adrenodoxin in steroid 
hydroxylation, P. oleovorans rubredoxin in omega- 
hydroxylation of alkanes and fatty acids)
(vi) ribonucleotide reductase
FeS proteins can be divided into two classes: firstly, 
the usually small electron transport proteins such as 
rubredoxins, ferredoxins, and adrenodoxin and, secondly, 
the more complex FeS redox enzymes. The latter often have 
additional prosthetic groups (e.g. flavins, copper, 
molybdenum, and perhaps selenium). We shall be mainly 
concerned with bacterial FeS proteins in the first category: 
rubredoxins and ferredoxins. These have been well studied 
at the sequence level.
5* 6.2C Preliminary comparison of the UPSORF 2 amino acid 
sequence with known proteins
All the similarities outlined below between UPSORF 2 
and various known proteins are very slight. Doolittle (1 9 8 1 )
has carefully considered the difficulties involved in 
establishing evolutionary relationships between distantly 
related proteins, the central problem being to distinguish 
chance similarity from common ancestry (or, rarely, 
convergent evolution). He has emphasised that the risk of 
chance "homology” between two amino acid sequences is often 
underestimated (especially where gaps must be inserted for 
optimal alignment) and the need for a rigorous statistical 
approach to such matters. The comparisons described here 
should therefore be regarded as preliminary. A more 
rigorous approach will be necessary once it is known if 
UPSORF 2 is expressed. Some discussion of quantitative 
methods of comparison will be found in the section on futur 
work.
(i) Anaerobic bacterial ferredoxins.
There are minute but tantalising "homologies" between 
anaerobic bacterial ferredoxins (ABF's) and the UPSORF 2 
amino acid sequence. All seven of the ABF sequences, listed 
by Yasunobu and Tanaka (1973) show strong homology among 
themselves, and all have a two-fold internal repeat which 
accounts for most of the molecule. All have about 53 a.a.* 
(6 kDa) hence the size of each repeat is roughly the same 
as that in UPSORF 2. Each of the ABF’s contain two FeS 
centres and each repeat contains a cluster of four cysteine 
residues, a distribution different from that of the four 
cysteines in each UPSORF 2 repeat. This cluster and some
associated constant conserved residues are shown below:
. . • ^ ys e CysGly Cys -------- Cys Pro • • •
. . . 1 2 3 4 5 6 7 8  9 \o I) II ...
In the first ABF repeat position "6” is always Ala (and 
likewise in four out of seven cases for the second repeat) 
giving:
. • • -- Cy13 G-ly (Ala) • • *
which is similar to the sequence around the first cysteine 
pair in repeats A and B of UPSORF 2:
...Cys Pro Cys Gly Ala...
In the positions immediately preceding the cysteine 
cluster three of the seven ABF first repeats have:
... Asp Ser...
-2 -1 0 
of which two are:
••.Asn Asp Ser.•.
- 2 - 1 0
Both the first and second repeats of all seven ABF’s have 
Asp (or in one case Glu) in the w-l,f position. All seven 
of the second repeats have Thr or Ser in the ”0" position. 
In UPSORF 2 the very first cysteine pair is directly 
preceded by:
...Asn Glu Ser...
Thus the sequence around the first cysteine pair of UPSORF 
resembles that around the first cysteine pair of ABF's 
(some more than others) over an interval of nine a.a. 
residues, respectively:
• • .Asn Glu Ser Cys Pro ---  Cys Gly Ala. • .
compared with
• . • (Asn)'^ 'S*> ^er Cys^?^ Cys Gly Ala. . .
(Glu)Thr
Five of the seven ABF's end with ...Glu-COOH (and one 
with Asp). Three end with ...Ala Glu-COOH. UPSORF 2 ends 
with ...Ala Glu-COOH.
In summary, there are traces of "homology" between 
UPSORF 2 and the ABF's as well as the common, properties of 
internal repetition, roughly similar repeat sizes, and k  
cysteines per repeat. As stated at the beginning, some or 
all of the homology is quite possibly fortuitous. Also, the 
possibility of homology due to convergent rather than divergent 
evolution must always be remembered, especially in cases 
such as this where any sequence similarity is very slight.
UPSORF 2 is not the gene for the ferredoxin present in 
E. coli and of unknown function (Knoell and Knappe, 197^ -) > 
as judged by the latter1s different size, a.a. composition, 
and N-terminal a.a. sequence.
(ii) Rubredoxins.
The three anaerobic bacterial rubredoxins (ABR's) 
listed by Yasunobu and Tanaka (1973) - those from Micrococcus 
aerogenes« Peptostreptococcus elsdenii. and Clostridium 
pasteurianum - are all small, 6 kDa proteins (52-5^ - a#a# 's) 
with 1 FeS centre, no internal repeats, considerable homology
amongst themselves, and no known function. The a.a. sequence 
of all three has the pattern:
TVi-r 1 4
H^N-Met. . . CySg^^ Cys Gly<— 28-29 a. a. ’s— »Cys Pro ---  Cys
Gly^f. .. ^ ®P-COOH J Yal Glu
The sequence around the second cysteine pair:
...Cys Pro — -—  Cys Gly^T^. • • 
is almost identical to that around the first cysteine pair 
in repeats A and B of UPSORF 2:
... Cys Pro — -—  Cys Gly Ala. . .
Like UPSORF 2 and the ABF’s all three ABR’s end with an 
acidic C-terminal residue.
Although the cysteine distribution in ABR’s is 
qualitatively more similar to that in UPSORF 2 than that 
in ABF’s, there are still very considerable differences. 
Firstly, in UPSORF 2 the Cys Pro - Cys pair comes first in 
the primary sequence. Secondly, the spacing is different 
(l6-l8 a.a’s in UPSORF 2 v. 28-29 a.a.’s in the ABR’s). 
Thirdly, the second cysteine pair in UPSORF 2 is not really 
homologous to the other cysteine pair in the ABR's, the 
former having 5 a.a.’s between the two cysteines.
The aerobic rubredoxin from P. oleovorans is a 20 kDa 
protein (1 7^ a.a.'s) with two internal repeats and some 
homology to the ABR’s. The first repeat has five cysteines 
arranged thus:
...Cys Pro AspCys<----- 29 a.a.’s ------- >CysProCysCys. . .
The degree of ’’homology” between the ABR’s and UPSORF 2 
is clearly as weak as that between the ABF's and UPSORF 2, 
and the same strictures must be applied here also. There
does seem to be a frequent use in FeS proteins of Cys------Cys
and, in rubredoxins, of CysPro Cys (ABF’s also contain
CysPro but in a different context).
(iii) Some other proteins.
Unfortunately the small FeS proteins are not the only 
proteins which contain important pairs of cysteine residues. 
For example, the small redox-active disulphide bridge 
proteins (= cysteine-hydrogen-donor proteins) glutaredoxin 
and thioredoxin both contain an essential pair of cysteine/ 
half cystine residues arranged thus:
1  2  r t• • • Cys --- ---- Cys...
The sequence of the E.coli glutaredoxin active centre (Hoog
et al., 1983) is:
••.Cys Pro Tyr Cys.•.
This sequence is conserved in calf thymus glutaredoxin 
(Klintrot erfc al., 1984). There is no other immediately 
obvious homology to UPSORF 2 nor to FeS proteins. The
existence of the conserved tetrapeptide emphasises the
difficulties involved in interpreting the very faint 
resemblances between UPSORF 2 and the ABF’s/ABR’s.
Most thioredoxins contain ...Cys Gly Pro Cys...
(Klintrot ejfc al_. , 1984). There is no easily recognisable 
homology between E.coli thioredoxin and UPSORF 2.
Metallothionein has 20 cysteines out of 6l a.a’s, no
internal repeats, and no homology to UPSORF 2.
There is no homology detectable by eye between UPSORF 2
and the region around the k cysteine residues which coordinat
2+the structural Zn in liver alcohol dehydrogenase.
5.6.3 Conclusions
There is nothing visible in the UPSORF 1 sequence which 
adds weight to the hypothesis that it is a gene. In contrast 
the 4-fold repetition within the UPSORF 2 sequence and the 
faint resemblances to some known proteins must make it very 
probable that UPSORF 2 is indeed a gene, especially when 
taken with the biased codon utilisation.
Speculation about the possible functions of UPSORF 2 
will be left until after the next section which considers 
indirect evidence for an operon (with polycistronic mRNA) 
encompassing aroE and at least UPSORF*s 1, 2, and 3» The 
possibility of such a link must clearly colour any discussion 
of the possible functions of UPSORF 2.
5.7 E3 specific activities of strains carrying particular 
aroE subclones
5.7»1 Background and summary of observations
This section considers again the wide variation in E3 
specific activities found with different aroE subclones.
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The relevant data were presented in Section 3 * 3 * 5  and some 
preliminary discussion was given in Section 3 * 3 * 6 *  Now 
that the precise position, and direction of transcription, 
of the aroE gene are known it is possible to analyse the 
specific activity result.s more rigorously.
The relevant aroE subclones are shown in detail in 
Figure 5*8. Recall that the E3 specific activity (s.a.) 
values for E« coli strain AB2834 containing class I subclones 
are generally 4-5 times higher than those for class II 
subclones, and about 25 times higher than those for the 
class III subclone, in the same host strain.
5 * 7 * 2  Factors complicating the interpretation of the 
specific activity results
5 * 7 * 2 A Interactions between vector and insert sequences 
The first difficulty to be faced is that the pAT153 
plasmid vector is not an inert container in which to study 
cloned E.coli DNA fragments.
Vector promoters are potentially able to distort the 
expression of cloned genes and there are two of relevance 
in the aroE subclones. Firstly, there is the tetracycline- 
resistance (tet^) promoter nP2n (Stuber and Bujard, 1981). 
Its Pribnow box (see later sections) is just on the BamHI 
side of the Hindlll site (see Figure 3 * 2 ). Hence, an 
insert extending clockwise from the Hindlll or Clal sites 
will usually, but not always, inactivate P2. If, by remote
chance, the insert fragment happens to contribute a passable 
Pribnow box, at the correct distance from the ”-35" region 
remaining in the vector, then there may be some residual 
transcription from the resulting hybrid promoter. Secondly, 
there is the "anti-tet M promoter MP1" (Stuber and Bujard,
1 9 8 1) which initiates transcription just clockwise from the 
Hindlll site but in an anti-clockwise direction. This 
promoter is 1.5 times stronger than P2. Insertions that 
leave the vector1s Hindlll-BamHI region intact will leave 
this promoter intact.
These promoters PI and P2 are significant because 
transcription of a cloned gene can be inhibited by a down­
stream opposing promoter unless there is a terminator to 
block the latterfs effect. Fortunately, detailed consideration 
(see below) of the various subclones allows one to discount 
the vector promoters as a possible explanation for the wide 
range in s.a. values.
It is assumed that the s.a. value for pIA306, where 
there are no interfering vector promoters, represents the 
full expression level of aroE under its normal promoter(s), 
when carried on pAT153»
RIn pIA303 the anti-tet promoter PI is in direct 
opposition to aroE transcription. However, pIA305 is a 
class I subclone so there is probably a protecting terminator 
between the Hindlll site and aroE (see Figure 5*8). Whatever 
the reason, one may conclude that the close proximity of an 
opposing promoter to the Hindlll site immediately downstream
from aroE does not have a significant deleterious effect 
on aroE expression, a point central to the argument as 
developed below. It also follows that sequences beyond 
(going in the direction of aroE transcription) this Hindlll 
site are probably not required for maximal aroE expression. 
One can certainly rule out retroregulation (Gottesman et al.,
1982) - reduced expression of a gene due to mRNA instability 
arising from loss of the normal 3 ' terminator structure - 
as a contributing factor in the reduced aroE expression from 
pIA303 and pIA301.
In pIA307 (Class i) aroE transcription is potentially 
opposed, at a distance of 2 kbp, by the tet promoter P2. 
Since PI is 1*5 times stronger than P2 yet did not seem to 
affect aroE expression in pIA303 one would not expect any 
effect of P2 in pIA307 especially given the chance of 
terminators in the intervening 2 kbp of E.coli sequence. 
pIA303 and pIA307 being class I subclones implies that all 
sequences required for maximal aroE expression are located
within the Aval-Hindlll region. This is confirmed by
(
pIA302 being class I.
In pIA304 aroE is positioned relative to P2 exactly 
as in pIA307 yet 307 is class I while 30*4- is class II. The 
major difference between these two plasmids is that the 
Aval-BamHI region is present in pIA307 but absent in pIA304.
piA303 confirms the implication of the 30k result that 
sequences upstream (relative to aroE) of the BamHI site 
are required for full expression. There are 1.4 kbp between
the BamHI site and the start of the aroE coding sequence.
In pIA301 the aroE gene is situated exactly as in 
pIA305 with respect to PI yet 305 is class I whereas 301 
is class III. Any residual P2 transcription would, if anything, 
tend to support aroE transcription. The loss of E.coli 
sequences between the BamHI and Clal sites appears to further 
reduce the expression of aroE relative to class II subclones.
In summary, one cannot explain any of the observed 
differences in E3 s.a.*s by invoking interactions with vector 
promoters. However, this conclusion should be treated with 
caution as there may be hidden complications. For example, 
there may be interactions between insert sequences and plasmid 
functions. One cannot exclude the possibility that the 
initial assumption made about pIA306 (and other class I 
subclones) is wrong and that, say, the copy number of the 
subclones having the Clal-Aval insert region is higher than 
for those lacking this region. This seems unlikely, however. 
None of the subclones have lost vector sequences during 
construction that are known to affect plasmid replication 
or partition.
5.7»2B Differences in plasmid size and host cell physiology
It was noted in Section 3 * 3 * 6  that the E3 s.a. was 
markedly influenced by the final value to which cultures
were grown, increasing as the final increased (probably
due to plasmid amplification). For this reason, s.a. values 
were only compared between cultures grown to similar final
A ^ 0>s • All cultures were grown from a standard inoculum 
in the same volume of the same medium in similar flasks 
and aerated by (roughly) the same shaking speed on the same 
orbital shaker. However, there is some scatter in the 
results for a given subclone/host strain which may be partly 
due to the physiological state of the cells not being fully 
controlled. This scatter emphasises the need to treat the 
data cautiously. In particular there might be subtle 
threshold effects. Even so, the great difference between 
class I and class III subclones (about 25 fold) cannot 
easily be. explained away.
One variable which can probably be eliminated as the 
source of the differences in E3 s.a. is plasmid size. It 
was at first thought that a larger plasmid might impose a 
greater ’’burden" on the host cell so that comparing 
values for cultures of strains containing different sized 
subclones might be an invalid control for the cells’ 
physiological state. However, pIA302 (class i) is smaller 
overall (6 .7  kbp) than pIA30^ (class II, 7*9 kbp), so that 
smaller size does not necessarily correlate with lower E3 
s.a. piA307 (class I, 8 .8  kbp total) is not much larger 
than pIA302+. pIA301 (class III, 5*5 kbp total) is only 
very slightly smaller than pIA303 (class II, 5*7 kbp total).
5.7» 2C Conclusions
Leaving aside all the caveats and provisos in the above 
sections there is a simple hypothesis which explains the E3
s.a. results: there are promoter sequences far upstream
from the aroE coding sequence which are required for the 
full expression of this gene. These sequences might either 
straddle the BamHI site as a single entity or be split 
between the Clal-BamHI region and the BamHI-Aval region.
Both possibilities could explain the progressive reduction 
from class I —» class II (BamHI truncation) — » class III 
(Clal truncation). This hypothesis is considered further 
in the next section.
5»7« 3 Is aroE part of an operon?
There are two obvious interpretations of the hypothesis 
advanced in the previous section.
One could imagine that aroE is expressed as a monocistronic 
mRNA with an exceptionally long 5' untranslated leader 
sequence (or sequences, if there are multiple initiation 
sites). This cannot be completely discounted but is very 
implausible for two reasons. Firstly, most E.coli mRNA1s 
have 5 1 untranslated leader sequences shorter than 200 bp 
(Kozak, 1 9 8 3). For sequences around or upstream of the 
BamHI site to affect transcription directly would require 
a leader sequence of at least 1.4 kb, the distance from 
the BamHI site to the start of the aroE coding sequence. 
Secondly, such a leader sequence would inevitably include 
UPSORF 2 which is very probably a gene.
Alternatively and more plausibly, one could imagine 
that aroE is like the majority of E.coli genes and is expressed
as a polycistronic mRNA. This hypothetical operon would 
include at least aroE and UPSORFTs 1, 2, and 3» If UPSORF 2 
is a gene and UPSORF 1 is not then one would be left with 
a 584 bp intercistronic region and almost all such regions 
in E.coli are less than 400 bp (Kozak, 1 9 8 3).
The operon hypothesis has been adopted as a model for 
further consideration. Experimental tests will be discussed 
later. A necessary feature of the model is that some 
promoter activity must remain after removing the region 
upstream from the BamHI site: in pIA304 and pIA303 (see
Figure 5*8) there is no possibility of vector sequences 
contributing to the observed expression of aroE. If 
UPSORF 3 is a gene then the whole operon's promoter must 
be upstream from the BamHI site. One must therefore invoke 
a subsidiary promoter downstream from the BamHI site but 
before the Clal site. Such subsidiary promoters within 
operons are known e.g. the trpP2 promoter within the E.coli 
trp operon (Lewin, 1 9 8 3). The low expression of E3 from 
pIA301 could be solely due to residual activity from a 
hybrid vector-insert tet promoter. However, examination 
of the DNA sequence immediately downstream from the Clal 
site shows this to be unlikely implying a second subsidiary 
promoter downstream from the Clal site. As will be described 
shortly there are several sequences upstream from aroE, 
both before and after the Clal site, which might act as 
weak promoters. However, this is undiluted speculation.
Ill What might UPSORF 2 be?
Assuming that UPSORF 2 is a gene, and this seems very 
likely, one can speculate on the function of the gene 
product. There are only a few clues. Firstly, there are 
the very slight similarities between UPSORF 2 and various 
small electron carrier proteins, particularly FeS ones. 
Secondly, UPSORF 2 might be part of an aroE operon and it 
will be assumed initially that all the cistrons of such an 
operon would be functionally related in some way. Thus, 
one can start by posing a less difficult question: is
there any possible undiscovered role in aromatic biosynthesis 
for a redox carrier protein?
Ubiquinone biosynthesis in E.coli, which proceeds from 
chorismate via 4-hydroxybenzoate, involves three hydroxylation 
steps of unknown mechanism; there is some evidence that a 
cytochrome P-450 system may be involved (Knoell et al.,
1978). The FeS protein adrenodoxin is required for steroid 
hydroxylation where it participates in a short non- 
phosphorylating electron transport chain to cytochrome P-450 
(Lovenberg, 1973> Stryer, 1 9 8 1). Camphor hydroxylation 
in Pseudomonas putida needs a ferredoxin ("putidaredoxin") 
which too is part of a cytochrome P-450 electron transport 
chain (Yoch and Carithers, 1979)* As mentioned in Section 
5.6.2C, the P. oleovorans rubredoxin is a component of an 
electron transport chain required for omega-hydroxylation 
of fatty acids and alkanes. Perhaps UPSORF 2 plays a role 
analogous to these in one or more of the hydroxylation steps
of ubiquinone biosynthesis. There is a precedent for an 
E.coli shikimate pathway gene being in an operon with a 
gene involved in a p'ost-chorismate branch pathway, namely 
the aroF-tyrA "tyr11 operon (Bachmann, 1 9 8 3) which contains 
the genes for El(Tyr) and chorismate mutase (T)-prephenate 
dehydrogenase.
A thought-provoking precedent is the first "mixed" 
operon in E.coli. the serC-aroA operon discovered by Duncan 
(1 9 8 5). Here the two cistrons encode products involved in 
quite different pathways. However, there is thought to be 
a functional link between the serine and aromatic biosynthetic 
pathways since both serine and chorismate are required for 
the synthesis of the iron chelating agent enterochelin and 
E. coli has a pressing need to scavenge iron and has many 
systems for doing so. The connection between iron uptake 
and aromatic biosynthesis has been suspected for a long 
time (Gibson and Pittard, 1968) and recent work on enterochelin 
biosynthesis has confirmed the connection (Fleming et al.,
1 9 8 3). It is conceivable that the putative UPSORF 2 
polypeptide resembles FeS proteins because it has an iron 
binding role in some iron uptake system and that the 
hypothetical operon is another example of the connections 
between aromatic biosynthesis and iron transport.
The E.coli genetic map (see Chapter One) was studied 
to see if UPSORF 2 could be correlated with any of the 
known genes adjacent to aroE.rrnD (an rRNA, tRNA operon) 
can be ruled out since it lies proximal to aroE and so must,
from the relative positions of genes on X spcl, be downstream 
from aroE. trkA, which is involved in potassium transport, 
is known to be more than 5 kbp upstream from aroE (Meek 
and Hayward, 1984; D.W. Meek, personal communication).
The position of tolM relative to nearby markers is considered 
uncertain (Bachmann, 1 9 8 3)* The original mapping data 
place it between aroE and rpsL.Cotransduction frequencies 
imply that tolM is much closer to rpsL than to aroE although 
this cannot yet be considered conclusive (Braun ejt al. ,
1980). However, despite the rather discouraging mapping 
data tolM merits further consideration in the light of the 
serC-aroA operon.
The phenotype of tolM mutants is high level tolerance 
(not resistance) to colicin M (Braun et_ al•, 1980). One 
of the many iron uptake systems of E.coli is the ferrichrome 
uptake system (Neilands, 1 9 8 2). Ferrichrome is ah iron 
chelator produced by fungi, often to be stolen by bacteria. 
The main component of the E.coli ferrichrome receptor (the 
tonA gene product) is also the unintended receptor for 
colicin M (Hantke and Braun, 1975> and references therein). 
There is tentative evidence that the wild-type tolM gene 
product (or that of a closely adjacent gene) is required 
for the inward movement of things bound to the ferrichrome 
receptor (Schaller _^t al. , 1981) and thus it might be a 
a new component of the ferrichrome iron uptake system.
It is not inconceivable that UPSORF 2 might be an FeS 
protein involved in a complex "flavin reductase" (diaphorase) 
activity for chorismate synthase (see Section 1.8).
5« 9 Possible transcriptional and translational control
signals in the DNA sequence
5.9»1 Speculative promoters in the DNA sequence
E.coli promoters contain two conserved regions (Hawley
and McClure, 1 9 8 3): the "-10" region ("Pribnow box";
Pribnow, 1975) centred about 10 bp upstream from the
transcriptional initiation site and, secondly, the "-35"
region centred about 35t>P upstream from the initiation site.
The consensus sequences for these regions are shown below:
5 1 TTGACA <---15-21 bp > TATAAT<--  4-8 bp > A/G 3'
" - 3 5 "  " - 1 0 "
The spacing between the "-35” and "-10" regions is usually 
+
1 7 - 1  bp and that between the "-10" region and the trans­
criptional initiation site (which is almost always a purine) 
is usually 6-7 bp. In Hawley and McClure's (1 9 8 3) analysis 
of 112 well established E.coli promoters the individual 
bases in the consensus sequences were each present in the 
percentages shown:
T82 T84 G79 A6k V  V  ”-35"
and T?9 A95 A59 A ^  "-10".
At present, attempts to locate promoters from DNA 
sequence alone are speculative since the context of each 
base-pair is important. However, analysis of promoter 
mutants shows that in most cases down-mutations decrease 
homology and up-mutations increase homology to the consensus 
sequence (Hawley and McClure, 1 9 8 3).
The DNA sequence was examined for speculative 
promoters, as described in Chapter Two, but only for those 
acting in the BamHI to Hindlll direction. Some sequences 
resembling consensus promoters are marked on Figure 5*9 
(BamHI-Clal) and on Figure 5*10 (Clal-Hindlll; no 
significant sequences straddle the Clal site). These 
sequences are shown in more detail in Table 5«5» Sequences 
(2) and (3 ) in the BamHI-Clal region look more convincing 
than the others but it must be emphasised that the matches 
to known "-10" and "-35” regions which are shown in Table 
5 .5  are of doubtful significance. A particular ”-10"/"-35" 
region will probably be compatible with only certain 
"-35"/"-10" regions and only at certain spacings.
The aroE operon hypothesis probably requires a subsidiary 
promoter in the BamHI-Clal region, as discussed in Section 
5 .7 .3 . Experiments designed to locate regions of promoter 
activity in the vicinity of aroE will be described later.
5.9.2 Palindromic structures and possible transcriptional 
terminators in the DNA sequence
5.9.2A Palindromes
Palindrome is used here only in the molecular biological 
sense. Palindromic structures in an E.coli DNA sequence 
("inverted repeats"; "hairpin structures") can be fortuitous, 
or binding sites for regulatory proteins, or involved in 
mRNA secondary structure and transcriptional termination.
Table 5*5 Speculative promoters in the DNA sequence
(a) BamHI-Clal (see Figure 5*9)
1. (51 )T T G G T A -15 bp----T T A A C T  - 6 bp - A
"-1 0 " identical to trp "-1 0 ".
2. (51 )C T G A A A -17 b p ----T A T C G T - 4 bp - G
”-1 0 " identical to trp R "-1 0 "; "-3 5 " identical to proposed 
"-3 5" for cloacin.
3 • (5 1 )T T G A G C - 20 b p --G A A A C T  - 6 bp - A
"—10" identical to mal EFG "-10"; "-3 5 " identical to proposed 
”-3 5 ” for rpsA.
(b) Clal-Hindlll (see Figure 5*10)
!• (51)T T G T C G ----- 20-bp---
T C G A A C ----- 17 b p ---C A C A A T - 7 bp - G
Closer "-3 5 " identical to E.coli deoPl and R100 RNA I "-35” ' 1 s.
2. (51 )T T G C C A ----- 21-b p ---G A G A A T  - 6 bp - A
T T  A A C T  15 b p ---
More distant "-3 5 " identical to proposed "-35” for purF.
NOTES: (i) Matches with consensus sequence are underlined.
(ii) The speculative promoters are numbered as in the 
figures.
(iii) No speculative promoters straddle the Clal site.
(iv) The significance of the identities given is 
doubtful - see text; for references see Hawley 
and McClure (1 9 8 3).
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A limited search was carried out for palindromic 
structures, as described in Chapter Two. (For convenience 
these structures will be discussed using the stem/loop 
nomenclature for hairpins without necessarily assuming 
that they ever take this form). Only those with central 
loop sizes ^ 3 and ^  10 bases would have been found by 
this search and, furthermore, only those where the symmetry 
related segments immediately flanking the central loop are 
^ k bp long. The larger structures found are shown in 
Figures 5*9 and 3*10 (and none straddle the Clal site).
In the BamHI-Clal sequence the first palindrome structure 
("I”) is rather extensive having a 3 base loop and a 17 base 
long stem containing 14 bp in k segments. It lies wholly 
within UPSORF 2 and its functional significance, if any, is 
unknown. It overlaps one of the better speculative promoters. 
Structure M2” will be described shortly in the section on 
ribosome binding sites. It may be of considerable functional 
importance.- There are two smaller structures (”3” and ,,4,,) 
which, like "1", happen to overlap one of the more plausible 
speculative promoters.
In the Clal-Hindlll sequence palindromic structure ,flft 
may be the transcriptional terminator for the aroE gene/operon 
and will be discussed in detail below. Two other smaller 
structures of doubtful significance are also marked.
5«9« 2B Transcriptional terminators in E. coli
There are two general classes of transcriptional 
termination signal in E.coli (Rosenberg and Court, 1979;
Holmes e^t al. , 1983)* Factor-independent terminators all 
have a relatively G/C rich inverted repeat followed by a 
run of T*s (in the sense strand). The second class, 
factor-dependent terminators, is rather diverse and few 
have been well characterised. Termination at these requires 
ancillary factors such as rho (or NusA). All contain 
palindromic structures, although the "hairpin” is often 
of doubtful stability, and some are associated with the 
sequence 3'*«» [caJ ATCAA...3’ in the sense strand.
5« 9» 2C Possible transcriptional terminators in the DNA sequence 
As mentioned above the palindromic structure labelled 
"1" in Figure 5*10 may be the transcriptional terminator for 
the aroE gene/operon. The loop size is 3 bases and the stem 
is 13 bases long, having 11 bp (3 G-C) and 2 G-A mismatches.
(it is associated with a compression in the DNA sequencing 
ladder for template 24-2). 14 bp beyond the end of the 
palindrome there is the sequence 3'•••ATCAA...3' (underlined 
in Figure 3»10) which is associated with some factor- 
dependent terminators. There are 66 bp between the aroE 
stop codon and the start of the stem. Although it is still 
impossible to recognise unambiguously a transcriptional 
terminator from sequence data alone, this structure is 
certainly a plausible candidate for a rho-dependent terminator.
It is worthy of note that 4 bases after the end of the 
stem is the sequence (in the sense strand) 5 ’•••CAAAAA...3'> 
followed 12 bases later by 3'•••GTAAAAAA...31• A putative 
terminator 43 bp after the stop codon of the aroD gene has 
the sequence 3'•••CTAAAAAA...3’ (in the sense strand) 
immediately following the 9 hp stem (Duncan, 1 9 8 3 )*
None of the other palindromic structures described 
resemble known terminators.
3»9« 3 Possible ribosome binding sites upstream from the 
large ORF's
5« 9« 3A Background
Shine and Dalgarno (1975) first noticed the imperfect 
complementarity between the 3* end of E.coli l6s rRNA 
and translational initiation regions. Their observation 
has proved to be generally valid (Stormo ejfc al., 1 9 8 2 ) and 
the term "Shine-Dalgarno” (S-D) sequence is now used for 
the region of a mRNA’s ribosome binding site which shows 
this complementarity. However, adjacent regions are not 
totally random.
The 3 ’ end of the l6S rRNA has the sequence:
3 ’AUUCCUCC...3’
which is complementary to:
3’•••UAAGGAGG...3'•
In the compilation of Stormo et_ al. (1 9 8 2) 8 3% of genes had 
at least either AGG or GGA or GAG 6-9 bases before the AUG,
although in one case there were 12 bases between the end-point 
of complementarity and the first base of the initiation codon. 
In addition to the S-D sequence there are often one or more 
stop codons in the ribosome binding site, at least in 
polycistronic mRNA*s, and sometimes (particularly in highly 
expressed proteins) all or part of the heptanucleotide 
PuPuUUUPuPu. The "spacer” between the S-D sequence and the 
initiation codon is often A/U rich.
5.9» 3B Results of sequence comparisons
There is a plausible S-D sequence upstream from the aroE
initiation codon. It is marked on Figure 5*10 and is shown
in detail below:
S-P
5 *...UGUUUCGACAGGGGUAACAUAAUG...3' (aroE) mRNA 
3* AUUCCUCC...5* 16S rRNA
There are four base-pairs including three contiguous base- 
pairs. A stop codon (that for UPSORF l) is underlined. The 
spacer region before the initiation codon (underlined twice) 
is A/T rich (6 out of 7)« Just upstream from the S-D sequence 
is:
5 ’•••UGUUUCG...31 (marked with a dashed line) 
which resembles the heptanucleotide mentioned above.
With UPSORF 1 the first three GTG*s and the first ATG 
will be considered as potential initiation codons. For each 
of the first and second GTG’s and the first ATG there is no 
significant complementarity (at least 3 contiguous bp with 
at least one G-C bp) within a reasonable distance (less than
13 bases). However, for the third GTG (the first initiation
codon after UPSORF 2) there is a possible S-D sequence:
S-D
5 1 . . . GGUUUC GGC GGAAUAAUAAC GUG. . . 3 * (UPSORF 1) mRNA 
AUUCCUCC.• • 5' l6S rRNA
There are three contiguous base-pairs, two of which are G-C; 
two stop codons (those at the end of UPSORF 2); an A/T rich 
spacer (7 out of 8); and the heptanucleotide 5 1•••GGUUUCG.••31 
two bases upstream of the three contiguous base-pairs (as 
for aroE).
For UPSORF 2 there is a poor region of complementarity 
beginning five bases upstream from the ATG initiation codon. 
However, the palindromic structure numbered ”2M in Figure 
5*9 may provide an excellent S-D sequence for UPSORF 2 by 
generating a hairpin in the mRNA. This possibility is 
illustrated in Figure 5*H* Six base-pairs can be drawn 
between the mRNA and the l6S rRNA. A similar hypothesis 
has been put forward previously in the case of the phage T4 
gene 3$ mRNA (Gold et^  al• , 1981). There are 23 bases between 
the gene 3& initiation codon and the first plausible S-D 
sequence but a hairpin in the mRNA is thought to reduce the 
separation to 3 bases. However, as here, no experimental 
tests have been done. It is not known, in general, whether 
the initiation complex could tolerate such a herniation, 
nor is it clear whether such unusual arrangements - if they 
exist - have some special import.
Figure 5*11 A hairpin in the mRNA may lead to a good S-D 
sequence for UPSORF 2.
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5» 9* ^  Conclusions
The discussion in Section 5*9 has been speculative to 
varying degrees, entirely so in the case of possible promoters. 
However, two potentially functional palindromic structures 
have been noted: the putative terminator after aroE (which 
resembles a possible terminator after aroD) and the hairpin 
structure in Figure The finding of almost equally
clear-cut S-D sequences for aroE and UPSORF 1 is reassuring 
(as is the existence of at least some provision for UPSORF 2) 
but the best evidence that UPSORF 1 might be a gene is still 
its biased codon utilisation.
In the next section consideration is given to experiments 
which might reveal whether there are indeed genes immediately 
upstream from aroE and, if so, whether they are part of an 
aroE operon.
5.10 Possibilities for future work on the putative aroE operon
5.10.1 Are there upstream genes and, if so, are they part of 
an aroE operon?
The basic question here is whether UPSORF1s 1 and 2 (and 
any others) are actually expressed as proteins. An answer 
could be obtained by analysis of the polypeptides produced 
by various aroE subclone plasmids when placed in an E.coli 
in vitro transcription/translation system (available commercially 
from Amersham). The most suitable subclone is pIA303 which 
carries only aroE, UPSORF 1, and UPSORF 2 on the Hindlll-BamHI 
fragment. pAT153 could be used as a control for plasmid
encoded functions. It would be sensible to test pIA307 
in such a system also, as well as pIA301. With the latter 
one would not expect to see any UPSORF 2 polypeptide, and 
reduced amounts of E3 and UPSORF 1 polypeptides.
The identification of any putative UPSORF polypeptides 
could be confirmed in various ways. Restriction site muta­
genesis at the Clal site, say, could be used to introduce a 
frameshift mutation in UPSORF 2 thus leading to a smaller 
product. Alternatively, suitable restriction fragments could 
be cloned in pKK223-3 and any overexpression of appropriately 
sized polypeptides detected by SDS PAGE of whole cell extracts. 
It would be important here not to discard the membrane fraction, 
most of which is spun out during the extraction procedure used 
for assays of E3 activity, in case the UPSORF gene products 
are associated with the cell membrane. Overexpressing constructs 
would be very useful for attempts at purifying the putative 
gene products (see below). A different approach would be to 
construct beta-galactosidase fusion proteins containing part 
or all of the UPSORF 1 or 2 sequences. This is relatively 
straightforward using the series of vectors developed by 
Ruther and Muller-Hill (1 9 8 3)* Such fusion proteins are 
often easily purified (by preparative SDS PAGE, for example) 
in a form suitable for the raising of antisera. The antisera 
can then be used as probes for Western blots of whole cell 
extracts of E.coli. As well as potentially providing further 
confirmation that UPSORF’s 1 and 2 are expressed, such anti­
sera could be exploited in other ways (see below).
If UPSORF’s 1 and 2 are translated then the next question 
is whether they are transcribed as part of a polycistronic 
mRNA with aroE. A tentative answer could be quickly obtained 
by Northern blot analysis (Thomas, 1980) of RNA isolated both 
from wild-type E.coli cells and from strains carrying particular 
aroE subclones. M13 clones containing known insert fragments 
could easily be used to construct radioactive hybridisation 
probes. Particular templates specific for the non-overlapping 
regions of aroE, UPSORF 1, and UPSORF 2 are available (e.g.
27-4 for aroE, 21-3 for UPSORF 1, and 19-8 for UPSORF 2). If
these three different classes of probe all detect a transcript 
of identical size then this is good evidence in favour of an 
operon rather than separate genes. It would then be necessary 
to confirm the operon model by mapping the location of 
transcriptional initiation and termination sites around aroE 
by SI analysis (Maniatis at al., 1 9 8 2).
§
At this stage one would probably wish to confirm the 
sequence of the Clal-BamHI region on both strands. It would 
also be interesting to extend the sequence upstream (with 
respect to aroE) from the BamHI site.
5.10.2 If UPSORF’s 1 and 2 are genes then how might their
functions be determined?
It may not prove easy'to determine the functions of the 
UPSORF 1 and 2 gene products. The option of raising antisera 
against the gene products by fusion protein techniques was 
mentioned above. The antibodies could be used as an assay 
for the purification to homogeneity of the gene products -
this would most sensibly be done after the construction of 
overproducing strains. N-terminal amino acid sequencing 
could be used to confirm that the purified proteins were 
encoded by UPSORF’s 1 and 2.
Should fusion protein techniques prove unsuccessful then 
an alternative approach to raising antibodies would be to 
synthesise oligopeptides, corresponding to segments of the 
deduced amino acid sequences, and to use these as immunogens. 
If it worked this approach would allow the construction of 
an antibody affinity column from which specifically bound 
protein could be gently eluted by means of the appropriate 
oligopeptide. Antisera, produced by whatever route, could 
also be used to study the cellular localisation of the gene 
products•
It is quite possible that the hypothetical gene products 
could be purified without any assay, given a high level of 
overexpression. The chromatographic behaviour of the desired 
polypeptide could be determined by comparing the elution 
profiles of crude extracts in the presence and absence of 
high level overexpression. This assumes there will be no 
adventitious obscuring peaks.
The purification to homogeneity of the UPSORF 2 gene 
product would permit the testing of several possibilities 
discussed earlier. For example, if UPSORF 2 encodes an iron- 
sulphur protein then, firstly, atomic absorption spectroscopy 
should reveal the presence of iron and, secondly, the protein 
should display the electron spin resonance signature 
characteristic of FeS proteins. One could also test the 
protein’s ability to bind iron.
Recently a powerful tool has been developed, analogous 
to some naturally occurring regulatory mechanisms, which is 
generally applicable to the problem of discovering a gene’s 
function. This is the technique of antisense RNA and it 
offers the hope of being able to switch off the in vivo 
expression of particular cloned genes at will (Pestka et. al.,
1984). A plasmid producing an antisense RNA specific for one 
of the UPSORF*s could be produced quite easily. It would be 
interesting to see whether the introduction of such a plasmid 
into an E.coli K12 host conferred any new growth requirements. 
The possibility of polarity effects must, however, be 
remembered (Pestka e_t al• , 1984).
It would be useful to know whether copy number over­
expression of the regions upstream from aroE in an E.coli 
tolM mutant host could confer near wild-type sensitivity to 
colicin M (see Section 5*8).
The deduced amino acid sequences of the UPSORF*s should 
be compared with all known amino acid sequences by computerised 
searching of a protein sequence database. Also, as mentioned 
in Section 5»6.2C, the preliminary analysis of the very weak 
similarities between UPSORF 2 and various known proteins must 
be placed on a much more rigorous and quantitative footing.
This also applies to any other faint similarities found by 
computer searches. A favoured method of rigorous analysis 
for faint homologies involves repeated scrambling (by computer) 
of the sequences to be compared and the construction of a
distribution curve for the number of random matches (Doolittle,
1981). One may then assess the statistical significance of 
the number of matches in the optimal alignment*of the real 
sequences. However, a penalty must be introduced for every 
gap inserted in aligning the two sequences: this is a
problematic area. An argument in favour of relatedness can 
be strengthened if a weak homology between two proteins is 
also found in a third distantly related protein.
5*11 Preliminary comparison of the E.coli shikimate
dehydrogenase sequence with that of other proteins
5 »11•1 N.crassa catabolic quinate/shikimate dehydrogenase
The N.crassa catabolic quinate/shikimate dehydrogenase -
the qa-3 gene product - was described in Section I.8 .5B.
This is the only protein with shikimate dehydrogenase activity,
other than E.coli E3, for which the amino acid sequence is
+known. However, E.coli E3 only works with NADP as cofactor 
whereas the qa-3 gene product prefers NAD+. A very preliminary 
comparison of the two amino acid sequences was carried out 
by dot matrix analysis using the "DOTPLOT" program from the 
WISGEN software package (Devereux ejfc al. , 1984; see Chapter 
Two). The initial results are shown in Figure ^ . 1 2 .  There 
is clearly no strong overall homology between the two 
sequences. However, there is a weak, broken, and displaced 
diagonal indicating some short stretches of possible homology. 
These short regions are compared in detail in Figure 5«13*
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At amino acid residue 65 in aroE and 99 in qa-3 there 
is possibly a conserved lysine residue (see Figure 5*13)•
This is of interest because it has been shown previously that 
the E3 activity of N.crassa arom is very susceptible to 
inhibition by two different chemical modification procedures 
both of which are directed at lysine residues (j. Lumsden 
and J.R. Coggins, unpublished results). Treatment either 
with methyl acetimidate or with formaldehyde plus sodium 
borohydride leads to rapid, pseudo-lst order inactivation of 
arom E3 and in both cases the presence of shikimate protects 
against loss of activity. It is not known whether the 
putative lysine residue implied by these results has an 
essential role in the active site or whether modification 
merely obstructs the active site or changes its conformation. 
It will be interesting to see whether the lysine "conserved" 
between aroE and qa-3 is also conserved in the sequence of 
the E3 region of yeast arom. Clearly a quantitative analysis 
of the relatedness of aroE and qa-3 must also be carried out: 
at present it is quite possible that the apparent homology 
is fortuitous.
5.11.2 Other dehydrogenases
No attempts have yet been made to compare the amino acid 
sequence of E.coli E3 with that of other NADP+-dependent 
dehydrogenases. However, a brief sketch of some relevant 
aspects of dehydrogenase structure is given below.
-f
Early work concentrated on four NAD -linked enzymes: 
lactate dehydrogenase (LDH), malate dehydrogenase (MDH), 
liver alcohol dehydrogenase (LADH), and glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH). The three-dimensional 
structures of these proteins were obtained by X-ray 
crystallography and protein sequencing (reviewed by Rossmann 
et al., 1975)* The finding that LDH and MDH were similar in 
overall structure was not too surprising. However, of great 
interest was the discovery that although the overall structures 
of GAPDH and LADH were quite different from those of LDH 
and MDH (and from each other) there was a striking similarity
■j*
in the conformation of the NAD binding domain in all four 
enzymes. (The conformation of the bound NAD+ is almost the 
same in each case.^ At the sequence level there are very few 
identical residues between LDH, GAPDH, and LADH (although 
there are significant homologies between different dehydrogenas 
with the same function). Sequence comparisons made prior to 
the determination of the structures gave confusing and often 
erroneous results. Only after alignment of the 3-D structures 
was it possible to detect a few important and invariant 
residues required for coenzyme binding (Rossmann et al.. 1975; 
Adams ejt al• , 1981; Rossmann} 1 9 8 3) • Detailed analysis of the 
structural homology between NAD+ binding domains suggests 
that they arose by divergence from a common ancestor.
Only more recently has attention turned to the structure 
of NADP+-dependent enzymes such as 6-phosphogluconate 
dehydrogenase (6PGDH), dihydrofolate reductase (DHFR), and
glutathione reductase (reviewed by Adams e_t al• , 1981;
Adams ejt al• , 1 9 8 3)* These are much more variable in
structure than the known NAD -dependent enzymes. The
structure of 6PGDH (from sheep liver) is almost entirely
lacking in beta-sheet which is in•immediate contrast with 
+ +other NADP - or NAD -linked dehydrogenases. The essence of 
an NAD binding domain is six strands of parallel beta-sheet 
with surrounding parallel alpha-helices. It was initially 
thought that the structures of NADP+-dependent enzymes might 
fall into several different functional classes e.g. those 
catalysing direct hydride transfer and those utilising both 
NADP+ and FAD as coenzymes. However, both DHFR and 6PGDH 
catalyse direct hydride transfer yet differ radically in 
structure, DHFR having six parallel strands of beta-sheet. 
Much more structural work is required on a variety of NADP+- 
linked enzymes if any patterns are to be detected. The 
potential availability of large quantities of E.coli E3, 
and the known amino acid sequence, make this NADP+-dependent 
enzyme a candidate worthy of consideration by X-ray 
crystallographers.
CHAPTER 6 GENERAL DISCUSSION AND FUTURE PROSPECTS
6.1 Sequence comparisons and the evolution of the arom
multifunctional enzyme
The main justification for the work described in this 
thesis is that it will eventually allow the comparison of 
the sequence of a multifunctional enzyme with the sequences 
of its monofunctional counterparts, and thus permit conclusions 
to be drawn about the mode of evolution of the multifunctional 
enzyme •
The work described here has contributed the amino acid 
sequence of E. coli shikimate dehydrogenase, one of the mono­
functional E. coli enzymes which correspond to the five activities 
of the N.crassa pentafunctional arom enzyme. The sequences of 
the other four E. coli enzymes have also been obtained in this 
laboratory (see Section 1.8). The AJR01 gene of S. cerevisiae, 
which almost certainly encodes a pentafunctional arom enzyme 
similar to that of N.crassa. is presently being sequenced in 
this laboratory (K. Duncan, personal communication; see 
Section 1.4.3C). This work is well advanced and it should 
be possible to make sequence comparisons very soon. As 
described in Chapter 1, the finding of homologies between a 
multifunctional enzyme and its monofunctional counterparts 
is good evidence that the multifunctional version arose by 
gene fusion. It will be interesting to see if the order of 
activities within the S.cerevisiae arom polypeptide is the
same as that found in the N.crassa arom polypeptide. Ultimately 
it should be feasible to extend the comparison to the relevant 
plant enzymes, in particular the bifunctional plant E2/E3 
enzyme (see below).
It is possible that one or more of the arom activities 
will have such slight homology to the appropriate E.coli enzyme 
that it is not possible to distinguish, from the sequence data 
alone, between chance similarity and common ancestry. If 
this should occur for E2 and/or E3 then assessment of the 
statistical significance of any weak homologies could be 
aided by comparison with the known qa-2 and qa-3 sequences 
(Doolittle, 198l). It would also be worth remembering that 
tertiary structure is often much more highly conserved than 
amino acid sequence in distantly related proteins (Doolittle, 
1981; Phillips _ej; al. , 1983)* The determination of protein 
structures by X-ray crystallography is still a major undertaking 
but one which has become steadily less laborious in recent 
years. The use of synchrotron sources and position-sensitive 
detectors has helped in this regard. Gene cloning has 
permitted the overexpression of many proteins not previously 
available in amounts sufficient for crystallisation, as was 
the case for the shikimate pathway enzymes. The determination 
of the arom structure would be a worthwhile exercise in its 
own right given the paucity of detailed structural information 
on multifunctional proteins.
The finding of homology between arom and its E.coli 
counterparts, each of the latter being an independent folding 
unit, would be consistent with the idea that each of the 
arom activities is located on a separate functional domain. 
However, it is possible that, as with some components of 
multienzyme complexes which do not function well in isolation, 
one or more arom domains might require some "quaternary" 
interactions for full activity.
Elucidation of the mode of evolution of the arom enzyme 
will leave open the question of whether there is any adaptive 
significance in this type of catalytic organisation. This 
area remains to be fully explored. The cloning of the 
relevant E.coli genes permits - if desired - the precise 
construction of artificial multifunctional enzymes (chimaeras)
6.2 Exploitation of the cloned aroE gene — present uses 
and future possibilities
The construction of pIA321, which greatly overproduces 
E. coli E3, was described in Chapter h • Strains containing 
this plasmid have been used in the laboratory of J.R. Knowles 
(personal communication) to provide a rich source of E3 for 
use (together with overproduced E2) as a coupling enzyme in 
continuous spectrophotometric assays of El.
Overproduced E.coli E3, purified to homogeneity by the 
author, has been used by M.S. Campbell and I.D. Hamilton 
(unpublished results) to raise polyclonal antisera in rabbits. 
Their preliminary experiments using Western blotting technique
suggest that the antisera may recognise a band in E.coli 
K12 extracts, subjected to SDS PAGE, whose mobility is the 
same as a band of much greater intensity recognised in crude 
extracts of pIA32l//AB283^-* These bands have the same 
mobility as pure overproduced E.coli E3 which also appears 
to be recognised by the antisera. These antisera against 
E. coli E3 were made in the hope that they might cross-react 
(if only very slightly) with the plant E2/E3 enzyme and thus 
provide a route to cloning the gene for this bifunctional 
plant protein. It was also hoped that the availability of 
large amounts of overproduced E3 might permit the use of 
an ”E.coli E3-Sepharose” column for the isolation of low 
affinity antibodies from a cross-reacting antiserum. These 
low affinity antibodies could then in turn be used to make 
an affinity column for the purification of the low abundance 
plant enzyme. Work on the antisera is still in progress 
but unfortunately initial results suggest that they do not 
cross-react significantly with the plant enzyme (M.S. Campbell 
and I.D. Hamilton, unpublished results).
It is conceivable that antisera against different E.coli 
shikimate pathway enzymes could be used to hunt for labile 
multi enzyme complexes containing two or more of these enzymes. 
Antibodies against different enzymes could be bound to different 
size classes of colloidal gold particles for use in immuno- 
electron microscopy of sections of E.coli cells. This 
approach would rely on "coincidence counting” - detection 
of a higher than expected frequency of particles of different 
sizes occurring next to each other.
There is a second way in which the aroE gene (and 
other cloned E.coli shikimate pathway genes) could be used 
in an effort to clone the analogous plant gene. The aroE 
gene could be used as a heterologous hybridisation probe, 
at very low stringency, to screen a plant cDNA or genomic 
library. Xf regions of homology are found between aroE 
and yeast AR01 then one could also try using as a probe a 
mixture of synthetic oligonucleotides made against the 
region most conserved between yeast and bacteria in the 
hope that this segment is also conserved in plants.
As described in Section there is evidence from
chemical modification studies for a lysine residue in or 
near the active site of N.crassa arom E3« If such a residue 
is also present in E.coli E3 then additional evidence of 
its importance (or not) could be obtained using the technique 
of site-directed mutagenesis (Winter ^t al•, 1 9 8 2).
6 .3  Cloning of E.coli shikimate pathway genes
Almost all E. coli sliikimate pathway genes have now been 
cloned. Only the gene for the shikimate kinase I isozyme 
and the mysterious arol remain unaccounted for. The latter 
should be clonable by relief of auxotrophy. The discovery 
that aroA is part of a mixed operon, and the possibility 
that aroE might also be part of an operon, emphasises the 
need to examine the other E.coli shikimate pathway genes 
for similar associations. The possibilities for future work 
on the putative aroE operon have already been discussed.
In this study the next known region of B. coli DNA 
sequence lies about 9 kbp upstream from aroE (Meek and 
Hayward, 1984; D.W. Meek, personal communication). It is 
perhaps time for a database to be set up with the purpose 
of collecting and ordering all E.coli DNA sequence data.
This would allow workers to send in pieces of sequence which 
might never otherwise be published. Such a centre could 
also notify independent groups that only a tiny segment 
remains unsequenced between their respective "territories”. 
Information could also be held on restriction maps of clones 
thus permitting the gradual assembly of a physical map of 
regions of the E.coli genome. The discovery, ”post-lac operon 
of attenuation, antisense RNA, and mixed operons suggests 
that the E.coli genome may still contain many surprises.
This is not a "simple” organism.
6.4 Renaturation of E3 activity after SDS PAGE
If generally applicable this technique could be used 
as a rapid screening method for the detection of large 
subunit m.w. forms of E3 after SDS PAGE of crude cell extracts 
Such high m.w. forms would be rather suggestive of multi­
functional proteins. Preliminary experiments with partially 
purified E2/E3 from peas were unsuccessful (M.S. Campbell, 
unpublished results). Obvious candidate species for further 
trials are S.cerevisiae. S.pombe. and Buglena gracilis.
It would also be tempting to extend the phylogenetic range 
to Archaebacteria, since this third major class of organisms 
has not yet been looked at.
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